Devices, systems and methods useable for treating sinusitis

Description

FIELD OF THE INVENTION

The present invention relates generally to medical devices and methods and more particularly to minimally invasive, devices, systems and methods for treating sinusitis and other ear, nose & throat disorders.

BACKGROUND

The nose is responsible for warming, humidifying and filtering inspired air and for conserving heat and moisture from expired air. The nose is formed mainly of cartilage, bone, mucous membranes and skin.

The bones in the nose contain a series of cavities known as paranasal sinuses that are connected by passageways. The paranasal sinuses include frontal sinuses, ethmoid sinuses, sphenoid sinuses and maxillary sinuses. The paranasal sinuses are lined with mucous-producing epithelial tissue and ultimately opening into the nasal cavity. Normally, mucous produced by the epithelial tissue slowly drains out of each sinus through an opening known as an ostium. If the epithelial tissue of one of these passageways becomes inflamed for any reason, the cavities which drain through that passageway can become blocked. This blockage can be periodic (resulting in episodes of pain) or chronic. This interference with drainage of mucous (e.g., occlusion of a sinus ostium) can result in mucosal congestion within the paranasal sinuses. Chronic mucosal congestion of the sinuses can cause damage to the epithelium that lines the sinus with subsequent decreased oxygen tension and microbial growth (e.g., a sinus infection).

Sinusitis:

The term “sinusitis” refers generally to any inflammation or infection of the paranasal sinuses caused by bacteria, viruses, fungi (molds), allergies or combinations thereof. It has been estimated that chronic sinusitis (e.g., lasting more than 3 months or so) results in 18 million to 22 million physician office visits per year in the United States.

Patients who suffer from sinusitis typically experience at least some of the following symptoms:

- headaches or facial pain
- nasal congestion or post-nasal drainage
- difficulty breathing through one or both nostrils
- bad breath
- pain in the upper teeth
  
  Thus, one of the ways to treat sinusitis is by restoring the lost mucous flow. The initial therapy is drug therapy using anti-inflammatory agents to reduce the inflammation and antibiotics to treat the infection. A large number of patients do not respond to drug therapy. Currently, the gold standard for patients with chronic sinusitis that do not respond to drug therapy is a corrective surgery called Functional Endoscopic Sinus Surgery.
  
  Current and Proposed Procedures for Sinus Treatment:

Functional Endoscopic Sinus Surgery

In FESS, an endoscope is inserted into the nose and, under visualization through the endoscope, the surgeon may remove diseased or hypertrophic tissue or bone and may enlarge the ostia of the sinuses to restore normal drainage of the sinuses. FESS procedures are typically performed with the patient under general anesthesia.

Although FESS continues to be the gold standard therapy for surgical treatment of severe sinus disease, FESS does have several shortcomings. For example, FESS can cause significant post-operative pain. Also, some FESS procedures are associated with significant postoperative bleeding and, as a result, nasal packing is frequently placed in the patient's nose for some period of time following the surgery. Such nasal packing can be uncomfortable and can interfere with normal breathing, eating, drinking etc. Also, some patients remain symptomatic even after multiple FESS surgeries. Additionally, some FESS procedures are associated with risks of iatrogenic orbital, intracranial and sinonasal injury. Many otolaryngologists consider FESS an option only for patients who suffer from severe sinus disease (e.g., those showing significant abnormalities under CT scan). Thus, patients with less severe disease may not be considered candidates for FESS and may be left with no option but drug therapy. One of the reasons why FESS procedures can be bloody and painful relates to the fact that instruments having straight, rigid shafts are used. In order to target deep areas of the anatomy with such straight rigid instrumentation, the physician needs to resect and remove or otherwise manipulate any anatomical structures that may lie in the direct path of the instruments, regardless of whether those anatomical structures are part of the pathology.

Balloon Dilation Based Sinus Treatment

Methods and devices for sinus intervention using dilating balloons have been disclosed in U.S. Pat. No. 2,525,183 (Robison) and United States Patent Publication No. 2004/0064150 A1 (Becker), issued as U.S. Pat. No. 8,317,816 on Nov. 27, 2012. For example, U.S. Pat. No. 2,525,183 (Robison) discloses an inflatable pressure device which can be inserted following sinus surgery and inflated within the sinus. The patent does not disclose device designs and methods for flexibly navigating through the complex nasal anatomy to access the natural ostia of the sinuses. The discussion of balloon materials is also fairly limited to thin flexible materials like rubber which are most likely to be inadequate for dilating the bony ostia of the sinus.

United States patent publication number 2004/0064150 A1 (Becker), issued as U.S. Pat. No. 8,317,816 on Nov. 27, 2012, discloses balloon catheters formed of a stiff hypotube to be pushed into a sinus. The balloon catheters have a stiff hypotube with a fixed pre-set angle that enables them to be pushed into the sinus. In at least some procedures wherein it is desired to position the balloon catheter in the ostium of a paranasal sinus, it is necessary to advance the balloon catheter through complicated or tortuous anatomy in order to properly position the balloon catheter within the desired sinus ostium. Also, there is a degree of individual variation in the intranasal and paranasal anatomy of human beings, thus making it difficult to design a stiff-shaft balloon catheter that is optimally shaped for use in all individuals. Indeed, rigid catheters formed of hypotubes that have pre-set angles cannot be easily adjusted by the physician to different shapes to account for individual variations in the anatomy. In view of this, the Becker patent application describes the necessity of having available a set of balloon catheters, each having a particular fixed angle so that the physician can select the appropriate catheter for the patient's anatomy. The requirement to test multiple disposable catheters for fit is likely to be very expensive and impractical. Moreover, if such catheter are disposable items (e.g., not sterilizable and reusable) the need to test and discard a number of catheters before finding one that has the ideal bend angle could be rather expensive.

Thus, although the prior art discloses the use of dilating balloons for sinus treatments, it does not disclose the various means for navigation through the complex anatomy without significant manipulation of non-pathogenic anatomical regions that obstruct direct access to the sinus openings. Further, the prior art only discloses balloons of relatively simple shapes or materials for dilating sinus openings. Further, this art does not sufficiently elaborate beyond endoscopy on other means for imaging or tracking the position of such devices within the sinus anatomy.

Thus, there is a need for new devices and methods for easily navigating the complex anatomy of the nasal cavities and paranasal sinuses and for treating disorders of the paranasal sinuses with minimal complications due to individual variations in anatomy and causing minimal trauma to or disruption of anatomical structures that are not pathogenic.

SUMMARY OF THE INVENTION

In general, the present invention provides methods, devices and systems for diagnosing and/or treating sinusitis or other conditions of the ear, nose or throat.

In accordance with the present invention, there are provided methods wherein one or more flexible or rigid elongate devices as described herein are inserted in to the nose, nasopharynx, paranasal sinus, middle ear or associated anatomical passageways to perform an interventional or surgical procedure. Examples of procedures that may be performed using these flexible catheters or other flexible elongate devices include but are not limited to remodeling or changing the shape, size or configuration of a sinus ostium or other anatomical structure that affects drainage from one or more paranasal sinuses; cutting, ablating, debulking, cauterizing, heating, freezing, lasing, forming an osteotomy or trephination in or otherwise modifying bony or cartilaginous tissue within paranasal sinus or elsewhere within the nose; removing puss or aberrant matter from the paranasal sinus or elsewhere within the nose; scraping or otherwise removing cells that line the interior of a paranasal sinus; delivering contrast medium; delivering a therapeutically effective amount of a therapeutic substance; implanting a stent, tissue remodeling device, substance delivery implant or other therapeutic apparatus; cutting, ablating, debulking, cauterizing, heating, freezing, lasing, dilating or otherwise modifying tissue such as nasal polyps, aberrant or enlarged tissue, abnormal tissue, etc.; grafting or implanting cells or tissue; reducing, setting, screwing, applying adhesive to, affixing, decompressing or otherwise treating a fracture; delivering a gene or gene therapy preparation; removing all or a portion of a tumor; removing a polyp; delivering histamine, an allergen or another substance that causes secretion of mucous by tissues within a paranasal sinus to permit assessment of drainage from the sinus; implanting a cochlear implant or indwelling hearing aid or amplification device, etc.

Still further in accordance with the invention, there are provided devices and systems for performing some or all of the procedures described herein. Introducing devices may be used to facilitate insertion of working devices (e.g. catheters e.g. balloon catheters, tissue cutting or remodeling devices, guidewires, devices for implanting elements like stents, electrosurgical devices, energy emitting devices, devices for delivering diagnostic or therapeutic agents, substance delivery implants, scopes etc) into the paranasal sinuses and other structures in the ear, nose or throat.

Still further in accordance with the invention, there are provided apparatus and methods for navigation and imaging of the interventional devices within the sinuses using endoscopic including stereo endoscopic, fluoroscopic, ultrasonic, radiofrequency localization, electromagnetic, magnetic and other radiative energy based modalities. These imaging and navigation technologies may also be referenced by computer directly or indirectly to pre-existing or simultaneously created 3-D or 2-D data sets which help the doctor place the devices within the appropriate region of the anatomy.

Still further in accordance with the invention, there are provided tubular guides, guidewires, balloon catheters, tubular sheaths and related methods for using such devices individually or in various combinations to dilate openings of paranasal sinuses (e.g., any transnasally accessible opening in a paranasal sinus or cranio-facial air cell, including but not limited to; natural ostia, surgically or medically altered ostia, surgically created or man made openings, antrostomy openings, ostiotomy openings, trephination openings, burr holes, drilled holes, ethmoidectomy openings, anatomical passageways, natural or man made passages, etc.) or other anatomical structures such as structures within the head or a human or animal subject that comprise bone covered at least in part by mucosal tissue.

Still further in accordance with the invention, there are provided specific methods and modes of construction for tubular guides, guidewires, balloon catheters, tubular sheaths.

Still further in accordance with the invention, there are provided methods for accessing (e.g., advancing a catheter, guide or other device to) openings of paranasal sinuses (e.g., any transnasally accessible opening in a paranasal sinus or cranio-facial air cell, including but not limited to; natural ostia, surgically or medically altered ostia, surgically created or man made openings, antrostomy openings, ostiotomy openings, trephination openings, burr holes, drilled holes, ethmoidectomy openings, anatomical passageways, natural or man made passages, etc.) or other anatomical structures within the body of a human or animal subject even though such openings or structures may be fully or partially hidden from direct or endoscopic view.

Further aspects, details and embodiments of the present invention will be understood by those of skill in the art upon reading the following detailed description of the invention and the accompanying drawings.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 shows a schematic diagram of a system for catheter-based minimally invasive sinus surgery of the present invention being used to perform a sinus surgery procedure on a human patient.

FIG. 1A is an enlarged view of portion “1A” of FIG. 1.

FIGS. 2A through 2D are partial sagittal sectional views through a human head showing various steps of a method for gaining access to a paranasal sinus using a guide and thereafter dilating or remodeling the ostial opening into the paranasal sinus.

FIGS. 2E through 2H are partial sagittal sectional views through a human head showing various steps of a method for gaining access to a paranasal sinus using a steerable guide and thereafter.

FIGS. 2M through 2O are partial sagittal sectional views through a human head showing various steps of a method for gaining access to a paranasal sinus using a balloon catheter that has a guide protruding from its distal end.

FIGS. 2P through 2X are partial sagittal sectional views through a human head showing various steps of a method of accessing an ethmoid sinus through a natural or artificially created opening of the ethmoid sinus.

FIGS. 2Y through 2AC are partial coronal sectional views through a human head showing various steps of a method for treating a mucocele in a frontal sinus.

FIG. 4A shows a partial longitudinal sectional view of a system for dilating a sinus ostium or other intranasal anatomical structure, such system comprising three progressively larger dilators useable in sequence.

FIGS. 4B through 4E show various steps of a method of dilating a nasal cavity using a working device comprising a balloon catheter with a pressure-expandable stent.

FIG. 4F shows a partial perspective view of a working device that comprises a side suction and/or side cutter.

FIG. 4G shows a partial perspective view of a working device that comprises a rotating cutter to cut away tissue.

FIGS. 4H and 4I show various steps of a method of dilating the ostium of a paranasal sinus or other nasal passageway using a mechanical dilator.

FIGS. 4J and 4K show perspective views of a mechanical dilator comprising a screw mechanism.

FIGS. 4L and 4M show sectional views of a mechanical dilator that comprises a pushable member.

FIGS. 4N and 4O show sectional views of a mechanical dilator that comprises a pullable member.

FIGS. 4P and 4Q show sectional views of a mechanical dilator that comprises a hinged member.

FIGS. 4R through 4W′ are schematic diagrams of alternative configurations for the distal portions of mechanical dilators of the types shown in FIGS. 4H through 4O.

FIG. 5A shows a perspective view of a balloon that comprises a conical proximal portion, a conical distal portion and a cylindrical portion between the conical proximal portion and the conical distal portion.

FIG. 5B shows a perspective view of a conical balloon.

FIG. 5C shows a perspective view of a spherical balloon.

FIG. 5D shows a perspective view of a conical/square long balloon.

FIG. 5E shows a perspective view of a long spherical balloon.

FIG. 5F shows a perspective view of a bi-lobed “dog bone” balloon.

FIG. 5G shows a perspective view of an offset balloon.

FIG. 5H shows a perspective view of a square balloon.

FIG. 5I shows a perspective view of a conical/square balloon.

FIG. 5J shows a perspective view of a conical/spherical long balloon.

FIG. 5K shows a perspective view of an embodiment of a tapered balloon.

FIG. 5L shows a perspective view of a stepped balloon.

FIG. 5M shows a perspective view of a conical/offset balloon.

FIG. 5N shows a perspective view of a curved balloon.

FIG. 5O shows a partial perspective view of a balloon catheter device comprising a balloon for delivering diagnostic or therapeutic substances.

FIG. 5P shows a partial perspective view of a balloon/cutter catheter device comprising a balloon with one or more cutter blades.

FIG. 5Q shows a perspective view of a balloon catheter device comprising a balloon with a reinforcing braid attached on the external surface of the balloon.

FIG. 5R shows a partial sectional view of a balloon catheter wherein inflation ports are located near the distal end of the balloon.

FIG. 5S shows a partial sectional view of an embodiment of a balloon catheter comprising multiple balloons inflated by a single lumen.

FIG. 5T shows a partial sectional view of a balloon catheter comprising multiple balloons inflated by multiple lumens.

FIGS. 5U through 5AB show perspective and sectional views of various embodiments of balloon catheters having sensors mounted thereon or therein.

FIG. 6A shows a partial perspective view of a shaft design useable in the various devices disclosed herein, wherein the shaft comprises an external spiral wire.

FIG. 6B shows a partial perspective view of a shaft design for the various devices disclosed herein, wherein the shaft comprises a stiffening wire.

FIG. 6C shows a partial perspective view of an embodiment of a shaft design for the various devices disclosed herein, wherein the shaft comprises stiffening rings.

FIG. 6D shows a partial perspective view of a shaft design for the various devices disclosed herein, wherein the shaft comprises controllable stiffening elements.

FIG. 6E shows a partial perspective view of a shaft design for the various devices disclosed herein, wherein the shaft comprises a hypotube.

FIG. 6F shows a partial perspective cut-away view of a shaft design for the various devices disclosed herein, wherein the shaft comprises a braid.

FIG. 6F′ is an enlarged side view of the braid of the device of FIG. 6F.

FIG. 6G shows a partial perspective view of an embodiment of a device comprising a shaft having a plastically deformable region.

FIG. 6H shows a partial perspective view of a device comprising a shaft having a flexible element.

FIG. 6I shows a partial perspective view of a shaft comprising a malleable element.

FIG. 6J shows a partial perspective view of the shaft of FIG. 6I in a bent configuration.

FIG. 6K shows a cross sectional view through plane 6K-6K of FIG. 6I.

FIG. 6L shows a partial sectional view of an embodiment of a controllably deformable shaft.

FIG. 6M shows a partial sectional view of the controllably deformable shaft of FIG. 6L in a deformed state.

FIG. 6N shows a perspective view of a balloon catheter comprising a rigid or semi-rigid member.

FIGS. 6O through 6Q show sectional views of a balloon catheter that comprises an insertable and removable element.

FIG. 7A shows a cross sectional view through a balloon catheter shaft comprising two cylindrical lumens.

FIG. 7B shows a cross sectional view through a balloon catheter shaft comprising an inner lumen and an annular outer lumen disposed about the inner lumen.

FIG. 7C shows a cross sectional view through a balloon catheter shaft which comprises a first tubular element with a first lumen, a second tubular element with a second lumen and a jacket surrounding the first and second tubular elements.

FIG. 7D shows a cross sectional view through a balloon catheter shaft comprising three lumens.

FIG. 7E shows a cross sectional view through a balloon catheter shaft comprising a cylindrical element, a tubular element that has a lumen and a jacket surrounding the cylindrical element and the tubular element.

FIG. 7F shows a cross sectional view of through a balloon catheter shaft comprising an embedded braid.

FIG. 7G shows a partial perspective view of a catheter shaft comprising a zipper lumen with a guide extending through a portion of the zipper lumen.

FIG. 7H shows a cross sectional view through line 7H-7H of FIG. 7G.

FIG. 7I shows is a partial longitudinal sectional view of a catheter shaft comprising a rapid exchange lumen with a guide extending through the rapid exchange lumen.

FIG. 7J shows a cross sectional view of the catheter shaft of FIG. 7I through line 7J-7J.

FIG. 7K shows a cross sectional view of the catheter shaft of FIG. 7I through line 7K-7K.

FIG. 7L is a partial perspective view of a balloon catheter device of the present invention comprising a through-lumen and a balloon inflation lumen within the shaft of the catheter.

FIG. 7M is a cross sectional view through line 7M-7M of FIG. 7L.

FIG. 7N is a cross sectional view through line 7N-7N of FIG. 7L.

FIG. 7O is a partial perspective view of another balloon catheter device of the present invention comprising a through lumen within the shaft of the catheter and a balloon inflation tube disposed next to and optionally attached to the catheter shaft.

FIG. 7P is a cross sectional view through line 7P-7P of FIG. 7O.

FIG. 7Q is a cross sectional view through line 7Q-7Q of FIG. 7O.

FIG. 8A shows a partial perspective view of a catheter shaft comprising distance markers.

FIG. 8B shows a partial perspective view of a catheter shaft comprising one type of radiopaque markers.

FIG. 8C shows a partial perspective view of a catheter shaft comprising another type of radiopaque markers.

FIG. 8D shows a partial perspective view of a balloon catheter comprising an array of radiopaque markers arranged on the outer surface of the balloon.

FIG. 8E shows a partial perspective view of a balloon catheter comprising an array of radiopaque markers arranged on an inner surface of the balloon.

FIG. 8E′ is a longitudinal sectional view of FIG. 8E.

FIG. 9A is a side view of a tubular guide device of the present invention.

FIG. 9B is a side view of a guidewire of the present invention.

FIG. 9C is a side view of a tubular sheath of the present invention.

FIG. 9D is a side view of a balloon catheter of the present invention.

FIG. 10A is a side view of a tubular guide device of the present invention having a straight distal portion.

FIG. 10B is a side view of a tubular guide device of the present invention having a 30 degree curve in its distal portion.

FIG. 10B′ is an enlarged view of the distal end of the tubular guide device of FIG. 10B.

FIG. 10C is a side view of a tubular guide device of the present invention having a 70 degree curve in its distal portion.

FIG. 10C′ is an enlarged view of the distal end of the tubular guide device of FIG. 10C.

FIG. 10D is a side view of a tubular guide device of the present invention having a 90 degree curve in its distal portion.

FIG. 10D′ is an enlarged view of the distal end of the tubular guide device of FIG. 10D.

FIG. 10E is a side view of a tubular guide device of the present invention having a 110 degree curve in its distal portion.

FIG. 10E′ is an enlarged view of the distal end of the tubular guide device of FIG. 10E.

FIG. 10F is a sectional view of the distal end of an embodiment of a tubular guide device of the present invention.

FIG. 10G is a sectional view of the distal end of another embodiment of a tubular guide device of the present invention.

FIG. 11 is a perspective view of a tubular guide device of the present invention.

FIG. 11A is a cross sectional view through line 11A-11A of FIG. 11.

FIG. 11B is a cross sectional view through line 11B-11B of FIG. 11.

FIG. 11C is a cross sectional view through line 11C-11C of FIG. 11.

FIG. 11C′ shows an enlarged view of region 11C′ in FIG. 11C

FIG. 12 is a longitudinal sectional view of a guidewire device of the present invention.

FIG. 13 A is a perspective view of an embodiment of a tubular sheath of the present invention,

FIG. 13B is a perspective view of another embodiment of a tubular sheath of the present invention.

FIG. 14 is a side view of a balloon catheter device of the present invention.

FIG. 14A is a cross sectional view through line 14A-14A of FIG. 14.

FIG. 14B is a cross sectional view through line 14B-14B of FIG. 14.

FIG. 14C is an enlarged view of segment 14C of FIG. 14.

FIG. 14D is an enlarged view of segment 14D of FIG. 14.

FIG. 14E is a cross sectional view of the balloon in FIG. 14C, taken along line 14E-14E of FIG. 14C.

DETAILED DESCRIPTION

The following detailed description, the accompanying drawings and the above-set-forth Brief Description of the Drawings are intended to describe some, but not necessarily all, examples or embodiments of the invention. The contents of this detailed description do not limit the scope of the invention in any way.

A number of the drawings in this patent application show anatomical structures of the ear, nose and throat. In general, these anatomical structures are labeled with the following reference letters:

- Nasal Cavity NC
- Nasopharynx NP
- Frontal Sinus FS
- Ethmoid Sinus ES
- Ethmoid Air Cells EAC
- Sphenoid Sinus SS
- Sphenoid Sinus Ostium SSO
- Maxillary Sinus MS
- Mucocele MC

FIGS. 1 and 1A provide a general showing of a minimally invasive surgery system of the present invention comprising a C-arm fluoroscope 1000 that is useable to visualize a first introducing device 1002 (e.g., a guide catheter or guide tube), a second introducing device 1004 (e.g., a guidewire or elongate probe) and a working device 1006 (e.g., a balloon catheter, other dilation catheter, debrider, cutter, etc.). FIGS. 2A-8E′ show certain non-limiting examples of the introducing devices 1002 (e.g., a guide catheter or guide tube), 1004 (guides, guidewires, elongate probes, etc.) and working devices 1006 (e.g., a balloon catheters, other dilation catheters, debrider, cutters, etc.) that may be useable in accordance with this invention. The devices 1002, 1004, 1006 may be radiopaque and/or may incorporate radiopaque markers such that C-arm fluoroscope 1000 may be used to image and monitor the positioning of the devices 1002, 1004, 1006 during the procedure. In addition to or, as an alternative to the use of radiographic imaging, the devices 1002, 1004, 1006 may incorporate and/or may be used in conjunction with one or more endoscopic devices, such as the typical rigid or flexible endoscopes or stereo endoscopes used by otolaryngologists during FESS procedures. Also, in addition to or as an alternative to radiographic imaging and/or endoscopic visualizations, some embodiments of the devices 1002, 1004, 1006 may incorporate sensors which enable the devices 1002, 1004, 1006 to be used in conjunction with image guided surgery systems or other electro-anatomical mapping/guidance systems including but not limited to: VectorVision (BrainLAB AG); HipNav (CASurgica); CBYON Suite (CBYON); InstaTrak, FluoroTrak, ENTrak (GE Medical); StealthStation Treon, iOn (Medtronic); Medivision; Navitrack (Orthosoft); OTS (Radionics); VISLAN (Siemens); Stryker Navigation System (Stryker Leibinger); Voyager, Z-Box (Z-Kat Inc.) and NOGA and CARTO systems (Johnson & Johnson). Commercially available interventional navigation systems can also be used in conjunction with the devices and methods. Further non-fluoroscopic interventional imaging technologies including but not limited to: OrthoPilot (B. Braun Aesculap); PoleStar (Odin Medical Technologies; marketed by Medtronic); SonoDoppler, SonoWand (MISON); CT Guide, US Guide (UltraGuide) etc. may also be used in conjunction with the devices and methods. Guidance under magnetic resonance is also feasible if the catheter is modified to interact with the system appropriately.

It is to be appreciated that the devices and methods of the present invention relate to the accessing and dilation or modification of sinus ostia or other passageways within the ear nose and throat. These devices and methods may be used alone or may be used in conjunction with other surgical or non-surgical treatments, including but not limited to the delivery or implantation of devices and drugs or other substances as described in copending U.S. patent application Ser. No. 10/912,578 entitled Implantable Devices and Methods for Delivering Drugs and Other Substances to Treat Sinusitis and Other Disorders filed on Aug. 4, 2004, issued as U.S. Pat. No. 7,361,168 on Apr. 22, 2008, the entire disclosure of which is expressly incorporated herein by reference.

FIGS. 2A through 2D are partial sagittal sectional views through a human head showing various steps of a method of gaining access to a paranasal sinus using a guide catheter. In FIG. 2A, a first introducing device in the form of a guide catheter 200 is introduced through a nostril and through a nasal cavity NC to a location close to an ostium SSO of a sphenoid sinus SS. The guide catheter 200 may be flexible. Flexible devices are defined as devices with a flexural stiffness less than about 200 pound-force per inch over a device length of one inch. The guide catheter 200 may be straight or it may incorporate one or more preformed curves or bends. In embodiments where the guide catheter 200 is curved or bent, the deflection angle of the curve or bend may be in the range of up to 135°. Examples of specific deflection angles formed by the curved or bent regions of the guide catheter 200 are 0°, 30°, 45°, 60°, 70°, 90°, 120° and 135°. Guide catheter 200 can be constructed from suitable elements like Pebax, Polyimide, Braided Polyimide, Polyurethane, Nylon, PVC, Hytrel, HDPE, PEEK, metals like stainless steel and fluoropolymers like PTFE, PFA, FEP and EPTFE. Guide catheter 200 can have a variety of surface coatings e.g. hydrophilic lubricious coatings, hydrophobic lubricious coatings, abrasion resisting coatings, puncture resisting coatings, electrically or thermal conductive coatings, radiopaque coatings, echogenic coatings, thrombogenicity reducing coatings and coatings that release drugs. In FIG. 2B, a second introduction device comprising a guidewire 202 is introduced through the first introduction device (i.e., the guide catheter 200) so that the guidewire 202 enters the sphenoid sinus SS through the ostium SSO. Guidewire 202 may be constructed and coated as is common in the art of cardiology. In FIG. 2C, a working device 204 for example a balloon catheter is introduced over guidewire 202 into the sphenoid sinus SS.

Thereafter, in FIG. 2D, the working device 204 is used to perform a diagnostic or therapeutic procedure. In this particular example, the procedure is dilation of the sphenoid sinus ostium SSO, as is evident from FIG. 2D. However, it will be appreciated that the present invention may also be used to dilate or modify any sinus ostium or other man-made or naturally occurring anatomical opening or passageway within the nose, paranasal sinuses, nasopharynx or adjacent areas. After the completion of the procedure, guide catheter 200, guidewire 202 and working device 204 are withdrawn and removed. As will be appreciated by those of skill in the art, in this or any of the procedures described in this patent application, the operator may additionally advance other types of catheters or of the present invention, a guidewire 202 may be steerable (e.g. torquable, actively deformable) or shapeable or malleable. Guidewire 202 may comprise an embedded endoscope or other navigation or imaging modalities including but not limited to fluoroscopic, X-ray radiographic, ultrasonic, radiofrequency localization, electromagnetic, magnetic, robotic and other radiative energy based modalities. In this regard, some of the figures show optional scopes SC is dotted lines. It is to be appreciated that such optional scopes SC may comprise any suitable types of rigid or flexible endoscopes and such optional scopes SC may be separate from or incorporated into the working devices and/or introduction devices of the present invention.

FIGS. 2E through 2H are partial sagittal sectional views through a human head showing various steps of a method of gaining access to a paranasal sinus using a steerable catheter. In FIG. 2E, an introducing device in the form of a steerable catheter 206 is introduced through a nostril. Although commercially available devices are neither designed, nor easily usable for this technique in the sinuses, examples of a device which has a steerable tip with functionality similar to that described here include but are not limited to the Naviport™ manufactured by Cardima, Inc. in Fremont, Calif.; Attain Prevail and Attain Deflectable catheters manufactured by Medtronic; Livewire Steerable Catheters manufactured by St. Jude Medical Inc.; Inquiry™ Steerable Diagnostic Catheters manufactured by Boston Scientific; TargetCath™ manufactured by EBI; Safe-Steer Catheter manufactured by Intraluminal Therapeutics, Inc.; Cynosar manufactured by Catheter Research, Inc.; Torque Control Balloon Catheter manufactured by Cordis Corp. and DynamicDeca Steerable Catheter and Dynamic XT Steerable Catheter manufactured by A.M.I. Technologies Ltd, Israel. Steerable catheter 206 comprises a proximal portion, a distal portion and a controllably deformable region between the proximal portion and the distal portion. In FIG. 2F, the steerable catheter 206 is steered through the nasal anatomy so that the distal portion of steerable catheter 206 is near an ostium SSO of a sphenoid sinus SS. In FIG. 2G, a working device in the form of a balloon catheter 208 is introduced through steerable catheter 206 so that it enters sphenoid sinus SS through the ostium SSO. Thereafter, balloon catheter 208 is adjusted so that the balloon of the balloon catheter is located in the ostium SSO. In FIG. 2H, balloon catheter 208 is used to dilate the ostium SSO. After completion of the procedure, steerable catheter 206 and balloon catheter 208 are withdrawn from the nasal anatomy. In this example, only a first introduction device in the form of a steerable catheter 206 is used to effect insertion and operative positioning of the working device (which in this example is balloon catheter 208). It will be appreciated, however, in some procedures, a second introduction device (e.g., an elongate guide member, guidewire, elongate probe, etc.) could be advanced through the lumen of the steerable catheter 206 and the working device 208 could then be advanced over such second introduction device to the desired operative location.

FIGS. 2I through 2L are partial sagittal sectional views through a human head showing various steps of a method for gaining access to a paranasal sinus using an introducing device in the form of a guidewire with a preset shape. In FIG. 2I, an introducing device in the form of a guidewire 210 with a preset shape is introduced in a nasal cavity. Guidewire 210 comprises a proximal portion and a distal portion and is shaped such that it can easily navigate through the nasal anatomy. In one embodiment, guidewire 210 is substantially straight. In another embodiment, guidewire 210 comprises an angled, curved or bent region between the proximal portion and the distal portion. Examples of the deflection angle of the angled, curved or bent regions are 0°, 30°, 45°, 60°, 70°, 90°, 120° and 135°. In FIG. 2J, guidewire 210 is advanced through the nasal anatomy so that the distal tip of guidewire enters a sphenoid sinus SS through an ostium SSO. In FIG. 2K, a working device in the form of a balloon catheter 212 is advanced along guidewire 210 into the sphenoid sinus SS. Typically, as described more fully herebelow, the working device will have a guidewire lumen extending through or formed in or on at least a portion of the working device 212 to facilitate advancement of the working device 212 over the guidewire 212 in the manner well understood in the art of interventional medicine. Thereafter, the position of balloon catheter 212 is adjusted so that the balloon of the balloon catheter is located in the ostium SSO. As described elsewhere in this application, the balloon catheter 212 may be radiopaque and/or may incorporate one or more visible or imagable markers or sensors. In FIG. 2L, balloon catheter 212 is used to dilate the ostium SSO. After completion of the procedure, guidewire 210 and balloon catheter 212 are withdrawn from the nasal anatomy. In one embodiment, balloon catheter 212 is shapeable or malleable.

FIGS. 2M through 2O are partial sagittal sectional views through a human head showing various steps of a method of gaining access to a paranasal sinus using a balloon catheter comprising a steering wire at its distal end. In FIG. 2M, a working device comprising a balloon catheter 214 comprising a proximal portion and distal portion is introduced in a nasal cavity. Balloon catheter 214 comprises a steering wire 216 at its distal end. In FIG. 2N, balloon catheter 214 is advanced through the nasal anatomy into a sphenoid sinus SS through a sphenoid sinus ostium SSO. Thereafter, the position of balloon catheter 214 is adjusted so that the balloon of the balloon catheter is located in the ostium SSO. In FIG. 2O, balloon catheter 214 is used to dilate the ostium SSO. After completion of the procedure, balloon catheter 214 is withdrawn from the nasal anatomy. In one embodiment, steering wire 216 can be retracted into or advanced from balloon catheter 214. The retraction or advancement of steering wire can be controlled by several means like a thumb wheel, a slide, a button hooked up to electronic motor and a trigger. In another embodiment, steering wire 216 may be hollow or may incorporate one or more lumen(s) to enable it to introduce or remove devices or diagnostic or therapeutic agents, examples of which are described in copending U.S. patent application Ser. No. 10/912,578 entitled Implantable Devices and Methods for Delivering Drugs and Other Substances to Treat Sinusitis and Other Disorders filed on Aug. 4, 2004, issued as U.S. Pat. No. 7,361,168 on Apr. 22, 2008, the entire disclosure of which is expressly incorporated herein by reference.

FIGS. 2P through 2X are partial sagittal sectional views through a human head showing various steps of a method for accessing an ethmoid sinus through a natural or artificially created opening of the ethmoid sinus. In FIG. 2P, an introducing device in the form of a guide catheter 218 is introduced in an ethmoid sinus ES. Ethmoid sinus ES comprises multiple ethmoid air cells EAC. In FIG. 2Q, a guidewire 220 is introduced through guide catheter into a first EAC. Thereafter, in FIG. 2R, a balloon catheter 222 is introduced over guidewire 220 into the first EAC. In FIG. 2S, balloon catheter 222 is inflated to dilate the structures of ES. In FIG. 2T, guide catheter 218, guidewire 220 and balloon catheter 222 are withdrawn leaving a first new passage in the ES. The newly created passage in the ES facilitates drainage of the mucous through the ES. Alternatively, in FIG. 2U, only balloon catheter 222 is withdrawn. The position of guide catheter 218 is adjusted and guidewire 220 is introduced into a second EAC. In FIG. 2V, balloon catheter 222 is introduced over guidewire 220 into the second EAC. In FIG. 2W, balloon catheter 222 is inflated to dilate the structures of ES. In FIG. 2X, guide catheter 218, guidewire 220 and balloon catheter 222 are withdrawn leaving a second new passage in the ES. The second new passage in the ES further facilitates drainage of the mucous through the ES. This method of dilating the structures of ES can be repeated to create multiple new passages in the ES.

FIGS. 2Y through 2AC are partial coronal sectional views through a human head showing various steps of a method for treating a mucocele in a frontal sinus. In FIG. 2Y, an introducing device in the form of a guide catheter 224 is introduced in a frontal sinus FS through the nasal cavity NC. Frontal sinus FS has a mucocele MC to be treated. In FIG. 2Z, a penetrating device 226 comprising a sharp tip 228 is introduced through guide catheter 224 such that penetrating device 226 punctures the MC at least partially. In FIG. 2AA, a balloon catheter 230 is introduced over penetrating device 226 into the MC. Thereafter, in FIG. 2AB, balloon catheter 230 is inflated to rupture the MC and allow the drainage of contents of the MC. In FIG. 2AC, penetrating device 226 and balloon catheter 230 are withdrawn.

The methods disclosed herein may also comprise the step of cleaning or lavaging anatomy within the nose, paranasal sinus, nasopharynx or nearby structures including but not limited to irrigating and suctioning. The step of cleaning the target anatomy can be performed before or after a diagnostic or therapeutic procedure.

The methods of the present invention may also include one or more preparatory steps for preparing the nose, paranasal sinus, nasopharynx or nearby structures for the procedure, such as spraying or lavaging with a vasoconstricting agent (e.g., 0.025-0.5% phenylephrine or Oxymetazoline hydrochloride (Neosynephrine or Afrin) to cause shrinkage of the nasal tissues, an antibacterial agent (e.g., provodine iodine (Betadine), etc. to cleanse the tissues, etc.

FIGS. 3A through 3C are partial coronal sectional views through a human head showing various steps of a method of accessing a paranasal sinus through an artificially created opening of the paranasal sinus. In FIG. 3A, a puncturing device 300 is inserted through a nostril and used to create an artificial opening in a maxillary sinus. There are several puncturing devices well known in the art like needles including needles, needles with bent shafts, dissectors, punches, drills, corers, scalpels, burs, scissors, forceps and cutters. In FIG. 3B, puncturing device 300 is withdrawn and a working device for example a balloon catheter 302 is introduced through the artificial opening into the maxillary sinus. In FIG. 3C, balloon catheter 302 is used to dilate the artificially created opening in the maxillary sinus. After this step, the balloon catheter 302 is withdrawn. It will be appreciated that, in some embodiments, the puncturing device 300 may have a lumen through which an introduction device (e.g., a guidewire or other elongate probe or member), may be inserted into the maxillary sinus and the puncturing device 300 may then be removed leaving such introduction device (e.g., a guidewire or other elongate probe or member) in place. In such cases, the working device (e.g., balloon catheter 302) may incorporate a lumen or other structure that allows the working device (e.g., balloon catheter 300) to be advanced over the previously inserted introduction device (e.g., a guidewire or other elongate probe or member).

In the methods illustrated so far, balloon catheters were used only as an example for the several alternate working devices that could be used with this invention. FIG. 4A shows a sectional view of an example of a working device comprising a set of three sequential dilators: a first sequential dilator 402, a second sequential dilator 404 and a third sequential dilator 406. The D₃of third sequential dilator 406 is greater than the diameter D₂of second sequential dilator 404 which in turn is greater than the diameter D₁of first sequential dilator 402. The sequential dilators may comprise one or more bent or angled regions. The sequential dilators can be constructed from a variety of biocompatible materials like stainless steel 316. A variety of other metals, polymers and materials can also be used to construct the sequential dilators.

FIGS. 4B through 4E show various steps of a method of dilating a nasal cavity using a working device comprising a balloon catheter with a pressure-expandable stent. In FIG. 4B, an introducing device e.g. a guidewire 416 is introduced into a nasal cavity e.g. an ostium of a sinus. In FIG. 4C, a balloon catheter 418 is introduced over guidewire 416 into the nasal cavity. Balloon catheter 418 comprises a pressure-expandable stent 420. The position of balloon catheter 418 is adjusted so that pressure-expandable stent 420 is located substantially within the target anatomy where the stent is to be deployed. In FIG. 4D, the balloon of balloon catheter 418 is expanded to deploy pressure-expandable stent 420. In FIG. 4E, balloon catheter 418 is withdrawn leaving pressure-expandable stent 420 in the nasal cavity. Several types of stent designs can be used to construct stent 420 like metallic tube designs, polymeric tube designs, chain-linked designs, spiral designs, rolled sheet designs, single wire designs etc. These designs may have an open celled or closed celled structure. A variety of fabrication methods can be used for fabricating stent 420 including but not limited to laser cutting a metal or polymer element, welding metal elements etc. A variety of materials can be used for fabricating stent 420 including but not limited to metals, polymers, foam type materials, plastically deformable materials, super elastic materials etc. Some non-limiting examples of materials that can be used to construct the stent are silicones e.g. silastic, polyurethane, gelfilm and polyethylene. A variety of features can be added to stent 420 including but not limited to radiopaque coatings, drug elution mechanisms etc.

FIG. 4F shows a partial perspective view of an embodiment of a working device comprising a side suction and/or cutting device 422 comprising a device body 424 having a side opening 426. Cutting device 422 is advanced into a passageway such as a nostril, nasal cavity, meatus, ostium, interior of a sinus, etc. and positioned so that side opening 426 is adjacent to matter (e.g., a polyp, lesion, piece of debris, tissue, blood clot, etc.) that is to be removed. Cutting device 422 is rotated to cut tissue that has been positioned in the side opening 426. Cutting device 422 may incorporate a deflectable tip or a curved distal end which may force side opening 426 against the tissue of interest. Further, this cutting device 422 may have an optional stabilizing balloon incorporated on one side of cutting device 422 to press it against the tissue of interest and may also contain one or more on-board imaging modalities such as ultrasound, fiber or digital optics, OCT, RF or electromagnetic sensors or emitters, etc.

FIG. 4G shows a partial perspective view of an embodiment of a working device comprising a rotating cutter device to cut away tissue. Rotating cutter device 428 comprises a rotating member 430 enclosed in an introducing device 432. Rotating member 430 comprises a rotating blade 434 located near the distal region of rotating member 430. Rotating blade 434 may be retractable into rotating member 430. Rotating cutter device 428 is inserted in a passageway 436 such as a nostril, nasal cavity, meatus, ostium, interior of a sinus, etc. and positioned so that rotating blade 434 is adjacent to matter (e.g., a polyp, lesion, piece of debris, tissue, blood clot, etc.) that is to be removed. Thereafter, rotating member 430 is rotated to cause rotating blade 434 to remove tissue. In one embodiment, rotating member 430 can be retracted into introducing device 432. In another embodiment, rotating cutter device 428 may comprise a mechanism for suction or irrigation near the distal end of rotating cutter device 428.

FIGS. 4H and 4I show various steps of a method of dilating a nasal cavity using a working device comprising a mechanical dilator 408. Mechanical dilator 408 comprises an outer member 410, an inner member 412 and one or more elongate bendable members 414. Inner member 412 can slide within outer member 410. The proximal ends of bendable members 414 are attached to distal end of outer member 410 and the distal ends of bendable members 414 are attached to distal end of inner member 412. In FIG. 4H, mechanical dilator 408 is inserted into an opening in the nasal anatomy e.g. an ostium of a sinus. Mechanical dilator 408 is positioned in the opening such that bendable members 414 are within the opening in the nasal anatomy. In FIG. 4I, relative motion of outer member 410 and inner member 412 causes the distal end of outer member 410 to come closer to the distal end of inner member 412. This causes bendable members 414 to bend such that the diameter of the distal region of mechanical dilator 408 increases. This causes bendable members 414 to come into contact with the opening in the nasal anatomy and exert an outward pressure to dilate the opening. Various components of mechanical dilator 408 like outer member 410, inner member 412 and bendable members 414 can be constructed from suitable biocompatible materials like stainless steel 316. A variety of other metals, polymers and materials can also be used to construct the various components of mechanical dilator 408. In one embodiment, outer member 410 is substantially rigid and inner member 412 is flexible. Outer member 410 can be substantially straight or may comprise one or more bent or angled regions. Inner member 412 may comprise one or more lumens.

FIGS. 4J and 4K illustrate a perspective view of a design of a mechanical dilator comprising a screw mechanism. FIG. 4J shows the mechanical dilator comprising an outer member 438 and an inner screw member 440. Inner screw member 440 is connected to outer member 438 through a first pivot 442 located on the distal end of outer member 438. The distal end of inner screw member 440 is connected to a second pivot 444. The mechanical dilator further comprises one or more bendable members 446. The distal end of bendable members 446 is attached to second pivot 444 and the proximal end of bendable members 446 is attached to first pivot 442. In FIG. 4K, inner screw member 440 is rotated in one direction. This causes second pivot 444 to come closer to first pivot 442. This causes bendable members 446 to bend in the radial direction exerting an outward radial force. This force can be used to dilate or displace portions of the anatomy. Outer member 438 can be substantially straight or may comprise one or more bent or angled regions. Inner screw member 440 may comprise one or more lumens.

FIGS. 4L and 4M illustrate sectional views of a design of a mechanical dilator comprising a pushable member. FIG. 4L shows the mechanical dilator comprising an outer member 448 comprising one or more bendable regions 449 on the distal end of outer member 448. Mechanical dilator further comprises an inner pushable member 450 comprising an enlarged region 452 on the distal end of inner pushable member 450. In FIG. 4M, inner pushable member 450 is pushed in the distal direction. This exerts an outward force on bendable regions 449 causing bendable regions 449 to bend in a radial direction exerting an outward force. This force can be used to dilate or displace portions of the anatomy. Outer member 448 can be substantially straight or may comprise one or more bent or angled regions. Inner pushable member 450 may comprise one or more lumens.

FIGS. 4N and 4O illustrate sectional views of a design of a mechanical dilator comprising a pullable member. FIG. 4N shows the mechanical dilator comprising an outer member 454 comprising one or more bendable regions 456 on the distal end of outer member 454. Mechanical dilator further comprises an inner pullable member 458 comprising an enlarged region 460 on the distal end of inner pullable member 458. In FIG. 4O, inner pullable member 458 is pulled in the proximal direction. This exerts an outward force on bendable regions 456 causing bendable regions 456 to bend in a radial direction exerting an outward force. This force can be used to dilate or displace portions of the anatomy. Outer member 454 can be substantially straight or may comprise one or more bent or angled regions. Inner pullable member 458 may comprise one or more lumens.

FIGS. 4P and 4Q illustrate sectional views of a design of a mechanical dilator comprising a hinged member. FIG. 4P shows the mechanical dilator comprising an outer member 462 comprising one or more bendable regions 464 located on the distal end of outer member 462. The mechanical dilator also comprises an inner member 466 located within outer member 462. In one embodiment, inner member 466 is tubular. The distal end of inner member 466 comprises one or more first hinges 468. First hinges 468 are hinged to the proximal ends of one or more moving elements 470. Distal ends of moving elements 470 are hinged to one or more second hinges 472 located on the inner surface of outer member 462. In FIG. 4Q, inner member 466 is pushed in the distal direction. This causes moving elements 470 to exert an outward radial force on bendable regions 464 causing bendable regions 464 to bend in an outward radial direction with an outward force. This outward force can be used to dilate or displace portions of the anatomy. Outer member 462 can be substantially straight or may comprise one or more bent or angled regions. Inner member 466 may comprise one or more lumens.

FIGS. 4R through 4W′ illustrate examples of configurations of mechanical dilators in FIGS. 4H through 4Q. FIG. 4R shows a sectional view of a mechanical dilator comprising an inner member 474, an outer stationary member 476 and an outer bendable member 478. In FIG. 4S, movement of inner member 474 displaces outer bendable member 478 in the radial direction with a force. This force can be used to dilate or displace portions of the anatomy. This configuration is useful to exert force in a particular radial direction. FIG. 4S′ shows a partial perspective view of the outer stationary member 476 of FIG. 4R. FIG. 4T shows a sectional view of a mechanical dilator comprising an inner member 480, a first outer hemi-tubular member 482 and a second outer hemi-tubular member 484. In FIG. 4U, movement of inner member 480 displaces first outer hemi-tubular member 482 and second outer hemi-tubular member 484 in the radial direction with a force. This force can be used to dilate or displace portions of the anatomy. This configuration is useful to exert force in two diametrically opposite regions. FIG. 4U′ shows a partial perspective view of the first outer hemi-tubular member 482 and the second outer hemi-tubular member 484 of FIG. 4T. FIG. 4V shows a sectional view of a mechanical dilator comprising an inner member 486, a first outer curved member 488 and a second outer curved member 490. In FIG. 4W, movement of inner member 486 displaces first outer curved member 488 and second outer curved member 490 in the radial direction with a force. This force can be used to dilate or displace portions of the anatomy. This configuration is useful to exert force over smaller areas in two diametrically opposite regions. FIG. 4W′ shows a partial perspective view of the first outer curved member 488 and the second outer curved member 490 of FIG. 4V. Similar designs for mechanical dilators in FIGS. 4H through 4Q are possible using three or more displaceable members. The inner member in the mechanical dilators disclosed herein may be replaced by a balloon for displacing the outer members to exert an outward radial force.

Several other designs of the working device may also be used including but not limited to cutters, chompers, rotating drills, rotating blades, tapered dilators, punches, dissectors, burs, non-inflating mechanically expandable members, high frequency mechanical vibrators, radiofrequency ablation devices, microwave ablation devices, laser devices (e.g. CO2, Argon, potassium titanyl phosphate, Holmium:YAG and Nd:YAG laser devices), snares, biopsy tools, scopes and devices that introduce diagnostic or therapeutic agents.

FIG. 5A shows a perspective view of an embodiment of a balloon comprising a conical proximal portion, a conical distal portion and a cylindrical portion between the conical proximal portion and the conical distal portion. FIGS. 5B to 5N show perspective views of several alternate embodiments of the balloon. FIG. 5B shows a conical balloon, FIG. 5C shows a spherical balloon, FIG. 5D shows a conical/square long balloon, FIG. 5E shows a long spherical balloon, FIG. 5F shows a dog bone balloon, FIG. 5G shows a offset balloon, FIG. 5H shows a square balloon, FIG. 5I shows a conical/square balloon, FIG. 5J shows a conical/spherical long balloon, FIG. 5K shows a tapered balloon, FIG. 5L shows a stepped balloon, FIG. 5M shows a conical/offset balloon and FIG. 5N shows a curved balloon.

The balloons disclosed herein can be fabricated from biocompatible materials including but not limited to polyethylene terephthalate, Nylon, polyurethane, polyvinyl chloride, crosslinked polyethylene, polyolefins, HPTFE, HPE, HDPE, LDPE, EPTFE, block copolymers, latex and silicone. The balloons disclosed herein can be fabricated by a variety of fabrication methods including but not limited to molding, blow molding, dipping, extruding etc.

The balloons disclosed herein can be inflated with a variety of inflation media including but not limited to saline, water, air, radiographic contrast materials, diagnostic or therapeutic substances, ultrasound echogenic materials and fluids that conduct heat, cold or electricity.

The balloons in this invention can also be modified to deliver diagnostic or therapeutic substances to the target anatomy. For example, FIG. 5O shows a partial perspective view of an embodiment of a balloon catheter device 500 comprising a balloon for delivering diagnostic or therapeutic substances. Balloon catheter device 500 comprises a flexible catheter 502 having a balloon 504 thereon. The catheter device 500 is advanced, with balloon 504 deflated, into a passageway such as a nostril, nasal cavity, meatus, ostium, interior of a sinus, etc. and positioned with the deflated balloon 504 situated within an ostium, passageway or adjacent to tissue or matter that is to be dilated, expanded or compressed (e.g., to apply pressure for hemostasis, etc.). Thereafter, the balloon 504 may be inflated to dilate, expand or compress the ostium, passageway, tissue or matter. Thereafter the balloon 504 may be deflated and the device 500 may be removed. This balloon 504 may also be coated, impregnated or otherwise provided with a medicament or substance that will elute from the balloon into the adjacent tissue (e.g., bathing the adjacent tissue with drug or radiating the tissue with thermal or other energy to shrink the tissues in contact with the balloon 504). Alternatively, in some embodiments, the balloon may have a plurality of apertures or openings through which a substance may be delivered, sometimes under pressure, to cause the substance to bathe or diffuse into the tissues adjacent to the balloon. Alternatively, in some embodiments, radioactive seeds, threads, ribbons, gas or liquid, etc. may be advanced into the catheter shaft 502 or balloon 504 or a completely separate catheter body for some period of time to expose the adjacent tissue and to achieve a desired diagnostic or therapeutic effect (e.g. tissue shrinkage, etc.).

The balloons in this invention can have a variety of surface features to enhance the diagnostic or therapeutic effects of a procedure. For example, FIG. 5P shows a partial perspective view of an embodiment of a balloon/cutter catheter device 506 comprising a flexible catheter 508 having a balloon 510 with one or more cutter blades 512 formed thereon. The device 506 is advanced, with balloon 510 deflated, into a passageway such as a nostril, nasal cavity, meatus, ostium, interior of a sinus, etc. and positioned with the deflated balloon 510 situated within an ostium, passageway or adjacent to tissue or matter that is to be dilated, expanded or compressed and in which it is desired to make one or more cuts or scores (e.g. to control the fracturing of tissue during expansion and minimize tissue trauma etc.). Thereafter, the balloon 510 is inflated to dilate, expand or compress the ostium, passageway, tissue or matter and causing the cutter blade(s) 512 to make cut(s) in the adjacent tissue or matter. Thereafter the balloon 510 is deflated and the device 506 is removed. The blade may be energized with mono or bi-polar RF energy or otherwise heated such that it will cut the tissues while also causing hemostasis and/or to cause thermal contraction of collagen fibers or other connective tissue proteins, remodeling or softening of cartilage, etc.

The balloons in this invention can have a variety of reinforcing means to enhance the balloon properties. For example, FIG. 5Q shows a perspective view of an embodiment of a balloon catheter device 514 comprising a flexible catheter 516 having a balloon 518 with one or more reinforcing means 520 thereon. In this example, reinforcing means 520 is a braid attached on the external surface of balloon 518. The reinforcing braid can be constructed from suitable materials like polymer filaments (e.g. PET or Kevlar filaments), metallic filaments (e.g. SS316 or Nitinol filaments) and metallic or non-metallic meshes or sheets. A variety of other reinforcing means can be used including but not limited to reinforcing coatings, external or internal reinforcing coils, reinforcing fabric, reinforcing meshes and reinforcing wires, reinforcing rings, filaments embedded in balloon materials etc. A reinforcing braid can be used with the balloon catheter device in FIG. 5Q.

The balloons in this invention can have a variety of inflation means to enhance the balloon properties. FIG. 5R shows a partial sectional view of an embodiment of a balloon catheter 522 comprising a shaft 524 and a balloon 526. Shaft 524 comprises a balloon inflation lumen. The distal portion of balloon inflation lumen terminates in inflation ports 528 located near the distal end of balloon 526. Thus, when balloon catheter 522 is inserted in an orifice and balloon 526 is inflated, the distal portion of balloon 526 inflates earlier than the proximal portion of balloon 526. This prevents balloon 526 from slipping back out of the orifice.

FIGS. 5S through 5T illustrate designs of balloon catheters comprising multiple balloons. FIG. 5S shows a partial sectional view of an embodiment of a balloon catheter 530 comprising a shaft 532 with a lumen 533. Lumen 533 opens into three orifices located on shaft 532 namely a first orifice 534, a second orifice 536 and a third orifice 538. The three orifices are used to inflate three balloons. First orifice 534 inflates a first balloon 540, second orifice 536 inflates a second balloon 542 and third orifice 538 inflates third balloon 544. In one embodiment, first balloon 540 and third balloon 544 are inflated with a single lumen and second balloon 542 is inflated with a different lumen. In another embodiment, first balloon 540, second balloon 542 and third balloon 544 interconnected and are inflated with a single lumen. A valve mechanism allows first balloon and second balloon to inflate before allowing second balloon to inflate.

Alternatively, the balloons can be inflated by separate lumens. FIG. 5T shows a partial sectional view of an embodiment of a balloon catheter 546 comprising a shaft 548 comprising a first inflation lumen 550, a second inflation lumen 552 and a third inflation lumen 554. The three inflation lumens are used to inflate three non-connected balloons. First inflation lumen 550 inflates a first balloon 556, second inflation lumen 552 inflates a second balloon 558 and third inflation lumen 554 inflates a third balloon 560.

The devices disclosed herein may comprise one or more navigation or visualization modalities. FIGS. 5U through 5AB illustrate perspective and sectional views of various embodiments of a balloon catheter comprising sensors. FIG. 5U shows a partial perspective view of a balloon catheter comprising an outer member 562, an inner member 564 and a balloon 566 attached to distal region of outer member 562 and distal region of inner member 564. The balloon catheter further comprises a first sensor 568 located on the distal region of outer member 562 and a second sensor 570 located on the distal region of inner member 564. FIG. 5V shows a cross section through plane 5V-5V in FIG. 5U. Outer member 562 comprises a first sensor lumen 572 to receive the lead from first sensor 568. Inner member 564 comprises a second sensor lumen 574 to receive the lead from second sensor 570. Inner member 564 further comprises a circular lumen 576. Outer member 562 and inner member 564 enclose an annular lumen 578. In one embodiment, annular lumen 578 is a balloon inflation lumen.

FIG. 5W shows a partial perspective view of a balloon catheter comprising an outer member 580, an inner member 582 and a balloon 584 attached to distal region of outer member 580 and distal region of inner member 582. The balloon catheter further comprises a first sensor 586 located on the distal region of inner member 582 and a second sensor 588 located on the distal region of inner member 582 distal to first sensor 586. FIG. 5X shows a cross section through plane 5X-5X in FIG. 5W. Inner member 582 comprises a first sensor lumen 590 to receive the lead from first sensor 586 and a second sensor lumen 592 to receive the lead from second sensor 588. Inner member 582 further comprises a circular lumen 594. Outer member 580 and inner member 582 enclose an annular lumen 596. In one embodiment, annular lumen 596 is a balloon inflation lumen.

With reference to FIGS. 5Y through 5AB, FIG. 5Y shows a partial perspective view of a balloon catheter comprising an outer member 598, an inner member 501 and a balloon 503 attached to distal region of outer member 598 and distal region of inner member 501. The balloon catheter further comprises a first sensor 505 located on the distal region of outer member 598 and a second sensor 507 located on the distal region of outer member 598 distal to first sensor 505. FIG. 5Z shows a cross section through plane 5Z-5Z in FIG. 5Y. Outer member 598 comprises a first sensor lumen 509 to receive the lead from first sensor 505 and a second sensor lumen 511 to receive the lead from second sensor 507. Inner member 501 comprises a circular lumen 513. Outer member 598 and inner member 501 enclose an annular lumen 515. In one embodiment, annular lumen 515 is a balloon inflation lumen.

With reference to FIGS. 5Y through 5AB, the leads from the sensors may be attached on the surface of an element of the balloon catheter without being enclosed in a lumen. FIG. 5AA shows a partial perspective view of a balloon catheter comprising an outer member 517, an inner member 519 and a balloon 521 attached to distal region of outer member 517 and distal region of inner member 519. The balloon catheter further comprises a first sensor 525 located on the distal region of outer member 517 and a second sensor 527 located on the distal region of inner member 519. Second sensor 527 comprises a lead 529. FIG. 5AB shows a cross section through plane 5AB-5AB in FIG. 5AA. Outer member 517 comprises a first sensor lumen 531 to receive the lead from first sensor 525. Inner member 519 comprises a circular lumen 533. Lead 529 from second sensor 527 is attached on the outer surface of inner member 519 and is oriented parallel to inner member 519. Outer member 517 and inner member 519 enclose an annular lumen 535. In one embodiment, annular lumen 535 is a balloon inflation lumen. The sensors mentioned in FIGS. 5U through 5AB can be electromagnetic sensors or sensors including but not limited to location sensors, magnetic sensors, electromagnetic coils, RF transmitters, mini-transponders, ultrasound sensitive or emitting crystals, wire-matrices, micro-silicon chips, fiber-optic sensors, etc.

FIGS. 6A through 6G illustrate partial perspective views of several embodiments of shaft designs for the various devices disclosed herein. These shaft designs are especially useful for devices that encounter high torque or high burst pressures or require enhanced pushability, steerability and kink resistance. FIG. 6A shows a partial perspective view of an embodiment of a shaft 602 comprising a spiral element 604 wound around the shaft. Spiral element 604 can be made of suitable materials like metals (e.g. SS316L, SS304) and polymers. In one embodiment, spiral element 604 is in the form of round wire of diameter between 0.04 mm to 0.25 mm. In another embodiment, spiral element is in the form of flat wire of cross section dimensions ranging from 0.03 mm×0.08 mm to 0.08 mm×0.25 mm. FIG. 6B shows a partial perspective view of an embodiment of a shaft 606 comprising a reinforcing filament 608. Reinforcing filament 608 is substantially parallel to the axis of shaft 606. Shaft 606 with reinforcing filament 608 can be covered with a jacketing layer. Reinforcing filament 608 can be made of suitable materials like metals, polymers, glass fiber etc. Reinforcing filament 608 can also have shape memory characteristics. In one embodiment, reinforcing filament 608 is embedded in shaft 606. In another embodiment, reinforcing filament is introduced through a lumen in shaft 606. Shaft 606 may comprise more than one reinforcing filament 608. FIG. 6C shows a partial perspective view of an embodiment of a shaft 610 comprising one of more stiffening rings 612 along the length of shaft 610. FIG. 6D shows a partial perspective view of an embodiment of a shaft 614 comprising a series of controllably stiffening elements 616 along the length of the shaft. Shaft 614 further comprises a tension wire 618 that runs through controllably stiffening elements 616 and is attached to the most distal stiffening element. The tension in tension wire 618 causes controllably stiffening elements 616 to come into contact with each other with a force. Friction between controllably stiffening elements 616 causes shaft 614 to have a certain stiffness. Increasing the tension in tension wire 618 increases the force with which controllably stiffening elements 616 come into contact with each other. This increases the friction between controllably stiffening elements 616 which in turn increases the stiffness of shaft 614. Similarly, reducing the tension in tension wire 618 reduces the stiffness of shaft 614. Controllably stiffening elements 616 can be made from suitable materials like metal, polymers and composites. In one embodiment, controllably stiffening elements 616 are separated from each other by one or more springs. Tension wire 618 can be made from metals like SS316. Tension wire 618 may also be used to cause the device to actively bend or shorten in response to tension. FIG. 6E shows a partial perspective view of an embodiment of a shaft 620 comprising a hypotube 622. In one embodiment, hypotube 622 is located on the exterior surface of shaft 620. In another embodiment, hypotube 622 is embedded in shaft 620. Hypotube 622 can be made of metals like stainless steel 316 or suitable polymers. FIGS. 6F and 6F′ show a partial perspective view of an embodiment of a shaft 624 comprising a reinforcing element 626 in the form of a reinforcing braid or mesh located on the outer surface of shaft 624. Reinforcing element 626 can be made of suitable materials like polymer filaments (e.g. PET or Keviar filaments), metallic wires e.g. SS316 wires etc. The braid pattern can be regular braid pattern, diamond braid pattern, diamond braid pattern with a half load etc. In one embodiment, the outer surface of reinforcing element 626 is covered with a jacketing layer.

The shafts of various devices disclosed herein may be non homogenous along their length. Examples of such shafts are illustrated in FIGS. 6G through 6H. FIG. 6G shows a partial perspective view of an embodiment of a device comprising a shaft 628 comprising a proximal portion 630, a distal portion 632, a working element 634 and a plastically deformable region 636 located between the proximal portion 630 and distal portion 632. Plastically deformable region 636 can be deformed by a physician to adjust the angle between proximal portion 630 and distal portion 632. This enables the devices to be used for several different anatomical regions of the same patient. Also, such devices can be adjusted for optimal navigation through a patient's anatomy. In one embodiment, shaft 628 comprises multiple plastically deformable regions. In another embodiment plastically deformable region 636 is located within working element 634. Such a design comprising one or more plastically deformable regions can be used for any of the devices mentioned herein like catheters with working elements, guide catheters, guide catheters with a pre-set shape, steerable guide catheters, steerable catheters, guidewires, guidewires with a pre-set shape, steerable guidewires, ports, introducers, sheaths etc.

FIG. 6H shows a partial perspective view of an embodiment of a device comprising a shaft with a flexible element. The design is illustrated as a shaft 638 comprising a proximal portion 640, a distal portion 642 and a working element 644 (e.g. a balloon). Shaft 638 further comprises a flexible element 646 located between proximal portion 640 and distal portion 642. This design enables proximal portion 640 to bend with respect to distal portion 642 making it easier to navigate through the complex anatomy and deliver working element 644 to the desired location. In one embodiment, shaft 638 comprises multiple flexible elements. In another embodiment, flexible element 646 is located within working element 644. Such a design comprising one or more flexible elements can be used for any of the devices mentioned herein like catheters with working elements, guide catheters, guide catheters with a pre-set shape, steerable guide catheters, steerable catheters, guidewires, guidewires with a pre-set shape, steerable guidewires, ports, introducers, sheaths etc.

FIGS. 6I through 6K illustrate an example of a shaft comprising a malleable element. FIG. 6I shows a partial perspective view of an embodiment of a shaft 648 comprising malleable element 650 and a lumen 652 wherein shaft 648 is in a substantially straight configuration. Malleable element 650 is embedded in shaft 648 such that the axis of malleable element 650 is substantially parallel to the axis of shaft 648. FIG. 6J shows a partial perspective view of the embodiment of FIG. 6I in a bent configuration. FIG. 6K shows a cross sectional view through plane 6K-6K of FIG. 6I showing shaft 648 comprising malleable element 650 and a lumen 652. In one embodiment, shaft 648 comprises more than one malleable element.

FIGS. 6L through 6M show an embodiment of a controllably deformable shaft. FIG. 6L shows a partial sectional view of an embodiment of a controllably deformable shaft 654 comprising a pull wire 656 attached to a pull wire terminator 658 located near the distal end of shaft 654. FIG. 6M shows a partial sectional view of the controllably deformable shaft 654 of FIG. 6L in a bent orientation when pull wire 656 is pulled in the proximal direction. The deformation can be varied by varying the location of pull wire terminator 658 and the stiffness of various sections of shaft 658. The stiffness of a section of shaft 658 can be varied by adding reinforcing coatings, external or internal reinforcing coils, reinforcing fabric, reinforcing meshes and reinforcing wires, hinged elements, embedded filaments, reinforcing rings etc.

FIG. 6N shows a perspective view of a balloon catheter comprising a rigid or semi-rigid member. The balloon catheter comprises a rigid or semi-rigid member 660 and a balloon 662 located on the distal region of rigid or semi-rigid member 660. Rigid or semi-rigid member 660 may comprise one or more lumens. Rigid or semi-rigid member 660 may comprise one or more bent, curved or angled regions. Balloon 662 is inflated by a balloon inflation tube 664 comprising a hub 666 at the proximal end of balloon inflation tube 664. In one embodiment, balloon inflation tube 664 is fully attached along its length to rigid or semi-rigid member 660. In another embodiment, balloon inflation tube 664 is partially attached along its length to rigid or semi-rigid member 660.

FIGS. 6O through 6Q illustrate sectional views of a balloon catheter comprising an insertable and removable element. FIG. 6O shows a balloon catheter 668 comprising a balloon 670, a first lumen 672 and a balloon inflation lumen 674 opening into balloon 670 through an inflation port 676. FIG. 6P shows an insertable element 678 having a proximal end 680 and a distal end 682. In one embodiment, distal end 682 ends in a sharp tip for penetrating tissue. In one embodiment, insertable element 678 comprises one or more bent, angled or curved regions 684. Insertable element 678 can be fabricated from a variety of materials to obtain properties including but not limited to rigidity, shape memory, elasticity, ability to be plastically deformed etc. In FIG. 6Q, insertable element 678 is inserted into balloon catheter 668 through first lumen 672. This combination can be used to perform a diagnostic or therapeutic procedure. Insertable element 678 may be removed during or after the procedure.

FIGS. 7A through 7K show cross sectional views of several embodiments of lumen orientation in the devices disclosed herein. FIG. 7A shows a cross sectional view of an embodiment of a shaft 702 comprising a first lumen 704 and a second lumen 706. In one embodiment, first lumen 704 is a guidewire lumen and second lumen 706 is an inflation lumen. FIG. 7B shows a cross sectional view of an embodiment of a shaft 708 comprising a first lumen 710 and a annular second lumen 712 such that second annular lumen 712 is substantially coaxial with first lumen 710. In one embodiment, first lumen 710 is a guidewire lumen and annular second lumen 712 is an inflation lumen. FIG. 7C shows a cross sectional view of an embodiment of a shaft 714 comprising a first tubular element 716 comprising a first lumen 718, a second tubular element 720 comprising a second lumen 722 and a jacket 724 surrounding first tubular element 716 and second tubular element 720. In one embodiment, first lumen 718 is a guidewire lumen and second lumen 722 is an inflation lumen. FIG. 7D shows a cross sectional view of an embodiment of a shaft 726 comprising a first lumen 728, a second lumen 730 and a third lumen 732. In one embodiment, first lumen 728 is a guidewire lumen, second lumen 730 is an irrigation/aspiration lumen and third lumen 732 is an inflation lumen. FIG. 7E shows a cross sectional view of an embodiment of a shaft 734 comprising a cylindrical element 736, a tubular element 738 comprising a lumen 740 and a jacket 742 surrounding cylindrical element 736 and tubular element 738. FIG. 7F shows a cross sectional view of an embodiment of a shaft 744 comprising a tubular member 746 comprising a first lumen 748 and a second lumen 750; a first coating 752 located on the outer surface of tubular member 746; a braid 754 located on the outer surface of first coating 752 and a second coating 756 surrounding braid 754. First lumen 748 is lined with a suitable coating 758 like hydrophilic lubricious coating, hydrophobic lubricious coating, abrasion resisting coating etc. In one embodiment, first lumen 748 is a guidewire lumen and second lumen 750 is an inflation lumen. The lumens disclosed herein can be lined with suitable coatings like hydrophilic lubricious coatings, hydrophobic lubricious coatings, abrasion resisting coatings, radiopaque coatings, echogenic coatings etc.

FIG. 7G shows a partial perspective view of an embodiment of a shaft 754* comprising a first lumen 756* and a zipper lumen 758*. Zipper lumen 758* allows a device like a guidewire 760* to be easily introduced into or removed from shaft 754*. FIG. 7H shows a cross sectional view through plane 7H-7H in FIG. 7G showing the orientations of first lumen 756* and zipper lumen 758*.

FIG. 7I shows a cross sectional view of an embodiment of a shaft 762 comprising a first lumen 764 and a rapid exchange lumen 766. Rapid exchange lumen 766 extends from the distal end of shaft 762 to a proximal region. Rapid exchange lumen 766 enables shaft 762 to be easily and quickly introduced or removed over an exchange device like a guidewire 768. FIG. 7J shows a cross sectional view through plane 7J-7J in FIG. 7I showing first lumen 764 and rapid exchange lumen 766. FIG. 7K shows a cross sectional view through plane 7K-7K in FIG. 7I showing first lumen 764.

FIGS. 7L through 7Q shows perspective and sectional views of lumens for the devices disclosed herein that are not present throughout the length of the devices. FIG. 7L shows a perspective view of a balloon catheter comprising a shaft 770, a balloon 772 and a lumen 774 that is present throughout shaft 770. The balloon catheter further comprises a balloon inflation lumen 776 that opens into balloon 772. The distal end of balloon inflation lumen 776 is plugged with a plug 778. FIG. 7M shows a cross section through plane 7M-7M in FIG. 7L showing shaft 770 comprising lumen 774 and balloon inflation lumen 776. FIG. 7N shows a cross section through plane 7N-7N in FIG. 7L showing shaft 770 comprising lumen 774 and plug 778. FIG. 7O shows a perspective view of a balloon catheter comprising a shaft 780, a balloon 782 and a lumen 786 that is present throughout shaft 780. The balloon catheter further comprises a balloon inflation lumen 784. The distal end of balloon inflation lumen 784 opens into balloon 782. FIG. 7P shows a cross section through plane 7P-7P in FIG. 7O showing shaft 780 comprising lumen 786 and balloon inflation lumen 784. FIG. 7Q shows a cross section through plane 7Q-7Q in FIG. 7O showing shaft 780 comprising lumen 786.

FIGS. 8A through 8E show partial perspective views of several embodiments of markers that may be present on the elements of the devices mentioned herein. FIG. 8A shows a partial perspective view of an embodiment of a shaft 800 comprising a plurality of distance markers 802 located along the length of shaft 800. FIG. 8B shows a partial perspective view of an embodiment of a shaft 804 comprising a plurality of radiographic markers 806 located along the length of shaft 804. FIG. 8C shows a partial perspective view of an embodiment of a shaft 808 comprising a plurality of ring shaped radiographic markers 810 located along the length of shaft 808. FIG. 8D shows a partial perspective view of an embodiment of a balloon catheter 812 comprising a shaft 814 and a balloon 816. Balloon 816 comprises a plurality of radiographic markers 818 located on the outer surface of the balloon 816. Such markers 818 may be in a linear arrangement, non-linear arrangement or any other configuration that performs the desired marking function (e.g., delineating the length and/or diameter of the balloon, marking the proximal and/or distal ends of the balloon, etc.). FIGS. 8E and 8E′ show partial perspective and longitudinal sectional views of an embodiment of a balloon catheter 820 comprising a shaft 822 and a balloon 824. Balloon 824 comprises a plurality of radiographic markers 826 located on the inner surface of the balloon 824. Such markers 826 may be in a linear arrangement, non-linear arrangement or any other configuration that performs the desired marking function (e.g., delineating the length and/or diameter of the balloon, marking the proximal and/or distal ends of the balloon, etc.). The devices disclosed herein may also comprise several other types of markers like ultrasound markers, radiofrequency markers and magnetic markers. Similarly, the devices disclosed herein may also comprise one or more sensors like electromagnetic sensors, electrical sensors, magnetic sensors, light sensors and ultrasound sensors.

FIGS. 9A-9D show components that may be used alone or in various combinations to perform transnasal procedures within paranasal sinuses and/or within openings (e.g., any transnasally accessible opening in a paranasal sinus or air cell including but not limited to; natural ostia, surgically altered natural ostia, surgically created openings, antrostomy openings, ostiotomy openings, burr holes, drilled holes, ethmoidectomy openings, natural or man made passageways, etc.) in paranasal sinuses. These devices may be sold or used separately or together (e.g., as a system or kit).

FIG. 9A shows a side view of a guide device 900 that comprises an elongate tube 902. Elongate tube 902 may be made of suitable biocompatible material(s) such polymers (e.g. Nylon, elastomeric polyether block amide (PEBAX), etc. The distal portion of elongate tube 902 may comprise a bent, angled or curved region. The inner surface of elongate tube 902 may be lined by a lubricious coating or a tubular lubricious liner. Such a lubricious coating or tubular lubricious liner is useful to facilitate passage of one or more devices through the lumen of guide device 900 especially when guide device 900 comprises an angled, curved or bent region. The distal portion of elongate tube 902 may comprise an atraumatic tip 904. Atraumatic tip 904 may be made of suitable biocompatible materials such as Pebax, etc. Atraumatic tip 904 prevents or reduces damage to the anatomy caused by the distal end of guide device 900. Guide device 900 further comprises a stiffening element e.g. a hypotube 906. Hypotube 906 may be made of suitable biocompatible materials such as stainless steel, titanium, nickel-titanium alloys (e.g., Nitinol), polymers such as Nylon etc. In one embodiment, guide device 900 further comprises an outer cover. The outer cover may be made of Nylon or other thermoplastic material. The outer cover substantially surrounds the outer surface of hypotube 906 and a region of elongate tube 902 emerging from the distal end of hypotube 906. This embodiment comprising an outer cover is especially useful for providing an outer lubricious surface on guide device 900. This embodiment comprising an outer cover is also useful for improving joint integrity between hypotube 906 and elongate tube 902. This embodiment comprising an outer cover is also useful for creating a smooth transition between the distal portion of elongate tube 902 and the distal end of hypotube 906. The proximal end of guide device 900 comprises a hub 908. In one embodiment, hub 908 is a female luer hub. The length of the portion of the guide device 900 that enters the body may range preferably from 2 inches to 6 inches, and the length of the portion that remains outside of the body is preferably at least 0.5 inches. Guide device 900 may be used for introducing one or more devices into the anatomy. Guide device 900 may also be used for applying suction to or providing lavage to an anatomical region. Proximal portion of guide device 900 may comprise a rotating valve device such as a Touhy-Borst device to lock down a device such as a sheath, guidewire, balloon catheter or other devices that are being inserted through guide device 900. Similarly, a Touhy-Borst device may be present on the proximal end of one or more devices disclosed herein. The distal region of guide device 900 or any other guide device disclosed herein may comprise a radiopaque marker such as a metal, polymer loaded with a radiopaque substance, etc. In one embodiment, multiple guide devices 900 of varying designs are provided in the system shown in FIGS. 9A through 9D. The system shown in FIGS. 9A through 9D may comprise more than one guide device.

FIG. 9B shows a side view of a guidewire 910. The outer diameter of guidewire 910 is preferably greater than 0.020 inches. In one embodiment, the outer diameter of guidewire 910 is 0.035 inches. Guidewire 910 comprises a proximal portion 912 and a distal portion 914. Distal portion 914 may comprise a substantially floppy tip. Stiffness of guidewire 910 may vary along the length of guidewire 910. In one embodiment, guidewire 910 comprises a lubricious coating made of materials such as polytetrafluoroethylene (PTFE). Guidewire 910 may comprise one or more radiopaque markers. The outer diameter of guidewire 910 is designed to enable passage of guidewire 910 through the balloon catheter shown in FIG. 9D. In one embodiment, outer diameter of guidewire 910 is 0.035 inches. Guidewire 910 can be used to introduce one or more devices into the anatomy. The system shown in FIGS. 9A through 9D may comprise more than one guidewire.

FIG. 9C shows a side view of a tubular sheath device 920 of the present invention. Sheath device 920 comprises an elongate tube 922 that may be made of any suitable biocompatible material(s) including, but not limited to polyethylene, elastomeric polyether block amide (PEBAX), etc. In one embodiment, elongate tube 922 may comprise a composite structure tube with lubricious inner liner, stainless steel braid or coil and a polymer jacket. The distal end of elongate tube 922 may comprise an atraumatic tip 924 that prevents or reduces damage to the anatomy caused by the distal end of elongate tube 922. The atraumatic tip may be made of a soft polymer or may be comprise an atraumatic, rounded distal end. The distal portion of elongate tube 922 comprises a navigation marker such as a radiopaque marker band 926. In one embodiment, radiopaque marker band 926 is made of a platinum-iridium alloy. The proximal end of elongate tube 922 comprises a hub 928. In one embodiment, hub 928 is a female luer hub. A portion of strain relief tubing 930 may be provided between hub 928 and elongate tube 922. In one embodiment, the proximal portion of sheath device 920 comprises a rotating hemostasis valve device such as a Touhy-Borst device to lock down a guidewire being introduced through sheath device 920. This enables sheath device 920 and the guidewire to be controlled as one unit. Sheath device 920 may be used for exchanging guidewires, lavage or suction of anatomical regions etc. Sheath device 920 may also be used to redirect guide wires during guide wire probing. Other uses of sheath device 920 include, but are not limited to, introduction and support of various interventional and diagnostic devices when performing procedures such as sinus ostia dilation, sinus lavage, and suction. Sheath device 920 may also be used to perform other diagnostic or therapeutic procedures including, but not limited to treatment of middle ear diseases or disorders via the Eustachian tube. The system shown in FIGS. 9A through 9D may comprise more than one sheath device.

FIG. 9D shows a side view of a balloon catheter. Balloon catheter 934 comprises an elongate shaft 936. Elongate shaft 936 may be made from suitable biocompatible polymers including, but not limited to Nylon, Pebax, polyethylene, etc. Distal portion of elongate shaft 936 may comprise one or more radiopaque marker bands. The catheter also has one marker on the proximal shaft which indicates approximately the exit of the balloon proximal bond from the distal end of the guiding catheter. Elongate shaft 936 comprises a balloon inflation lumen for inflating or deflating a balloon 938 located on the distal portion of elongate shaft 936. Balloon 938 may be a compliant or non-compliant balloon. Balloon 938 is designed to provide an inflatable segment of known diameter and length at recommended inflation pressures. In one embodiment, balloon 938 is a non-compliant balloon made of PET. In one embodiment, elongate shaft 936 further comprises a guidewire lumen. The guidewire lumen may be coaxial to the balloon inflation lumen. The guidewire lumen may be variously designed to enable passage of one or more guidewires such as guidewire 910 may be inserted through the guidewire lumen. In an alternate embodiment, balloon catheter 934 comprises a fixed guidewire 940 such that the distal end of fixed guidewire 940 forms the distal end of balloon catheter 934. Fixed guidewire 940 may be used for navigation balloon catheter 934 through the anatomy. In the embodiment of balloon catheter 934 shown in FIG. 9D, the proximal end of balloon catheter comprises a ‘Y’ connector 942. The proximal end of ‘Y’ connector 942 comprises a first luer port 944 that leads to a guidewire lumen in balloon catheter 934. In one embodiment, the region of guide device around first luer port 944 comprises a rotating hemostasis valve device such as a Touhy-Borst device to lock down a guidewire being introduced through first luer port 944. This enables balloon catheter 934 and guidewire 910 to be controlled as one unit. ‘Y’ connector 942 further comprises a second luer port 946 that is in fluid communication with the balloon inflation lumen in balloon catheter 934. Balloon 938 is inflated by injecting a suitable inflation medium such as diluted contrast solution through second luer port 946. In one embodiment, proximal portion of elongate shaft 936 comprises a visual marker. The visual marker is used to verify relative location of balloon 938 relative to distal end of guide device 900 when balloon catheter 934 is used introduced through guide device 900. The visual marker completely enters proximal end of guide device 900 when material of balloon 938 completely exits the distal end of guide device 900. Thus, erroneous inflation of balloon 938 within guide device 900 can be prevented. Balloon catheter 934 can be used to dilate anatomical regions such as ostia and spaces within the paranasal sinus cavities for diagnostic and therapeutic procedures. The system shown in FIGS. 9A through 9D may comprise more than one balloon catheter.

The system in FIGS. 9A through 9D can be used to treat anatomical regions such as paranasal sinuses, ostia or passageways leading to paranasal sinuses, etc. In one embodiment of a method of treating sinusitis by dilating an opening in a paranasal sinus, a suitable guide device 900 is inserted through the nose. Guide device 900 is then advanced such that the distal end of guide device 900 is located near the opening (e.g., any transnasally accessible opening in a paranasal sinus or air cell including but not limited to; natural ostia, surgically altered natural ostia, surgically created openings, antrostomy openings, ostiotomy openings, burr holes, drilled holes, ethmoidectomy openings, natural or man made passageways, etc.) of interest. The step of advancement of guide device 900 may be performed under endoscopic visualization. An initial endoscopic examination may also be performed before introducing guide device 900 through the nose. The exact location of the distal end of guide device 900 depends on the sinus to be accessed. To access a maxillary, frontal or anterior Ethmoid sinus, the distal tip of guide device 900 is placed under the middle turbinate just beyond the uncinate process. To access an Ethmoid sinus in patients with an intact middle turbinate, guide device 900 is placed lateral to the middle turbinate. To access a sphenoid or posterior Ethmoid sinus, the distal tip of guide device 900 is passed posteriorly, medial to the middle turbinate. To treat a patient who has already undergone a FESS, sphenoid sinuses may be accessed by advancing guide device 900 through what used to be the bulla, lateral to the middle turbinate.

Thereafter, a suitable guidewire 910 is introduced through guide device 900 such that the distal end of guidewire 910 emerges out of the distal end of guide device 900. Guidewire 910 is then used to access an opening of a paranasal sinus ((e.g., any transnasally accessible opening in a paranasal sinus or air cell including but not limited to; natural ostia, surgically altered natural ostia, surgically created openings, antrostomy openings, ostiotomy openings, burr holes, drilled holes, ethmoidectomy openings, natural or man made passageways, etc.). If guidewire 910 encounters substantial resistance, guidewire 910 is retracted, the position of guidewire 910 is slightly changed and the access of the opening of the paranasal sinus is retried. An optional torque device may be placed on guidewire 910 during the step of accessing the opening of the paranasal sinus if more guidewire torque control and steerability is desired. The position of guide device 900 and guidewire 910 can be tracked with fluoroscopy. Successful access of the sinus opening of the paranasal sinus is marked by smooth easy passage of guidewire 910 into and beyond the opening of the paranasal sinus. Thereafter, guidewire 910 may be passed into the sinus until some light resistance is felt or approximately 2-7 cm of the distal portion of guidewire 910 is inside the sinus. The position of guidewire 910 can be confirmed with fluoroscopy.

Thereafter, a suitable balloon catheter 934 is passed over guidewire 910 through guide device 900, into the opening of the paranasal sinus. Thereafter, balloon catheter 934 is positioned across a target region to be dilated. The position of balloon catheter 934 may be confirmed using fluoroscopy and/or endoscopy.

Thereafter, an inflation device is used to inflate balloon 938 with gradually increasing pressure. During the step of inflating balloon 938, the diameter, shape and position of the balloon can be tracked using fluoroscopy and/or endoscopy. Balloon 938 is further inflated until balloon 938 becomes fully expanded. Care is taken during the step of inflating balloon 938 to ensure that the pressure in balloon 938 does not exceed a maximum allowed pressure. After balloon 938 is fully expanded, the pressure created by the inflation device is released. A vacuum is then applied by the inflation device to deflate balloon 938.

Thereafter, guide device 900, guidewire 910 and balloon catheter 934 are removed together as one unit. The dilation of the opening of the paranasal sinus can be determined using endoscopy.

Several variations of the abovementioned procedure are possible. In one method embodiment, guidewire 910 is pre-loaded into guide device 900. Guidewire 910 and guide device 900 are then co-introduced into the anatomy such that the distal tip of guide device 900 is located near a target region of the anatomy. In another method embodiment, balloon catheter 934 is preloaded over guidewire 910. The combination of balloon catheter 934 and guidewire 910 is in turn preloaded inside of guide device 900. This combination of balloon catheter 9341 guidewire 910 and guide device 900 can be introduced in the nasal cavity such the distal end of the combination is positioned near a desired target region. Thereafter, guidewire 910 is advanced into the desired target region such as a sinus cavity. Thereafter, balloon catheter 934 is advanced over guidewire 910. Balloon 938 is then inflated to dilate an anatomical region.

Balloons of different diameters may be used for dilating the same region of the target anatomy. The target anatomy may be pre-dilated before dilating the target anatomy by balloon 938. This step is performed by using a balloon catheter with a balloon of a diameter smaller than the diameter of balloon 938. The target anatomy may be re-dilated after dilating the target anatomy by balloon 938. This step is performed by using a balloon catheter with a balloon of a diameter larger than the diameter of balloon 938. The steps of pre-dilation or re-dilation can be performed by inserting one or more additional balloon catheters over the guidewire used to insert balloon catheter 934. The steps of pre-dilation or re-dilation may be repeated using multiple balloon catheters if desired.

Balloon catheter 934 may be used to dilate multiple regions of the anatomy. This method embodiment is especially useful for optimal dilation of a longer passageway. In this technique, the balloon is positioned in one location, inflated, and then deflated. Instead of retracting the balloon completely, it is simply repositioned to the new location by advancing or retracting it over the guidewire while keeping the guide and the guidewire in place. The balloon is then re-inflated and deflated. This process can be repeated multiple times until the entire passageway has been dilated as desired. This may also be employed as a means of predilating the opening of the paranasal sinus to allow subsequent passage of the balloon catheter. Balloon catheter 934 may be used to break or crack a bony region in an opening of a paranasal sinus ((e.g., any transnasally accessible opening in a paranasal sinus or air cell including but not limited to; natural ostia, surgically altered natural ostia, surgically created openings, antrostomy openings, ostiotomy openings, burr holes, drilled holes, ethmoidectomy openings, natural or man made passageways, etc.) or other anatomical structure where bone is substantially covered by mucosal tissue. The breaking or cracking of the bony region may be indicated by a sudden drop in a pressure gauge located on the inflation device. The breaking or cracking of the bony region may also be accompanied by an audible sound. The sudden drop in pressure or the audible sound can be used as feedback of the success of the step of breaking or cracking of the bony region.

A sinus seeker such as a maxillary sinus seeker, frontal sinus seeker etc. may be used to locate an opening into a paranasal sinus (e.g., any transnasally accessible opening in a paranasal sinus or air cell including but not limited to; natural ostia, surgically altered natural ostia, surgically created openings, antrostomy openings, ostiotomy openings, burr holes, drilled holes, ethmoidectomy openings, natural or man made passageways, etc.) and/or to plan a trajectory for introducing one or more devices disclosed herein. The sinus seeker may be used before or after the step of insertion of devices such as guide device 900, guidewire 910, sheath device 920, balloon catheter 934, etc.

Endoscope(s) may be used to monitor and/or guide one or more steps of the various methods disclosed herein. For example, an endoscope maybe used to direct guidewire 910 into various ostia or ducts or passageways to ensure proper placement of guidewire 910. Distal portions of one or more devices disclosed herein may be of a suitable color to enable the one or more devices to be visualized by the endoscope. A combination of endoscopic visualization and fluoroscopic visualizations may be used to monitor and/or guide one or more steps of the various methods disclosed herein.

A sheath device such as sheath device 920 may be used to provide further support and direction during the placement of guidewire 910. In one method embodiment, sheath device 920 is introduced through guide device 900 such that the distal tip of sheath device 920 is closer to the target region than the distal tip of guide device 900. Thereafter, guidewire 910 is introduced through sheath device 920. Thereafter, sheath device 920 is retracted while keeping guidewire 910 in place. Balloon catheter 934 is then inserted over guidewire 934 and the opening of the paranasal sinus is dilated. In one embodiment, after the opening of the paranasal sinus is dilated, balloon 938 is deflated. Thereafter, only balloon catheter 934 is removed from the anatomy while keeping guidewire 910 and guide device 900 in place. Thereafter, sheath device 920 is inserted through guide device 900 over guidewire 910 into the sinus. Guidewire 910 is then retracted completely and alternate suction and irrigation are employed to drain the sinus of any puss, tissue or fluids that may reside within the cavity. In another method embodiment, balloon catheter 934 is used to provide irrigation with or without some limited suction of low viscosity fluids. This is done after the dilation step by keeping balloon catheter 934 in the anatomy, removing guidewire 910 and then irrigating/suctioning through guidewire lumen of balloon catheter 934.

FIGS. 10A through 10E′ show side views of embodiments of guide devices. One or more of these guide devices may be provided as a part of the system shown in FIGS. 9A through 9D. FIG. 10A shows a side view of a first embodiment of a guide device comprising a substantially straight distal portion. Guide device 1000 comprises an elongate tube 1002. Elongate tube 1002 may be made of suitable biocompatible materials such polymers e.g. Nylon, Pebax, etc. In a preferred embodiment, the material of elongate tube 1002 has Rockwell hardness in the range of about 70R to about 110R. In this preferred embodiment, the distal portion is flexible enough to prevent or reduce damage to the anatomy. Yet, the distal portion is rigid enough to retain its shape as one or more devices are passed through guide device 900. Furthermore, the distal portion is rigid enough to enable a user to use the distal portion to displace anatomical structures. The distal portion of elongate tube 1002 comprises a curved, bent or angled region curved at an angle of less then 5 degrees. In one embodiment, distal portion of elongate tube 1002 is substantially straight. The inner surface of elongate tube 1002 may be lined by a lubricious coating or a tubular lubricious liner made of a suitable biocompatible material such as PTFE. In one embodiment, the outer diameter of elongate tube 1002 is around 0.134+/−0.005 inches. The distal portion of elongate tube 1002 comprises an atraumatic tip 1004. Atraumatic tip 1004 may be made of suitable biocompatible materials including, but not limited to Pebax, etc. Atraumatic tip 1004 prevents or reduces damage to the anatomy caused by the distal end of guide device 1000. In one embodiment, length of atraumatic tip 1004 is 0.08+/−0.04 inches and the material of tip 1004 has Shore Durometer hardness in the range of about 35D to about 72D. Guide device 1000 further comprises a hypotube 1006. Hypotube 1006 may be made of suitable biocompatible materials such as stainless steel 304, titanium, Nitinol, polymers such as Nylon etc. In one embodiment, the outer diameter of hypotube 1006 is 0.154+/−0.005 inches. In one embodiment of a method of constructing guide device 1000, a stainless steel hypotube 1006 is bonded to an elongate tube 1002 such as a Nylon elongate tube 1002 to increase the strength of elongate tube 1002. In one embodiment, hypotube 1006 is heat bonded to elongate tube 1002. One or more openings, perforations or holes may be located on hypotube 1006 to enable material of elongate tube 1002 to melt into the one or more openings, perforations or holes. When the melted material of elongate tube 1002 solidifies, an additional mechanical bonding is created between hypotube 1006 and elongate tube 1002. The proximal end of guide device 1000 comprises a hub 1008. In one embodiment, hub 1008 is a female luer hub. Hub 1008 may have wings 1009 to enable a user to turn guide device 1000. In one embodiment, the axial length of guide device 1000 is 5+/−0.25 inches. In one embodiment, the inner diameter of guide device 1000 is around 0.1 inches. The distal portion of guide device 1000 may comprise a radiopaque marker. In one embodiment, the radiopaque marker is a platinum/iridium marker band. The guide device design shown in FIG. 10A is especially suited for trans-nasal access of the sphenoid sinuses.

FIG. 10B shows a side view of a first embodiment of a guide device comprising a bent, angled or curved distal portion. Guide device 1010 comprises an elongate tube 1012. Elongate tube 1012 may be made of suitable biocompatible materials such polymers e.g. Nylon, Pebax, etc. Elongate tube 1012 comprises a substantially straight proximal portion enclosed by a hypotube and a distal portion comprising a curved, bent or angled region. The angle of the curved, bent or angled region of the distal portion can range from 5 degrees to 45 degrees. In this embodiment, distal portion of elongate tube 1012 is bent by an angle of around 30 degrees. The inner surface of elongate tube 1012 may be lined by a lubricious coating or a tubular lubricious liner made of a suitable biocompatible material such as PTFE. In one embodiment, the outer diameter of elongate tube 1012 is around 0.134+/−0.005 inches. The distal portion of elongate tube 1012 comprises an atraumatic tip 1014. Atraumatic tip 1014 may be made of suitable biocompatible materials including, but not limited to Pebax, etc. Atraumatic tip 1014 prevents or reduces damage to the anatomy caused by the distal end of guide device 1010. In one embodiment, length of atraumatic tip 1014 is 0.08+/−0.04 inches. Guide device 1010 further comprises a hypotube 1016 covering the proximal portion of elongate tube 1012. Hypotube 1016 may be made of suitable biocompatible materials such as stainless steel 304, titanium, Nitinol, polymers such as Nylon etc. In one embodiment, the outer diameter of hypotube 1016 is 0.154+/−0.005 inches. In one embodiment of a method of constructing guide device 1010, a stainless steel hypotube 1016 is bonded to a Nylon elongate tube 1012. The proximal end of guide device 1010 comprises a hub 1018. In one embodiment, hub 1018 is a female luer hub. Hub 1018 may have wings 1019 to enable a user to turn guide device 1010. Wings 1019 may be aligned in the plane of the curve of the distal tip as an indicator of the position and orientation of the distal tip in the anatomy. In one embodiment, the axial length of guide device 1010 is 5+/−0.25 inches. In one embodiment, the inner diameter of guide device 1010 is around 0.1 inches. The distal portion of guide device 1010 may comprise a radiopaque marker. In one embodiment, the radiopaque marker is a platinum/iridium marker band. FIG. 10B′ shows an enlarged view of the distal portion of the guide device in FIG. 10B. FIG. 10B′ shows elongated tube 1012 enclosed by hypotube 1016. Distal end of elongated tube 1012 comprises atraumatic tip 1014. Several parameters defined hereafter characterize the design of the distal portion of guide device 1010. The width of the distal end of guide device 1010 is called W as shown. The length measured from the proximal-most point on the distal curved portion of elongate tube 1012 to the distal tip is called L1. L1 is measured along the linear direction of the straight proximal portion of guide device 1010 as shown in FIG. 10B′. The length of the straight region of elongate tube 1012 from the distal end of the proximal portion till the proximal most point on the curved region of the distal portion is called L2. In one particular embodiment, W is 0.34+/−0.08 inches, L1 is 0.46+/−0.08 inches, L2 is 0 to 2 inches and the radius of curvature of the distal curved region of elongate tube 1012 is 0.180 inches. The guide device design shown in FIGS. 10B and 10B′ is especially suited for trans-nasal access of the sphenoid sinuses.

FIG. 10C shows a side view of a second embodiment of a guide device comprising a bent, angled or curved distal portion. The design of guide device 1020 is similar to the design of guide device 1010. Guide device 1020 comprises an elongate tube 1022. The distal portion of elongate tube 1022 comprises a curved, bent or angled region curved at an angle ranging from 30 degrees to 100 degrees. In this embodiment, distal portion of elongate tube 1022 is bent by an angle of around 70 degrees. The distal portion of elongate tube 1022 comprises an atraumatic tip 1024. Guide device 1020 further comprises a hypotube 1026. The proximal end of guide device 1020 comprises a hub 1028. In one embodiment, hub 1028 is a female luer hub. Hub 1028 may have wings 1029 to enable a user to turn guide device 1020. FIG. 10C′ shows an enlarged view of the distal portion of the guide device in FIG. 10C. FIG. 10C′ shows elongated tube 1022 enclosed by hypotube 1026. Distal end of elongated tube 1022 comprises atraumatic tip 1024. In one particular embodiment, W is 0.45+/−0.08 inches, L1 is 0.32+/−0.08 inches, L2 is 0 to 2 inches and the radius of curvature of the distal curved region of elongate tube 1022 is 0.180 inches. The guide device design shown in FIGS. 10C and 10C′ is especially suited for trans-nasal access of the frontal sinuses.

FIG. 10D shows a side view of a second embodiment of a guide device comprising a bent, angled or curved distal portion. The design of guide device 1030 is similar to the design of guide device 1010. Guide device 1030 comprises an elongate tube 1032. The distal portion of elongate tube 1032 comprises a curved, bent or angled region curved at an angle ranging from 70 degrees to 135 degrees. In this embodiment, distal portion of elongate tube 1032 is bent by an angle of around 90 degrees. The distal portion of elongate tube 1032 comprises an atraumatic tip 1034. Guide device 1030 further comprises a hypotube 1036. The proximal end of guide device 1030 comprises a hub 1038. In one embodiment, hub 1038 is a female luer hub. Hub 1038 may have wings 1039 to enable a user to turn guide device 1030. FIG. 10D′ shows an enlarged view of the distal portion of the guide device in FIG. 10D. FIG. 10D′ shows elongated tube 1032 enclosed by hypotube 1036. Distal end of elongated tube 1032 comprises atraumatic tip 1034. In one particular embodiment, W is 0.39+/−0.080 inches, L1 is 0.25+/−0.08 inches, L2 is 0 to 2 inches and the radius of curvature of the distal curved region of elongate tube 1032 is 0.180 inches. W may be as small as 5 mm with a corresponding reduction in the radius of curvature of the distal curved region of elongate tube 1032. The guide device design shown in FIGS. 10D and 10D′ is especially suited for trans-nasal access of the maxillary sinuses.

FIG. 10E shows a side view of a second embodiment of a guide device comprising a bent, angled or curved distal portion. The design of guide device 1040 is similar to the design of guide device 1010. Guide device 1040 comprises an elongate tube 1042. The distal portion of elongate tube 1042 comprises a curved, bent or angled region curved at an angle ranging from 100 degrees to 120 degrees. In this embodiment, distal portion of elongate tube 1042 is bent by an angle of around 110 degrees. The distal portion of elongate tube 1042 comprises an atraumatic tip 1044. Guide device 1040 further comprises a hypotube 1046. The proximal end of guide device 1040 comprises a hub 1048. In one embodiment, hub 1048 is a female luer hub. Hub 1048 may have wings 1049 to enable a user to turn guide device 1040. FIG. 10E′ shows an enlarged view of the distal portion of the guide device in FIG. 10E. FIG. 10E′ shows elongated tube 1042 enclosed by hypotube 1046. Distal end of elongated tube 1042 comprises atraumatic tip 1044. In one particular embodiment, W is 0.46+/−0.08 inches, L1 is 0.25+/−0.08 inches, L2 is 0 to 0.5 inches and the radius of curvature of the distal curved region of elongate tube 1042 is 0.180 inches. L1 and W may be smaller than 0.25+/−0.08 inches and 0.46+/−0.08 inches respectively. The guide device design shown in FIGS. 10E and 10E′ is especially suited for trans-nasal access of the maxillary sinuses.

FIG. 10F shows a partial longitudinal sectional view through the plane 10-10 in FIG. 10A showing a first embodiment of the distal tip of a guide device. Distal portion of guide device 1000 comprises elongate tube 1002. Distal portion of elongate tube 1002 has an atraumatic tip 1004. In this embodiment, the distal edge of atraumatic tip 1004 has a tapered distal edge to reduce tissue injury due to guide device 1000. Guide device 1000 further comprises a radiographic marker band 1050. In this embodiment, marker band 1050 is located on the inner surface of atraumatic tip 1004. Guide device 1000 further comprises a lubricious liner 1052 located on the inner surface of guide device 1000.

FIG. 10G shows a partial longitudinal sectional view through the plane 10-10 in FIG. 10A showing a second embodiment of the distal tip of a guide device. Distal portion of guide device 1000 comprises elongate tube 1002. Distal portion of elongate tube 1002 has an atraumatic tip 1004. In this embodiment, the distal edge of atraumatic tip 1004 has a rounded distal edge to reduce tissue injury due to guide device 1000. Guide device 1000 further comprises a radiographic marker band 1050. In this embodiment, marker band 1050 is located on the inner surface of atraumatic tip 1004. Guide device 1000 further comprises a lubricious liner 1052 located on the inner surface of guide device 1000.

FIG. 11 shows a perspective view of an embodiment of a guide device. Guide device 1100 comprises an elongate tube 1102. The distal portion of elongate tube 1102 comprises a curved, bent or angled region. The distal portion of elongate tube 1102 comprises an atraumatic tip 1104. Guide device 1100 further comprises a hypotube 1106. The proximal end of guide device 1100 comprises a hub 1108. In one embodiment, hub 1108 is a female luer hub. Hub 1108 may have wings 1110 to enable a user to torque guide device 1100. FIG. 11A shows a cross sectional view through line 11A-11A of FIG. 11. FIG. 11A shows a cross section of guide device 1100 showing elongate tube 1102 surrounded by hypotube 1106. In this embodiment, inner surface of elongate tube 1106 is lined by a lubricious coating or a lubricious liner 1112. Lubricious liner 1112 may be made of suitable biocompatible materials such as PTFE. FIG. 11B shows a cross sectional view through line 11B-11B of FIG. 11. FIG. 11B shows a cross section of guide device 1100 showing elongate tube 1102. In this embodiment, inner surface of elongate tube 1106 is lined by a lubricious coating or a lubricious liner 1112. FIG. 11C shows a cross sectional view through line 11C-11C of FIG. 11. FIG. 11C shows a cross section of guide device 1100 showing atraumatic tube 1104 enclosing a radiographic marker band 1114. In this embodiment, inner surface of guide device 1100 is lined by a lubricious coating or a lubricious liner 1112. FIG. 11C′ shows an enlarged view of region 11C′ in FIG. 11C showing atraumatic tube 1104 enclosing radiographic marker band 1114 and lubricious liner 1112.

FIG. 12 shows a longitudinal sectional view of a guidewire. Guidewire 1200 is a flexible guidewire comprising a core wire comprising a proximal portion 1202, a middle portion 1204 and a distal portion 1206. In one embodiment, proximal portion 1202 and distal portion 1206 are substantially cylindrical with the diameter of proximal portion 1202 greater than the diameter of distal portion 1206. This causes the distal portion of guidewire 1200 to be substantially floppy. In one embodiment, the length of the floppy region is about 20 cm. Middle portion comprises a tapered shape. The core wire can be made of suitable biocompatible materials such as stainless steel, Nitinol, etc. Guidewire 1200 further comprises an outer coil 1208. Outer coil 1208 may be made of suitable biocompatible materials including, but not limited to stainless steel. Outer coil 1208 is connected to the core wire at the distal end of guidewire 1200 by a smooth, burr free soldered or welded distal joint 1210 to get an atraumatic distal tip. Similarly, outer coil 1208 is connected to the core wire at the proximal end of guidewire 1200 by a smooth, burr free soldered or welded proximal joint 1212 to get an atraumatic proximal tip. Guidewire 1200 may further comprise an inner coil located on the distal portion of guidewire 1200 enclosed by outer coil 1208. The inner coil may be made of suitable radiopaque materials to allow visualization of the distal portion of guidewire 1200 under fluoroscopy. In one particular embodiment, the inner coil is made of an alloy of 92% platinum and 8% tungsten. A part or the entire outer surface of guidewire 1200 may comprise a lubricious coating such as a PTFE coating. In one embodiment, the length A of middle portion 1204 is about 16.5 cm, length B of distal portion 1206 is about 7 cm and the total length C of guidewire 1200 is about 75 cm. In another embodiment, the length A of middle portion 1204 is about 17 cm, length B of distal portion 1206 is about 7 cm and the total length C of guidewire 1200 is about 120 cm. In another embodiment, the length A of middle portion 1204 is about 13 cm, length B of distal portion 1206 is about 11 cm and the total length C of guidewire 1200 is about 120 cm. In one embodiment, the diameter of guidewire 1200 is about 0.035 inches. Various designs of guidewire 1200 may be used to design guidewire 910 in FIG. 9B. Multiple guidewires with various design parameters such as outer diameter, stiffness, length may be supplied as a part of a system such as the system shown in FIGS. 9A through 9D. Guidewire 1200 may be used to access various regions in the anatomy. It can be used to facilitate placement of other devices during various diagnostic or therapeutic procedures. Guidewire 1200 may be torquable to facilitate navigation of guidewire 1200 especially through tortuous anatomy. Specific uses of guidewire 1200 include, but are not limited to introduction and support of various diagnostic or therapeutic devices for performing procedures such as sinus ostia dilation, lavage of anatomical spaces such as paranasal sinuses, suction, etc. Another specific use of guidewire 1200 is introduction of devices for treatment of the middle ear via the Eustachian tube. A portion of the distal end of guidewire 1200 may be introduced into a paranasal sinus so that the portion of guidewire 1200 is coiled inside the paranasal sinus. This enables a user to estimate the contour of the paranasal sinus.

FIG. 13A shows an embodiment of a sheath device comprising a substantially straight distal end. Sheath device 1350 comprises a flexible elongate shaft 1352. Elongate shaft 1352 is substantially straight and comprises a lumen. Elongate shaft 1352 may be made of suitable biocompatible materials including, but not limited to polyethylene, Nylon, etc. In one embodiment, elongate shaft 1352 comprises a stiffening means including, but not limited to metal braids or coils, polymer jackets, etc. In another embodiment, stiffness of elongate shaft 1352 is increased by crosslinking material of elongate shaft 1352 by exposing it to an electron beam. Distal end of elongate shaft 1352 may comprise an atraumatic tip made of a soft polymer or a radiused tip. Distal portion of elongate shaft 1352 may also comprise a radiopaque marker such as a platinum-iridium radiographic marker to enable visualization of the distal portion of elongate shaft 1352 under fluoroscopy. The inner surface of elongate shaft may be lined with a lubricious coating or a lubricious inner liner. The proximal end of elongate shaft 1352 comprises a hub 1354. In one embodiment, hub 1354 is a female luer hub. Hub 1354 comprises one or more wings 1356 that are used by a user to torque sheath device 1350. A strain relief tubing 1358 may be provided between hub 1354 and elongate shaft 1352. Strain relief tubing 1358 may be made of suitable biocompatible materials such as polyimide. Sheath device 1350 may be made in various sizes and shapes to facilitate access to various anatomical regions such as various paranasal sinuses and passageways and openings leading to the paranasal sinuses. In an embodiment, the effective length of sheath device 1350 is 29+/−1 cm, the outer diameter of elongate shaft 1352 is 0.052+/−0.003 inches, and inner diameter of elongate shaft 1352 is 0.040+/−0.003 inches. Such a device is compatible with guide devices of an inner diameter greater than 0.056 inches. Such a device is especially suited for lavaging an anatomical region. In another embodiment, the effective length of sheath device 1350 is 35+/−2 cm, the outer diameter of elongate shaft 1352 is 0.059+/−0.002 inches, and inner diameter of elongate shaft 1352 is 0.039+1−0.001 inches Such a device is compatible with guide devices of an inner diameter greater than 0.065 inches. Such a device is especially suited for suctioning an anatomical region, exchanging elongate devices, supporting the introduction or removal of elongate devices, etc. In another embodiment, the effective length of sheath device 1350 is 22+/−1 cm, the outer diameter of elongate shaft 1352 is 0.088+/−0.002 inches, and inner diameter of elongate shaft 1352 is 0.065+1−0.001 inches. Such a device is compatible with guide devices of an inner diameter greater than 0.097 inches. Such a device is especially suited for suctioning an anatomical region, supporting the introduction of thinner elongate devices, etc.

FIG. 13B shows another embodiment of a sheath device comprising a bent, curved or angled distal end. Design of sheath device 1360 is substantially similar to design of sheath device 1350. Sheath device 1360 comprises a flexible elongate shaft 1362. The distal portion of elongate shaft 1362 comprises a bent, curved or angled region to facilitate access to various anatomical regions such as various paranasal sinuses and passageways and openings leading to the paranasal sinuses. In one embodiment, distal portion of elongate shaft 1362 comprises a bent region bent by an angle of around 30 degrees. In another embodiment, distal portion of elongate shaft 1362 comprises a bent region bent by an angle of around 45 degrees. The proximal end of elongate shaft 1362 comprises a hub 1364. In one embodiment, hub 1364 is a female luer hub. Hub 1364 comprises one or more wings 1366 that are used by a user to torque sheath device 1360. Wings 1366 may be aligned in the plane of the bent, curved or angled region of the elongate shaft 1362. A strain relief tubing 1368 may be provided between hub 1364 and elongate shaft 1362. In an embodiment, the effective length of sheath device 1360 is 29+/−1 cm, the outer diameter of elongate shaft 1362 is 0.052+/−0.003 inches, and inner diameter of elongate shaft 1362 is 0.040+/−0.003 inches. Such a device is compatible with guide devices of an inner diameter greater than 0.056 inches. Such a device is especially suited for ravaging an anatomical region. In another embodiment, the effective length of sheath device 1360 is 35+/−2 cm, the outer diameter of elongate shaft 1362 is 0.059+/−0.002 inches, and inner diameter of elongate shaft 1362 is 0.039+/−0.001 inches Such a device is compatible with guide devices of an inner diameter greater than 0.065 inches. Such a device is especially suited for suctioning an anatomical region, exchanging elongate devices, supporting the introduction or removal of elongate devices, etc. In another embodiment, the effective length of sheath device 1360 is 22+/−1 cm, the outer diameter of elongate shaft 1362 is 0.088+/−0.002 inches, and inner diameter of elongate shaft 1362 is 0.065+/−0.001 inches. Such a device is compatible with guide devices of an inner diameter greater than 0.097 inches. Such a device is especially suited for suctioning an anatomical region, supporting the introduction of thinner elongate devices, etc.

Sheath device 1350 and sheath device 1360 can be used as a part of the system shown in FIGS. 9A through 9D. The sheath devices disclosed herein can be used for lavage, suction, and exchange of wires in anatomical regions such as the paranasal sinuses. The sheath devices may also be used to redirect guide wires during guide wire probing. Specific uses for the sheath devices include, but are not limited to, the introduction and support of various interventional and diagnostic devices when performing procedures such as sinus ostia dilation, sinus ravage, and suction. The sheath devices may also be used for other applications including, but not limited to treatment of the middle ear via the Eustachian tube, etc.

FIG. 14 shows a side view of en embodiment of a balloon catheter. The balloon catheter design disclosed in FIG. 14 may be used as balloon catheter 934 in FIG. 9D. In FIG. 14, balloon catheter 1400 comprises an elongate shaft 1402. In one embodiment, outer diameter of elongate shaft 1402 is around 0.046″+/−0.005″. In another embodiment, outer diameter of elongate shaft 1402 is around 0.066″+/−0.005″. Elongate shaft 1402 comprises a guidewire lumen to allow balloon catheter 1400 to be introduced over a guidewire such as a 0.035″ guidewire. A balloon 1404 is located on the distal portion of elongate shaft 1402. In one embodiment, balloon 1404 is a non-compliant balloon of compliance ranging from 0.025 to 0.030 mm per atmosphere. Balloon 1404 may be made of suitable biocompatible materials including, but not limited to PET, Nylon, etc. Balloon 1404 may be coated with one or more balloon coatings including, but not limited to puncture resistance coating, abrasion resistance coating, anti-tack coating, etc. In a particular embodiment, balloon 1404 is made of PET of a wall thickness around 0.002 inches coated by a 0.002 inch thick polyurethane coating with a tensile strength of 12,000 to 16,000 psi and a burst pressure of more than 16 atmospheres. The working length of balloon 1404 may range from 4 mm to 50 mm. In one embodiment, working length of balloon is around 16+/−1 mm. Balloon 1404 may be inflated to a suitable working pressure of around 12 to 16 atmospheres. In one embodiment of a system comprising multiple balloon catheters, three balloon catheters of inflated balloon diameters around 3+/−0.5 mm, 5+/−0.5 mm and 7+/−0.5 mm are provided in the system. In another embodiment of a system comprising multiple balloon catheters, two balloon catheters of inflated balloon diameters around 5+/−0.5 mm and 7+/−0.5 mm are provided in the system. Balloon catheter 1400 of an inflated balloon diameter around 7 mm is especially suitable for dilating passageways leading to the maxillary sinuses. Balloon catheter 1400 of an inflated balloon diameter around 9 mm is especially suitable for dilating passageways leading to the paranasal sinuses in patients that have undergone a previous sinus surgery. Balloon 1404 may be folded to reduce its profile. The folding may be done to produce multiple folded wings of the balloon material. For example, a 7 mm diameter balloon may be folded to produce 4 to 7 folded wings of the balloon material. In the embodiment of balloon catheter 1400 shown in FIG. 14, the proximal end of balloon catheter 1400 comprises a ‘Y’ connector 1406. The proximal end of ‘Y’ connector 1406 comprises a first luer port 1408 that leads to a guidewire lumen in balloon catheter 1400. ‘Y’ connector 1406 further comprises a second luer port 1410 that is in fluid communication with a balloon inflation lumen in balloon catheter 1400. Balloon 1404 is inflated by injecting a suitable inflation medium such as diluted contrast solution through second luer port 1410 by an inflation device 1412. In one embodiment, inflation device 1412 is connected to second luer port 1410 by a segment of extension tubing. A stress relief tubing 1414 may be located between ‘Y’ connector 1406 and elongate shaft 1402. Elongate shaft 1402 may comprise a first catheter shaft marker 1416 with or without a second catheter shaft marker 1418. In one embodiment, length of balloon catheter 1400 is 30+/−1 cm.

FIGS. 14A and 14B show cross sectional views of the balloon catheter of FIG. 14 through lines 14A-13A and 14B-13B respectively. FIG. 14A shows a cross section of elongate shaft 1402. Elongate shaft 1402 comprises an outer tube 1420 and an inner tube 1422. Outer tube 1420 and inner tube 1422 can be made of suitable biocompatible polymers including, but not limited to Pebax, Nylon, etc. Inner tube 1422 encloses a guidewire lumen. In one embodiment, the guidewire lumen has an internal diameter greater than 0.0155 inches to enable insertion of balloon catheter 1400 into the anatomy over a 0.014″ guidewire. In another embodiment, the guidewire lumen has an internal diameter greater than 0.0360 inches to enable insertion of balloon catheter 1400 into the anatomy over a 0.035″ guidewire. The lumen between outer tube 1420 and an inner tube 1422 encloses a balloon inflation lumen that is in fluid communication with balloon 1404. FIG. 14B shows a cross section of elongate shaft 1402 at a region distal to balloon 1404. Elongate shaft 1402 comprises an inner tube 1422 without outer tube 1420 since outer tube 1420 opens into balloon 1404. FIG. 14C shows an enlarged view of segment 14C of FIG. 14. Distal end of outer tube 1420 opens into balloon 1404. In one embodiment, the length of inner tube 1422 distal to balloon 1404 is 3.0+/−0.75 mm. In another embodiment, the length of inner tube 1422 distal to balloon 1404 is 5.0+/−0.75 mm. In this example, balloon 1404 is a standard balloon comprising a cylindrical body, two conical tapers, and two necks. Alternatively, balloon 1404 may also comprise other types of balloon designs. The portion of inner tube 1422 enclosed by balloon 1404 may comprise one or more radiographic markers. In this example, inner tube 1422 comprises two radiographic markers 1424. Radiographic markers 1424 are used to verify the position of balloon 1404 during the use of balloon catheter 1400. FIG. 14D shows an enlarged perspective view of segment 14D in FIG. 14. Elongate shaft 1402 comprises visual markers such as a first catheter shaft marker 1416 and a second catheter shaft marker 1418. The visual markers are used to verify relative location of balloon 1404 relative to distal end of a guide device when balloon catheter 1404 is introduced through the guide device. When second balloon catheter shaft marker 1481 enters the proximal end of the guide device, the distal tip of balloon catheter 1400 emerges out of the distal end of the guide device. First catheter shaft marker 1416 starts to enter the proximal end of the guide device when the material of balloon 1404 starts to emerge out of the distal end of the guide device. First catheter shaft marker 1416 completely enters proximal end of the guide device when material of balloon 938 completely emerges out of the distal end of the guide device. Thus, erroneous inflation of balloon 1404 within the guide device can be prevented. In one embodiment, the distance from the distal end of first catheter shaft marker 1316 and the distal tip of balloon catheter 1400 is 15.0+/−1.0 cm. FIG. 14E shows a cross sectional view of the balloon in FIG. 14C through line 14E-14E. Inner tube 1422 is surrounded by balloon 1404. Balloon 1404 is made of suitable biocompatible materials and may comprise one or more coatings on the outer surface of balloon 1404.

A probing tool could be used in conjunction with the various methods and devices disclosed herein. The probing tool is a generally rigid, elongate element that is inserted through the nose. The distal end of the probing tool may be substantially straight or may comprise a curved, angled or bent region. The distal region or end of the probing tool is advanced to reach an opening of a paranasal sinus (e.g., any transnasally accessible opening in a paranasal sinus or cranio-facial air cell, including but not limited to; natural ostia, surgically or medically altered ostia, surgically created or man made openings, antrostomy openings, ostiotomy openings, trephination openings, burr holes, drilled holes, ethmoidectomy or an anatomical region substantially near such opening of a paranasal sinus. The probing tool is then used to determine the location and/or that opening or anatomical region. Information about the location and/or the orientation of that opening or anatomical region can be appreciated or determined in many ways.

For example, the orientation of the proximal region of the probing tool outside the nose provides the user information about the location and/or the orientation of the opening or anatomical region. In a second embodiment, the location and/or orientation of the probing tool in the anatomy is visualized under endoscopic and/or fluoroscopic visualization to provide the user information about the location and/or the orientation of the opening or anatomical region. In a third embodiment, the probing tool comprises a navigational modality such as an electromagnetic surgical navigation modality. The location and orientation of the distal region of the probing tool can then be visualized using the electromagnetic surgical navigation modality to obtain information about the location and/or the orientation of the opening or anatomical region. The information about the location and/or the orientation of an opening or anatomical region is then used to plan the trajectory of introducing one or more diagnostic, therapeutic or introducing devices into the opening or anatomical region. This has the advantage of reducing procedure time. Examples of such probing tools include, but are not limited to frontal sinus seekers, maxillary sinus seekers, etc. The probing tools may be solid or may comprise a lumen. The diagnostic, therapeutic or introducing devices may be introduced over the probing devices, through the probing device or may replace the probing device. The probing tools may be made of suitable biocompatible materials including, but not limited to stainless steel, Nitinol, polymers etc.

As described herein, the present invention includes methods for accessing an opening of a paranasal sinus (e.g., any transnasally accessible opening in a paranasal sinus or cranio-facial air cell, including but not limited to; natural ostia, surgically or medically altered ostia, surgically created or man made openings, antrostomy openings, ostiotomy openings, trephination openings, burr holes, drilled holes, ethmoidectomy openings, anatomical passageways, natural or man made passages, etc.) or other anatomical region substantially near such opening of a paranasal sinus. In these methods a probing tool, such as a maxillary sinus seeker, is used to determine the location and orientation of the opening or anatomical region (e.g., the maxillary sinus ostium). In the case of a maxillary sinus ostium, this is done by navigating the distal region of the maxillary sinus seeker around the uncinate process such that the distal end of the maxillary sinus seeker enters the maxillary sinus ostium. The position and orientation of the proximal region of the maxillary sinus seeker is then used to determine the location and/or orientation of the maxillary sinus ostium. Thereafter, the maxillary sinus seeker is removed from the anatomy. Thereafter, a diagnostic or therapeutic device e.g. a fixed wire balloon catheter is used to access the maxillary sinus ostium. Alternatively, an access device e.g. a guide device may be placed in a suitable location and orientation and a diagnostic or therapeutic device may be advanced into the maxillary sinus ostium using the guide device.

In another embodiment of a method of accessing an ostium or a passageway leading to a paranasal sinus, a probing tool such as a frontal sinus seeker comprising a lumen is used to determine the location and orientation of the passageway leading to a frontal sinus. Thereafter, a guidewire is introduced through the lumen of the frontal sinus seeker into the frontal sinus. Thereafter, the frontal sinus seeker is exchanged over the guidewire for a diagnostic or therapeutic device such as a balloon catheter.

The term “diagnostic or therapeutic substance” as used herein is to be broadly construed to include any feasible drugs, prodrugs, proteins, gene therapy preparations, cells, diagnostic agents, contrast or imaging agents, biologicals, etc. Such substances may be in bound or free form, liquid or solid, colloid or other suspension, solution or may be in the form of a gas or other fluid or nano-fluid. For example, in some applications where it is desired to treat or prevent a microbial infection, the substance delivered may comprise pharmaceutically acceptable salt or dosage form of an antimicrobial agent (e.g., antibiotic, antiviral, antiparasitic, antifungal, etc.), a corticosteroid or other anti-inflammatory (e.g., an NSAID), a decongestant (e.g., vasoconstrictor), a mucous thinning agent (e.g., an expectorant or mucolytic), an agent that prevents of modifies an allergic response (e.g., an antihistamine, cytokine inhibitor, leucotriene inhibitor, IgE inhibitor, immunomodulator), etc. Other non-limiting examples of diagnostic or therapeutic substances that may be useable in this invention are described in copending U.S. patent application Ser. No. 10/912,578 entitled Implantable Devices and Methods for Delivering Drugs and Other Substances to Treat Sinusitis and Other Disorders filed on Aug. 4, 2004, issued as U.S. Pat. No. 7,361,168 on Apr. 22, 2008, the entire disclosure of which is expressly incorporated herein by reference.

The term “nasal cavity” used herein to be broadly construed to include any cavity that is present in the anatomical structures of the nasal region including the nostrils and paranasal sinuses.

The term “trans-nasal” means through a nostril.

Reference herein to an “opening of a paranasal sinus” pr “opening in a paranasal sinus” shall mean: any transnasally accessible opening in a paranasal sinus or cranio-facial air cell, including but not limited to; natural ostia, surgically or medically altered ostia, surgically created or man made openings, antrostomy openings, ostiotomy openings, trephination openings, burr holes, drilled holes, ethmoidectomy openings, anatomical passageways, natural or man made passages, etc.

Although the methods and devices disclosed herein are illustrated in conjunction with particular paranasal sinuses, it is understood that these methods and devices can be used in other paranasal sinuses as well as other anatomical passageways of the ear, nose or throat.

Optionally, any of the working devices and guide catheters described herein may be configured or equipped to receive or be advanced over a guidewire or other guide member (e.g., an elongate probe, strand of sure material, other elongate member) unless to do so would render the device inoperable for its intended purpose. Some of the specific examples described herein include guidewires, but it is to be appreciated that the use of guidewires and the incorporation of guidewire lumens is not limited to only the specific examples in which guidewires or guidewire lumens are shown. The guidewires used in this invention may be constructed and coated as is common in the art of cardiology. This may include the use of coils, tapered or non-tapered core wires, radioopaque tips and/or entire lengths, shaping ribbons, variations of stiffness, PTFE, silicone, hydrophilic coatings, polymer coatings, etc. For the scope of this invention, these wires may possess dimensions of length between 5 and 75 cm and outer diameter between 0.005″ and 0.050″.

Several modalities can be used with the devices and methods disclosed herein for navigation and imaging of the devices within the anatomy. For example, the devices disclosed herein may comprise an endoscope for visualization of the target anatomy. The devices may also comprise ultrasound imaging modalities to image the anatomical passageways and other anatomical structures. The devices disclosed herein may comprise one or more magnetic elements especially on the distal end of the devices. Such magnetic elements may be used to navigate through the anatomy by using external magnetic fields. Such navigation may be controlled digitally using a computer interface. The devices disclosed herein may also comprise one or more markers (e.g. infra-red markers). The markers can be used to track the precise position and orientation of the devices using image guidance techniques. Several other imaging or navigating modalities including but not limited to fluoroscopic, radiofrequency localization, electromagnetic, magnetic and other radiative energy based modalities may also be used with the methods and devices disclosed herein. These imaging and navigation technologies may also be referenced by computer directly or indirectly to pre-existing or simultaneously created 3-D or 2-D data sets which help the doctor place the devices within the appropriate region of the anatomy.

The distal tip of devices mentioned herein may comprise a flexible tip or a soft, atraumatic tip. Also, the shaft of such devices may be designed for enhanced torquability.

The embodiments herein have been described primarily in conjunction with minimally invasive procedures, but they can also be used advantageously with existing open surgery or laparoscopic surgery techniques.

It is to be appreciated that the invention has been described hereabove with reference to certain examples or embodiments of the invention but that various additions, deletions, alterations and modifications may be made to those examples and embodiments without departing from the intended spirit and scope of the invention. For example, any element or attribute of one embodiment or example may be incorporated into or used with another embodiment or example, unless to do so would render the embodiment or example unsuitable for its intended use. Also, where the steps of a method or process are described, listed or claimed in a particular order, such steps may be performed in any other order unless to do so would render the embodiment or example un-novel, obvious to a person of ordinary skill in the relevant art or unsuitable for its intended use. All reasonable additions, deletions, modifications and alterations are to be considered equivalents of the described examples and embodiments and are to be included within the scope of the following claims.

Claims

1. A method of using a dilation catheter system to treat a patient, the dilation catheter system comprising: (a) a guide; and(b) a dilation catheter comprising: (i) a shaft, and(ii) a dilator coupled with a distal portion of the shaft, wherein the dilator includes a coating, wherein the coating includes a diagnostic or therapeutic substance,the method comprising:(a) advancing a distal end of the guide within a passageway associated with drainage of a paranasal sinus;(b) advancing the dilator along the guide to thereby position the dilator within the passageway associated with the drainage of the paranasal sinus; and(c) expanding the dilator such that the coating of the dilator is in contact with the passageway associated with the drainage of the paranasal sinus to deliver the diagnostic or therapeutic substance to the passageway associated with the drainage of the paranasal sinus.
2. The method of claim 1, wherein the passageway associated with the drainage of the paranasal sinus includes a meatus or an ostium.
3. The method of claim 1, wherein the paranasal sinus is a frontal sinus, wherein the act of expanding the dilator further comprises expanding the dilator such that the coating of the dilator is in contact with the passageway associated with the drainage of the frontal sinus to deliver the diagnostic or therapeutic substance to the passageway associated with the drainage of the frontal sinus.
4. The method of claim 1, wherein the diagnostic or therapeutic substance includes a drug to treat sinusitis of the patient, wherein expanding the dilator further comprises expanding the dilator such that the coating is in contact with the passageway associated with the drainage of the paranasal sinus to deliver the drug to the passageway associated with the drainage of the paranasal sinus to treat the sinusitis.
5. The method of claim 1, wherein the diagnostic or therapeutic substance includes a corticosteroid, wherein expanding the dilator further comprises expanding the dilator such that the coating is in contact with the passageway associated with the drainage of the paranasal sinus to deliver the corticosteroid to the passageway associated with the drainage of the paranasal sinus.
6. The method of claim 1, wherein the diagnostic or therapeutic substance includes an anti-inflammatory agent, wherein expanding the dilator further comprises expanding the dilator such that the coating is in contact with the passageway associated with the drainage of the paranasal sinus to deliver the anti-inflammatory agent to the passageway associated with the drainage of the paranasal sinus.
7. The method of claim 1, wherein expanding the dilator further comprises expanding the dilator such that the coating of the dilator is in contact with the passageway associated with the drainage of the paranasal sinus to deliver the diagnostic or therapeutic substance to the passageway associated with the drainage of the paranasal sinus.
8. The method of claim 1, wherein the dilator comprises an expandable balloon having an outer surface, wherein expanding the dilator further comprises dilating the passageway associated with the drainage of the paranasal sinus with the expandable balloon such that the coating disposed on the outer surface of the expandable balloon is in contact with the passageway associated with the drainage of the paranasal sinus to deliver the diagnostic or therapeutic substance to the passageway associated with the drainage of the paranasal sinus.
9. The method of claim 1, wherein the guide includes a lumen, wherein advancing the dilator further comprises advancing the dilator through the lumen of the guide to thereby position the dilator within the passageway associated with the drainage of the paranasal sinus.
10. The method of claim 1, wherein advancing the dilator further comprises sliding the dilator over the guide to thereby position the dilator within the passageway associated with the drainage of the paranasal sinus.
11. A method of using a dilation catheter system to treat a patient, the dilation catheter system comprising: (a) a guide; and(b) a catheter comprising: (i) a shaft, and(ii) a working device coupled with a distal portion of the shaft, wherein the working device includes a coating, wherein the coating includes an anti-inflammatory agent,the method comprising:(a) advancing a distal end of the guide within or near a passageway associated with drainage of a paranasal sinus;(b) advancing the working device along the guide to thereby position the working device within or near the passageway associated with the drainage of the paranasal sinus; and(c) contacting the coating of the working device to the passageway associated with the drainage of the paranasal sinus to deliver the anti-inflammatory agent to the passageway associated with the drainage of the paranasal sinus.
12. The method of claim 11, wherein the paranasal sinus is a frontal sinus, wherein the act of contacting the coating of the working device to the passageway associated with the drainage of the paranasal sinus further comprises contacting the coating of the working device to the passageway associated with the drainage of the frontal sinus to deliver the anti-inflammatory agent to the passageway associated with the drainage of the frontal sinus.
13. The method of claim 11, wherein the anti-inflammatory agent includes a corticosteroid, wherein contacting the coating of the working device to the paranasal sinus further comprises contacting the coating of the working device to the paranasal sinus to deliver the corticosteroid to the paranasal sinus.
14. The method of claim 11, wherein the working device includes an expandable balloon, wherein contacting the coating of the working device to the paranasal sinus further comprises inflating the expandable balloon to an inflated configuration such that the coating is contacting the paranasal sinus to deliver the anti-inflammatory agent to the paranasal sinus.
15. The method of claim 14, wherein the expandable balloon defines a guidewire lumen, wherein the dilation catheter system further comprises a guidewire slidably disposed within the guidewire lumen of the expandable balloon, wherein the method further comprises distally advancing the guidewire distally past the guidewire lumen and the distal end of the guide while the expandable balloon is in a deflated configuration.
16. A method of using a dilation catheter system to treat a patient, the dilation catheter system comprising: (a) a guide; and(b) a balloon catheter comprising: (i) a shaft, and(ii) an expandable balloon coupled with a distal portion of the shaft, wherein the expandable balloon is configured to move between deflated and inflated configurations, wherein the expandable balloon includes a coating, wherein the coating includes a corticosteroid,the method comprising:(a) advancing a distal end of the guide within or near a passageway associated with drainage of a paranasal sinus of the patient;(b) advancing the expandable balloon of the balloon catheter along the guide to thereby position the expandable balloon within or near the passageway associated with the drainage of the paranasal sinus; and(c) inflating the expandable balloon to dilate the passageway associated with the drainage of the paranasal sinus to deliver the corticosteroid to the passageway associated with the drainage of the paranasal sinus.
17. The method of claim 16, further comprising: (a) deflating the expandable balloon from the inflated configuration to the deflated configuration; and(b) withdrawing the guide and the expandable balloon from the patient while the expandable balloon is in the deflated configuration.
18. The method of claim 17, wherein advancing the expandable balloon further comprises sliding the expandable balloon over the guide to thereby position the expandable balloon within or near the passageway associated with the drainage of the paranasal sinus.
19. The method of claim 16, wherein the guide includes a steerable guide catheter, wherein advancing the distal end of the guide further comprises steering a distal end of the steerable guide catheter within or near the passageway associated with the drainage of the paranasal sinus of the patient.

RELATED APPLICATION

This application is a continuation of U.S. patent application Ser. No. 15/651,101, entitled “Devices, Systems and Methods Useable for Treating Sinusitis,” Jul. 17, 2017, now U.S. Pat. No. 10,500,380, issued Dec. 10, 2019, which is a continuation of U.S. patent application Ser. No. 14/221,550, entitled “Devices, Systems and Methods Useable for Treating Sinusitis,” filed Mar. 21, 2014, which is a continuation of U.S. patent application Ser. No. 11/928,097, entitled “Devices, Systems and Methods Useable for Treating Sinusitis,” filed on Oct. 30, 2007 (issued as U.S. Pat. No. 8,715,169 on May 6, 2014), which is a continuation of U.S. patent application Ser. No. 11/150,847, entitled “Devices, Systems and Methods Useable for Treating Sinusitis,” filed on Jun. 10, 2005 (issued as U.S. Pat. No. 7,803,150 on Sep. 28, 2010), which is a continuation-in-part of U.S. patent application Ser. No. 10/944,270, entitled “Apparatus and Methods for Dilating and Modifying Ostia of Paranasal Sinuses and Other Intranasal or Paranasal Structures,” filed on Sep. 17, 2004 (and now abandoned), which is a continuation-in-part of Ser. No. 10/829,917, entitled “Devices, Systems and Methods for Diagnosing and Treating Sinusitis and Other Disorders of the Ears, Nose and/or Throat,” filed on Apr. 21, 2004 (issued as U.S. Pat. No. 7,654,997 on Feb. 2, 2010), the entire disclosures of such earlier filed applications being expressly incorporated herein by reference.

US Referenced Citations (1096)

Number	Name	Date	Kind
446173	Hancock	Feb 1891	A
504424	De Pezzer	Sep 1893	A
513667	Buckingham	Jan 1894	A
705346	Hamilton	Jul 1902	A
798775	Forsyte	Sep 1905	A
816792	Green	Apr 1906	A
1080934	Shackleford	Dec 1913	A
1200267	Sunnergren	Oct 1916	A
1650959	Pitman	Nov 1927	A
1735519	Vance	Nov 1929	A
1828986	Stevens	Oct 1931	A
1878671	Cantor	Sep 1932	A
2201749	Vandegrift	May 1940	A
2493326	Trinder	Jan 1950	A
2525183	Robison	Oct 1950	A
2847997	Tibone	Aug 1958	A
2899227	Jeanrenaud	Aug 1959	A
2906179	Bower	Sep 1959	A
2995832	Alderson	Aug 1961	A
3009265	Bexark	Nov 1961	A
3037286	Bower	Jun 1962	A
3173418	baran	Mar 1965	A
3347061	Stuemky	Oct 1967	A
3376659	Asin et al.	Apr 1968	A
3384970	Avalear	May 1968	A
3393073	Reutenauer et al.	Jul 1968	A
3435826	Fogarty	Apr 1969	A
3447061	Russell et al.	May 1969	A
3469578	Bierman	Sep 1969	A
3477438	Allen et al.	Nov 1969	A
3481043	Esch	Dec 1969	A
3486539	Jacuzzi	Dec 1969	A
3506005	Gilio et al.	Apr 1970	A
3509638	Macleod	May 1970	A
3515137	Santomieri	Jun 1970	A
3515888	Lewis	Jun 1970	A
3527220	Summers	Sep 1970	A
3531868	Stevenson	Oct 1970	A
3552384	Pierie et al.	Jan 1971	A
3624661	Shebanow	Nov 1971	A
3731963	Pond	May 1973	A
3766924	Pidgeon	Oct 1973	A
3792391	Ewing	Feb 1974	A
3800788	White	Apr 1974	A
3802096	Matern	Apr 1974	A
3804081	Kinoshita	Apr 1974	A
3834394	Hunter et al.	Sep 1974	A
3847145	Grossan	Nov 1974	A
3850176	Gottschalk	Nov 1974	A
3856000	Chikama	Dec 1974	A
3859993	Bitner	Jan 1975	A
3871365	Chikama	Mar 1975	A
3894538	Richter	Jul 1975	A
3903893	Scheer	Sep 1975	A
3910617	Scalza et al.	Oct 1975	A
3921636	Zaffaroni	Nov 1975	A
3948254	Zaffaroni	Apr 1976	A
3948262	Zaffaroni	Apr 1976	A
3967618	Zaffaroni	Jul 1976	A
3993069	Buckles et al.	Nov 1976	A
3993072	Zaffaroni	Nov 1976	A
3993073	Zaffaroni	Nov 1976	A
4016251	Higuchi et al.	Apr 1977	A
4052505	Higuchi et al.	Oct 1977	A
4053975	Olbrich et al.	Oct 1977	A
4069307	Higuchi et al.	Jan 1978	A
4102342	Akiyama et al.	Jul 1978	A
4138151	Nakao	Feb 1979	A
4184497	Kolff et al.	Jan 1980	A
4198766	Camin et al.	Apr 1980	A
4207890	Mamajek et al.	Jun 1980	A
4209919	Kirikae et al.	Jul 1980	A
4213095	Falconer	Jul 1980	A
4217898	Theeuwes	Aug 1980	A
4268115	Slemon et al.	May 1981	A
4299226	Banka	Nov 1981	A
4299227	Lincoff	Nov 1981	A
4311146	Wonder	Jan 1982	A
4312353	Shahbabian	Jan 1982	A
4338941	Payton	Jul 1982	A
D269204	Trepp	May 1983	S
4388941	Riedhammer	Jun 1983	A
RE31351	Falconer	Aug 1983	E
4435716	Zandbergen	Mar 1984	A
4437856	Valli	Mar 1984	A
4441495	Hicswa	Apr 1984	A
4445892	Hussein et al.	May 1984	A
4450150	Sidman	May 1984	A
4459977	Pizon et al.	Jul 1984	A
4464175	Altman et al.	Aug 1984	A
4471779	Antoshkiw et al.	Sep 1984	A
4499899	Lyons, III	Feb 1985	A
4517979	Pecenka	May 1985	A
4554929	Samson et al.	Nov 1985	A
4564364	Zaffaroni et al.	Jan 1986	A
4571239	Heyman	Feb 1986	A
4571240	Samson et al.	Feb 1986	A
4581017	Sahota	Apr 1986	A
4585000	Hershenson	Apr 1986	A
D283921	Dyak	May 1986	S
4589868	Dretler	May 1986	A
4592357	Ersek	Jun 1986	A
4596528	Lewis et al.	Jun 1986	A
D284892	Glassman	Jul 1986	S
4603564	Kleinhany et al.	Aug 1986	A
4606346	Berg et al.	Aug 1986	A
4607622	Fritch et al.	Aug 1986	A
4637389	Heyden	Jan 1987	A
4639244	Rizk et al.	Jan 1987	A
4641654	Samson et al.	Feb 1987	A
4645495	Vaillancourt	Feb 1987	A
4669469	Gifford, III	Jun 1987	A
4672961	Davies	Jun 1987	A
4675613	Naegeli et al.	Jun 1987	A
4682607	Vaillancourt et al.	Jul 1987	A
4684363	Ari et al.	Aug 1987	A
4686965	Bonnet et al.	Aug 1987	A
4691948	Austin, Jr. et al.	Sep 1987	A
4696544	Costella	Sep 1987	A
4700694	Shishido	Oct 1987	A
4708434	Tsuno	Nov 1987	A
4708834	Cohen et al.	Nov 1987	A
4726772	Amplatz	Feb 1988	A
4736970	McGourty et al.	Apr 1988	A
4737141	Spits	Apr 1988	A
4748869	Ohtsuka	Jun 1988	A
4748969	Wardle	Jun 1988	A
4748986	Morrison et al.	Jun 1988	A
4753637	Horneffer	Jun 1988	A
4755171	Tennant	Jul 1988	A
4771776	Powell et al.	Sep 1988	A
4784117	Miyazaki	Nov 1988	A
4793359	Sharrow	Dec 1988	A
4795439	Guest	Jan 1989	A
4796629	Grayzel	Jan 1989	A
4802461	Cho	Feb 1989	A
4803076	Ranade	Feb 1989	A
4811743	Stevens	Mar 1989	A
4815478	Buchbinder et al.	Mar 1989	A
4819619	Augustine et al.	Apr 1989	A
4834709	Banning et al.	May 1989	A
4846186	Box et al.	Jul 1989	A
4847258	Sturm et al.	Jul 1989	A
4851228	Zentner et al.	Jul 1989	A
4854330	Evans, III et al.	Aug 1989	A
4862874	Kellner	Sep 1989	A
4867138	Kubota et al.	Sep 1989	A
4883465	Brennan	Nov 1989	A
4897651	DeMonte	Jan 1990	A
4898577	Badger et al.	Feb 1990	A
4917419	Mora, Jr. et al.	Apr 1990	A
4917667	Jackson	Apr 1990	A
4919112	Siegmund	Apr 1990	A
4920967	Cottonaro et al.	May 1990	A
4925445	Sakamoto et al.	May 1990	A
4926858	Gifford, III et al.	May 1990	A
4940062	Hampton et al.	Jul 1990	A
4943275	Stricker	Jul 1990	A
4946466	Pinchuk et al.	Aug 1990	A
4953553	Tremulis	Sep 1990	A
4961433	Christian	Oct 1990	A
4966163	Kraus et al.	Oct 1990	A
4984581	Stice	Jan 1991	A
4986810	Semrad	Jan 1991	A
4991588	Pflueger et al.	Feb 1991	A
4994033	Shockey et al.	Feb 1991	A
4998916	Hammerslag et al.	Mar 1991	A
4998917	Gaiser et al.	Mar 1991	A
5001825	Halpern	Mar 1991	A
5002322	Fukumoto	Mar 1991	A
5009655	Daignault, Jr. et al.	Apr 1991	A
5019075	Spears et al.	May 1991	A
5019372	Folkman et al.	May 1991	A
5020514	Heckele	Jun 1991	A
5021043	Becker et al.	Jun 1991	A
5024650	Hagiwara et al.	Jun 1991	A
5024658	Kozlov et al.	Jun 1991	A
5026384	Farr et al.	Jun 1991	A
5030227	Rosenbluth et al.	Jul 1991	A
5040548	Yock	Aug 1991	A
5041089	Mueller et al.	Aug 1991	A
5044678	Detweiler	Sep 1991	A
5049132	Shaffer et al.	Sep 1991	A
5053007	Euteneuer	Oct 1991	A
5055051	Duncan	Oct 1991	A
5060660	Gambale et al.	Oct 1991	A
5067489	Lind	Nov 1991	A
5069226	Tamauchi et al.	Dec 1991	A
5084010	Plaia et al.	Jan 1992	A
5087244	Wolinsky et al.	Feb 1992	A
5087246	Smith	Feb 1992	A
5090595	Vandoninck	Feb 1992	A
5090910	Narlo	Feb 1992	A
5090959	Samson et al.	Feb 1992	A
5099845	Besz et al.	Mar 1992	A
5102402	Dror et al.	Apr 1992	A
5112228	Zouras	May 1992	A
5116311	Lofstedt	May 1992	A
5127393	McFarlin et al.	Jul 1992	A
5137517	Loney et al.	Aug 1992	A
5139510	Goldsmith, III et al.	Aug 1992	A
5139832	Hayashi et al.	Aug 1992	A
D329496	Wotton	Sep 1992	S
5152747	Olivier	Oct 1992	A
5156595	Adams	Oct 1992	A
5161534	Berthiaume	Nov 1992	A
5163989	Campbell et al.	Nov 1992	A
5165420	Strickland	Nov 1992	A
5167220	Brown	Dec 1992	A
5168864	Shockey	Dec 1992	A
5169386	Becker et al.	Dec 1992	A
5171233	Amplatz et al.	Dec 1992	A
5180368	Garrison	Jan 1993	A
5183470	Wettermann	Feb 1993	A
5189110	Ikematu et al.	Feb 1993	A
5195168	Yong	Mar 1993	A
5195971	Sirhan	Mar 1993	A
5197457	Adair	Mar 1993	A
5201908	Jones	Apr 1993	A
5207695	Trout, III	May 1993	A
5211952	Spicer et al.	May 1993	A
5213576	Abiuso et al.	May 1993	A
5215105	Kizelshteyn et al.	Jun 1993	A
5215965	Lezdey	Jun 1993	A
5221260	Burns et al.	Jun 1993	A
5226302	Anderson	Jul 1993	A
5230348	Ishibe et al.	Jul 1993	A
5236422	Eplett, Jr.	Aug 1993	A
5238004	Sahatjian et al.	Aug 1993	A
5243996	Hall	Sep 1993	A
D340111	Yoshikawa	Oct 1993	S
5250059	Andreas et al.	Oct 1993	A
5251092	Brady et al.	Oct 1993	A
5252183	Shaban et al.	Oct 1993	A
5255679	Imran	Oct 1993	A
5256144	Kraus et al.	Oct 1993	A
5263926	Wilk	Nov 1993	A
5264260	Saab	Nov 1993	A
5267965	Deniega	Dec 1993	A
5269752	Bennett	Dec 1993	A
5270086	Hamlin	Dec 1993	A
5273052	Kraus et al.	Dec 1993	A
5275593	Easley et al.	Jan 1994	A
5286254	Shapland et al.	Feb 1994	A
5290310	Makower et al.	Mar 1994	A
5292305	Boudewijn et al.	Mar 1994	A
5295694	Levin	Mar 1994	A
5300085	Yock	Apr 1994	A
5304121	Sahatjian	Apr 1994	A
5304123	Atala et al.	Apr 1994	A
5306272	Cohen et al.	Apr 1994	A
5308326	Zimmon	May 1994	A
5312430	Rosenbluth et al.	May 1994	A
5313967	Lieber et al.	May 1994	A
5314408	Salmon et al.	May 1994	A
5314417	Stephens et al.	May 1994	A
5314443	Rudnick	May 1994	A
5315618	Yoshida	May 1994	A
5318008	Bullard	Jun 1994	A
5318528	Heaven et al.	Jun 1994	A
5324306	Makower et al.	Jun 1994	A
5328471	Slepian	Jul 1994	A
5333620	Moutafis et al.	Aug 1994	A
5334143	Carroll	Aug 1994	A
5334167	Cocanower	Aug 1994	A
5334187	Fischell et al.	Aug 1994	A
5335671	Clement	Aug 1994	A
5336163	DeMane et al.	Aug 1994	A
5341818	Abrams et al.	Aug 1994	A
5342296	Persson et al.	Aug 1994	A
5343865	Gardineer et al.	Sep 1994	A
5345945	Hodgson et al.	Sep 1994	A
5346075	Nichols et al.	Sep 1994	A
5346508	Hastings	Sep 1994	A
5348537	Wiesner et al.	Sep 1994	A
5350396	Eliachar	Sep 1994	A
5356418	Shturman	Oct 1994	A
5368049	Raman et al.	Nov 1994	A
5368558	Nita	Nov 1994	A
5368566	Crocker	Nov 1994	A
5370640	Koloff	Dec 1994	A
5372138	Crowley et al.	Dec 1994	A
5372584	Zink et al.	Dec 1994	A
D355031	Yoshikawa	Jan 1995	S
5378234	Hammerslag et al.	Jan 1995	A
5385562	Adams et al.	Jan 1995	A
5386817	Jones	Feb 1995	A
5386828	Owens et al.	Feb 1995	A
5391147	Imran et al.	Feb 1995	A
5391179	Mezzoli	Feb 1995	A
5395367	Wilk	Mar 1995	A
5397305	Kawula et al.	Mar 1995	A
5402799	Colon et al.	Apr 1995	A
5409444	Kensey	Apr 1995	A
5411475	Atala et al.	May 1995	A
5411476	Abrams et al.	May 1995	A
5411477	Saab	May 1995	A
5415633	Lazarus	May 1995	A
5425370	Vilkomerson	Jun 1995	A
5439446	Barry	Aug 1995	A
5441483	Avitall	Aug 1995	A
5441494	Ortiz	Aug 1995	A
5441497	Narciso, Jr.	Aug 1995	A
5445646	Euteneuer et al.	Aug 1995	A
5450853	Hastings et al.	Sep 1995	A
5451221	Cho et al.	Sep 1995	A
5454817	Katz	Oct 1995	A
5458572	Campbell et al.	Oct 1995	A
5459700	Jacobs	Oct 1995	A
5464395	Faxon	Nov 1995	A
5465717	Imran et al.	Nov 1995	A
5465733	Hinohara et al.	Nov 1995	A
5478309	Sweezer et al.	Dec 1995	A
5478565	Geria	Dec 1995	A
5486181	Cohen et al.	Jan 1996	A
5496338	Miyagi et al.	Mar 1996	A
5497783	Urick et al.	Mar 1996	A
5507301	Wasicek et al.	Apr 1996	A
5507725	Savage et al.	Apr 1996	A
5507766	Kugo et al.	Apr 1996	A
5507795	Chiang et al.	Apr 1996	A
5512055	Domb et al.	Apr 1996	A
5514128	Hillsman et al.	May 1996	A
5519532	Broome	May 1996	A
5531676	Edwards et al.	Jul 1996	A
5533985	Wang	Jul 1996	A
5538008	Crowe	Jul 1996	A
5546964	Stangerup	Aug 1996	A
5549542	Kovalcheck	Aug 1996	A
5558073	Pomeranz et al.	Sep 1996	A
5558652	Henke	Sep 1996	A
5562619	Mirarchi et al.	Oct 1996	A
5568809	Ben-haim	Oct 1996	A
5571086	Kaplan et al.	Nov 1996	A
5578007	Imran	Nov 1996	A
5578048	Pasqualucci et al.	Nov 1996	A
5582575	Heckele et al.	Dec 1996	A
5584827	Korteweg et al.	Dec 1996	A
5591194	Berthiaume	Jan 1997	A
5599284	Shea	Feb 1997	A
5599304	Shaari	Feb 1997	A
5599576	Opolski	Feb 1997	A
5601087	Gunderson et al.	Feb 1997	A
5601585	Banik et al.	Feb 1997	A
5601594	Best	Feb 1997	A
5607386	Flam	Mar 1997	A
5617870	Hastings et al.	Apr 1997	A
5626374	Kim	May 1997	A
5633000	Grossman et al.	May 1997	A
5634908	Loomas	Jun 1997	A
5638819	Manwaring et al.	Jun 1997	A
5643251	Hillsman et al.	Jul 1997	A
5645789	Roucher, Jr.	Jul 1997	A
5647361	Damadian	Jul 1997	A
5653690	Booth et al.	Aug 1997	A
5656030	Hunjan et al.	Aug 1997	A
5662674	Debbas	Sep 1997	A
5664567	Linder	Sep 1997	A
5664580	Erickson et al.	Sep 1997	A
5665052	Bullard	Sep 1997	A
5669388	Vilkomerson	Sep 1997	A
5673707	Chandrasekaran	Oct 1997	A
5676673	Ferre et al.	Oct 1997	A
5679400	Tuch	Oct 1997	A
5682199	Lankford	Oct 1997	A
5685838	Peters et al.	Nov 1997	A
5685847	Barry	Nov 1997	A
5690373	Luker	Nov 1997	A
5693065	Rains, III	Dec 1997	A
5694945	Ben-Haim	Dec 1997	A
5697159	Linden	Dec 1997	A
5700286	Tartaglia et al.	Dec 1997	A
5707376	Kavteladze et al.	Jan 1998	A
5707389	Louw et al.	Jan 1998	A
5708175	Loyanagi et al.	Jan 1998	A
5711315	Jerusalmy	Jan 1998	A
5713839	Shea	Feb 1998	A
5713946	Ben-Haim	Feb 1998	A
5718702	Edwards	Feb 1998	A
5720300	Fagan et al.	Feb 1998	A
5720719	Edwards et al.	Feb 1998	A
5722401	Pietroski et al.	Mar 1998	A
5722984	Fischell et al.	Mar 1998	A
5729129	Acker	Mar 1998	A
5730128	Pomeranz et al.	Mar 1998	A
5733248	Adams et al.	Mar 1998	A
5749357	Linder	May 1998	A
5749920	Quiachon et al.	May 1998	A
5752513	Acker et al.	May 1998	A
5752971	Rosenbluth et al.	May 1998	A
5762604	Kieturakis	Jun 1998	A
5766158	Opolski	Jun 1998	A
5769821	Abrahamson et al.	Jun 1998	A
5775327	Randolph et al.	Jul 1998	A
5776158	Chou	Jul 1998	A
5779699	Lipson	Jul 1998	A
5789391	Jacobus et al.	Aug 1998	A
5792100	Shantha	Aug 1998	A
5797878	Bleam	Aug 1998	A
5803089	Ferre et al.	Sep 1998	A
5814016	Valley et al.	Sep 1998	A
5819723	Joseph	Oct 1998	A
5820568	Willis	Oct 1998	A
5820592	Hammerslag	Oct 1998	A
5823961	Fields et al.	Oct 1998	A
5824044	Quiachon et al.	Oct 1998	A
5824048	Tuch	Oct 1998	A
5824173	Fontirroche et al.	Oct 1998	A
5826576	West	Oct 1998	A
5827224	Shippert	Oct 1998	A
5827323	Klieman et al.	Oct 1998	A
5830188	Abouleish	Nov 1998	A
5833608	Acker	Nov 1998	A
5833645	Lieber et al.	Nov 1998	A
5833650	Imran	Nov 1998	A
5833682	Amplatz et al.	Nov 1998	A
5836638	Slocum	Nov 1998	A
5836935	Ashton et al.	Nov 1998	A
5836951	Rosenbluth et al.	Nov 1998	A
5837313	Ding et al.	Nov 1998	A
5843089	Sahatjian et al.	Dec 1998	A
5843113	High	Dec 1998	A
5846259	Berthiaume	Dec 1998	A
5857998	Barry	Jan 1999	A
5862693	Myers et al.	Jan 1999	A
5865767	Frechette et al.	Feb 1999	A
5872879	Hamm	Feb 1999	A
5873835	Hastings	Feb 1999	A
5879324	Von Hoffmann	Mar 1999	A
5882333	Schaer et al.	Mar 1999	A
5882346	Pomeranz et al.	Mar 1999	A
5887467	Butterweck et al.	Mar 1999	A
5902247	Coe et al.	May 1999	A
5902333	Roberts et al.	May 1999	A
5904701	Daneshvar	May 1999	A
5908407	Frazee et al.	Jun 1999	A
5916147	Boury	Jun 1999	A
5916193	Stevens et al.	Jun 1999	A
5916213	Haissaguerre et al.	Jun 1999	A
5928192	Maahs	Jul 1999	A
5931811	Haissaguerre et al.	Aug 1999	A
5931818	Werp et al.	Aug 1999	A
5932035	Koger et al.	Aug 1999	A
5935061	Acker et al.	Aug 1999	A
5941816	Barthel et al.	Aug 1999	A
5941849	Amos, Jr. et al.	Aug 1999	A
D413629	Wolff et al.	Sep 1999	S
5947988	Smith	Sep 1999	A
5947991	Cowan	Sep 1999	A
5949929	Hamm	Sep 1999	A
5954693	Barry	Sep 1999	A
5954694	Sunseri	Sep 1999	A
5957842	Littmann et al.	Sep 1999	A
5967984	Chu et al.	Oct 1999	A
5968085	Morris et al.	Oct 1999	A
5971975	Mills et al.	Oct 1999	A
5976074	Moriyama	Nov 1999	A
5979290	Simeone	Nov 1999	A
5980503	Chin	Nov 1999	A
5980551	Summers et al.	Nov 1999	A
5984945	Sirhan	Nov 1999	A
5985307	Hanson et al.	Nov 1999	A
5987344	West	Nov 1999	A
5989025	Conley	Nov 1999	A
5993462	Pomeranz et al.	Nov 1999	A
5997562	Zadno-Azizi et al.	Dec 1999	A
6006126	Cosman	Dec 1999	A
6006130	Higo et al.	Dec 1999	A
6007516	Burbank et al.	Dec 1999	A
6007991	Sivaraman et al.	Dec 1999	A
6010511	Murphy	Jan 2000	A
6013019	Fischell et al.	Jan 2000	A
6015414	Werp et al.	Jan 2000	A
6016429	Khafizov et al.	Jan 2000	A
6016439	Acker	Jan 2000	A
6019736	Avellanet et al.	Feb 2000	A
6019777	Mackenzie	Feb 2000	A
6021340	Randolph et al.	Feb 2000	A
6022313	Ginn et al.	Feb 2000	A
6027461	Walker et al.	Feb 2000	A
6027478	Katz	Feb 2000	A
6039699	Viera	Mar 2000	A
6042561	Ash et al.	Mar 2000	A
6048299	von Hoffmann	Apr 2000	A
6048358	Barak	Apr 2000	A
6053172	Hovda et al.	Apr 2000	A
6056702	Lorenzo	May 2000	A
6059752	Segal	May 2000	A
6063022	Ben-Haim	May 2000	A
6063079	Hovda et al.	May 2000	A
6071233	Ishikawa et al.	Jun 2000	A
6079755	Chang	Jun 2000	A
6080190	Schwartz	Jun 2000	A
6083148	Williams	Jul 2000	A
6083188	Becker et al.	Jul 2000	A
6086585	Hovda et al.	Jul 2000	A
6092846	Fuss et al.	Jul 2000	A
6093150	Chandler et al.	Jul 2000	A
6093195	Ouchi	Jul 2000	A
6102891	van Erp et al.	Aug 2000	A
6109268	Thapliyal et al.	Aug 2000	A
6113567	becker	Sep 2000	A
6117105	Bresnaham et al.	Sep 2000	A
6122541	Cosman et al.	Sep 2000	A
6123697	Shippert	Sep 2000	A
6135991	Muni et al.	Oct 2000	A
6136006	Johnson et al.	Oct 2000	A
6139510	Palermo	Oct 2000	A
6142957	Diamond et al.	Nov 2000	A
6146402	Munoz	Nov 2000	A
6146415	Fitz	Nov 2000	A
6148823	Hastings	Nov 2000	A
6149213	Sokurenko et al.	Nov 2000	A
6159170	Borodulin et al.	Dec 2000	A
6171298	Matsuura et al.	Jan 2001	B1
6171303	Ben-Haim	Jan 2001	B1
6174280	Oneda et al.	Jan 2001	B1
6176829	Vilkomerson	Jan 2001	B1
6179776	Adams et al.	Jan 2001	B1
6179788	Sullivan	Jan 2001	B1
6179811	Fugoso et al.	Jan 2001	B1
6183433	Bays	Feb 2001	B1
6183461	Matsuura et al.	Feb 2001	B1
6183464	Sharp et al.	Feb 2001	B1
6190353	Makower et al.	Feb 2001	B1
6190381	Olsen et al.	Feb 2001	B1
6193650	Ryan, Jr.	Feb 2001	B1
6195225	Komatsu et al.	Feb 2001	B1
6200257	Winkler	Mar 2001	B1
6206870	Kanner	Mar 2001	B1
6206900	Tabatabaei et al.	Mar 2001	B1
6213975	Laksin	Apr 2001	B1
6221042	Adams	Apr 2001	B1
6231543	Hegde et al.	May 2001	B1
6234958	Snoke et al.	May 2001	B1
6238364	Becker	May 2001	B1
6238391	Olsen et al.	May 2001	B1
6238430	Klumb et al.	May 2001	B1
6241519	Sedelmayer	Jun 2001	B1
6248092	Miraki et al.	Jun 2001	B1
6249180	Maalej et al.	Jun 2001	B1
6254550	McNamara et al.	Jul 2001	B1
6264087	Whitman	Jul 2001	B1
6268574	Edens	Jul 2001	B1
6270477	Bagaoisan et al.	Aug 2001	B1
6280433	McIvor et al.	Aug 2001	B1
6283908	Aviram et al.	Aug 2001	B1
6290689	Delaney et al.	Sep 2001	B1
6293957	Peters et al.	Sep 2001	B1
6295990	Lewis et al.	Oct 2001	B1
6296638	Davison et al.	Oct 2001	B1
6302875	Makower et al.	Oct 2001	B1
6304768	Blume et al.	Oct 2001	B1
6306105	Rooney et al.	Oct 2001	B1
6306124	Jones et al.	Oct 2001	B1
D450382	Nestenborg	Nov 2001	S
6322495	Snow et al.	Nov 2001	B1
6328564	Thurow	Dec 2001	B1
6328730	Harkrider, Jr.	Dec 2001	B1
6332089	Acker et al.	Dec 2001	B1
6332891	Himes	Dec 2001	B1
6340360	Lyles et al.	Jan 2002	B1
6344028	Barry	Feb 2002	B1
6348041	Klint	Feb 2002	B1
6352503	Matsui et al.	Mar 2002	B1
6364856	Ding et al.	Apr 2002	B1
6369039	Palasis	Apr 2002	B1
6372229	Ollerenshaw	Apr 2002	B1
6375615	Flaherty et al.	Apr 2002	B1
6375629	Muni et al.	Apr 2002	B1
6379319	Garibotto et al.	Apr 2002	B1
6381485	Hunter et al.	Apr 2002	B1
6383146	Klint	May 2002	B1
6386197	Miller	May 2002	B1
6389313	Marchitto et al.	May 2002	B1
6390993	Cornish et al.	May 2002	B1
6394093	Lethi	May 2002	B1
6398758	Jacobsen et al.	Jun 2002	B1
6409863	Williams et al.	Jun 2002	B1
6419653	Edwards et al.	Jul 2002	B2
6423012	Kato et al.	Jul 2002	B1
6425877	Edwards	Jul 2002	B1
6432986	Levin	Aug 2002	B2
6436119	Erb et al.	Aug 2002	B1
6440061	Wenner et al.	Aug 2002	B1
6443947	Marko et al.	Sep 2002	B1
6445939	Swanson et al.	Sep 2002	B1
6450975	Brennan et al.	Sep 2002	B1
6450989	Dubrul et al.	Sep 2002	B2
6464650	Jafari et al.	Oct 2002	B2
6468202	Irion et al.	Oct 2002	B1
6468297	Williams et al.	Oct 2002	B1
6485475	Chelly	Nov 2002	B1
6488653	Lombardo	Dec 2002	B1
6491940	Levin	Dec 2002	B1
6494894	Mirarchi	Dec 2002	B2
6500130	Kinsella et al.	Dec 2002	B2
6500189	Lang et al.	Dec 2002	B1
6503087	Eggert et al.	Jan 2003	B1
6503185	Waksman et al.	Jan 2003	B1
6503263	Adams	Jan 2003	B2
6511418	Shahidi et al.	Jan 2003	B2
6511471	Rosenman et al.	Jan 2003	B2
6514249	Maguire et al.	Feb 2003	B1
6517478	Khadem	Feb 2003	B2
6520954	Ouchi	Feb 2003	B2
6524129	Cote et al.	Feb 2003	B2
6524299	Tran et al.	Feb 2003	B1
6526302	Hassett	Feb 2003	B2
6527753	Sekine et al.	Mar 2003	B2
6529756	Phan et al.	Mar 2003	B1
6533754	Hisamatsu et al.	Mar 2003	B1
6536437	Dragisic	Mar 2003	B1
6537294	Boyle et al.	Mar 2003	B1
6543452	Lavigne	Apr 2003	B1
6544223	Kokish	Apr 2003	B1
6544230	Flaherty et al.	Apr 2003	B1
6549800	Atalar et al.	Apr 2003	B1
6551239	Renner et al.	Apr 2003	B2
6562022	Hoste et al.	May 2003	B2
6569146	Werner et al.	May 2003	B1
6569147	Evans et al.	May 2003	B1
6571131	Nguyen	May 2003	B1
6572538	Takase	Jun 2003	B2
6572590	Stevens et al.	Jun 2003	B1
6579285	Sinofsky	Jun 2003	B2
6585639	Kotmel et al.	Jul 2003	B1
6585717	Wittenberger et al.	Jul 2003	B1
6585718	Hayzelden et al.	Jul 2003	B2
6585794	Shimoda et al.	Jul 2003	B2
6589164	Flaherty	Jul 2003	B1
6589237	Woloszko et al.	Jul 2003	B2
6591130	Shahidi	Jul 2003	B2
6596009	Jelic	Jul 2003	B1
6607546	Murken	Aug 2003	B1
6610059	West, Jr.	Aug 2003	B1
6612999	Brennan et al.	Sep 2003	B2
6613066	Fukaya et al.	Sep 2003	B1
6616601	Hayakawa	Sep 2003	B2
6616659	de la Torre et al.	Sep 2003	B1
6616678	Nishtala et al.	Sep 2003	B2
6616913	Mautone	Sep 2003	B1
6619085	Hsieh	Sep 2003	B1
6633773	Reisfeld	Oct 2003	B1
6634684	Spiessl	Oct 2003	B2
6638233	Corvi et al.	Oct 2003	B2
6638268	Niazi	Oct 2003	B2
6638291	Ferrera et al.	Oct 2003	B1
6645193	Mangosong	Nov 2003	B2
6645223	Boyle et al.	Nov 2003	B2
6650927	Keidar	Nov 2003	B1
6652472	Jafari et al.	Nov 2003	B2
6652480	Imran et al.	Nov 2003	B1
6656166	Lurie et al.	Dec 2003	B2
6659106	Hovda et al.	Dec 2003	B1
6663589	Halevy	Dec 2003	B1
6669689	Lehmann et al.	Dec 2003	B2
6669711	Noda	Dec 2003	B1
6672773	Glenn et al.	Jan 2004	B1
6673025	Richardson et al.	Jan 2004	B1
6679833	Smith et al.	Jan 2004	B2
6679871	Hahnen	Jan 2004	B2
6685648	Flaherty et al.	Feb 2004	B2
6689096	Loubens et al.	Feb 2004	B1
6689146	Himes	Feb 2004	B1
6702735	Kelly	Mar 2004	B2
6712757	Becker et al.	Mar 2004	B2
6714809	Lee et al.	Mar 2004	B2
6716183	Clayman et al.	Apr 2004	B2
6716216	Boucher et al.	Apr 2004	B1
6716813	Lim et al.	Apr 2004	B2
6719749	Schweikert et al.	Apr 2004	B1
6719763	Chung et al.	Apr 2004	B2
6726701	Gilson et al.	Apr 2004	B2
6738656	Ferre et al.	May 2004	B1
6740191	Clarke et al.	May 2004	B2
6741884	Freeman et al.	May 2004	B1
6743168	Luloh et al.	Jun 2004	B2
6755812	Peterson et al.	Jun 2004	B2
6758857	Cioanta et al.	Jul 2004	B2
6776772	de Vrijer et al.	Aug 2004	B1
6780168	Jellie	Aug 2004	B2
6783522	Fischell	Aug 2004	B2
6783536	Vilsmeier et al.	Aug 2004	B2
6786864	Matsuura et al.	Sep 2004	B2
6796960	Cioanta et al.	Sep 2004	B2
6811544	Schaer	Nov 2004	B2
6817364	Garibaldi et al.	Nov 2004	B2
6817976	Rovegno	Nov 2004	B2
6827683	Otawara	Dec 2004	B2
6827701	MacMahon et al.	Dec 2004	B2
6832715	Eungard et al.	Dec 2004	B2
D501677	Becker	Feb 2005	S
6849062	Kantor	Feb 2005	B2
6851290	Meier et al.	Feb 2005	B1
6855136	Dorros et al.	Feb 2005	B2
6860264	Christopher	Mar 2005	B2
6860849	Matsushita et al.	Mar 2005	B2
6866669	Buzzard et al.	Mar 2005	B2
6878106	Herrmann	Apr 2005	B1
6890329	Carroll et al.	May 2005	B2
6899672	Chin et al.	May 2005	B2
6902556	Grimes et al.	Jun 2005	B2
6913763	Lerner	Jul 2005	B2
6927478	Paek	Aug 2005	B2
6939361	Kleshinski	Sep 2005	B1
6939374	Banik et al.	Sep 2005	B2
6953431	Barthel	Oct 2005	B2
6955657	Webler	Oct 2005	B1
6966906	Brown	Nov 2005	B2
6971998	Rosenman et al.	Dec 2005	B2
6979290	Mourlas et al.	Dec 2005	B2
6979979	Xu et al.	Dec 2005	B2
6984203	Tartaglia et al.	Jan 2006	B2
6989024	Hebert et al.	Jan 2006	B2
6991597	Gellman et al.	Jan 2006	B2
6997931	Sauer et al.	Feb 2006	B2
6997941	Sharkey et al.	Feb 2006	B2
7004173	Sparks et al.	Feb 2006	B2
7004176	Lau	Feb 2006	B2
7008412	Maginot	Mar 2006	B2
7011654	Dubrul et al.	Mar 2006	B2
7022105	Edwards	Apr 2006	B1
7037321	Sachdeva	May 2006	B2
7043961	Pandey	May 2006	B2
7044964	Jang et al.	May 2006	B2
7048711	Rosenman et al.	May 2006	B2
7052474	Castell et al.	May 2006	B2
7056284	Martone et al.	Jun 2006	B2
7056287	Taylor et al.	Jun 2006	B2
7056303	Dennis et al.	Jun 2006	B2
7056314	Florio et al.	Jun 2006	B1
7074197	Reynolds et al.	Jul 2006	B2
7074426	Kochinke	Jul 2006	B2
7097612	Bertolero et al.	Aug 2006	B2
7108677	Courtney et al.	Sep 2006	B2
7108706	Hogle	Sep 2006	B2
7117039	Manning et al.	Oct 2006	B2
7128718	Hojeibane et al.	Oct 2006	B2
7131969	Hovda et al.	Nov 2006	B1
7140480	Drussel et al.	Nov 2006	B2
D534216	Makower et al.	Dec 2006	S
7160255	Saadat	Jan 2007	B2
7169140	Kume	Jan 2007	B1
7169163	Becker	Jan 2007	B2
7172562	McKinley	Feb 2007	B2
7174774	Pawar et al.	Feb 2007	B2
7182735	Shireman et al.	Feb 2007	B2
7184827	Edwards	Feb 2007	B1
7186224	Windheuser	Mar 2007	B2
7207981	Quinn et al.	Apr 2007	B2
7214201	Burmeister et al.	May 2007	B2
7233820	Gilboa	Jun 2007	B2
7235099	Duncavage et al.	Jun 2007	B1
7237313	Skujins et al.	Jul 2007	B2
7248914	Hastings et al.	Jul 2007	B2
7252677	Burwell et al.	Aug 2007	B2
7282057	Surti et al.	Oct 2007	B2
7292885	Scott et al.	Nov 2007	B2
7294345	Haapakumpu et al.	Nov 2007	B2
7294365	Hayakawa et al.	Nov 2007	B2
7303533	Johansen et al.	Dec 2007	B2
7309334	von Hoffmann	Dec 2007	B2
7313430	Urquhart et al.	Dec 2007	B2
7316168	van der Knokke et al.	Jan 2008	B2
7316656	Shireman et al.	Jan 2008	B2
7318831	Alvarez et al.	Jan 2008	B2
7322934	Miyake et al.	Jan 2008	B2
7326235	Edwards	Feb 2008	B2
7338467	Lutter	Mar 2008	B2
7343920	Toby et al.	Mar 2008	B2
7347868	Burnett et al.	Mar 2008	B2
7359755	Jones et al.	Apr 2008	B2
7361168	Makower et al.	Apr 2008	B2
7366562	Dukesherer	Apr 2008	B2
7371210	Brock et al.	May 2008	B2
7381205	Thommen	Jun 2008	B2
7384407	Rodriguez et al.	Jun 2008	B2
7410480	Muni et al.	Aug 2008	B2
7419497	Muni et al.	Sep 2008	B2
7438701	Theeuwes et al.	Oct 2008	B2
7442191	Hovda et al.	Oct 2008	B2
7452351	Miller et al.	Nov 2008	B2
7454244	Kassab et al.	Nov 2008	B2
7462175	Chang et al.	Dec 2008	B2
7471994	Ford et al.	Dec 2008	B2
7481218	Djupesland	Jan 2009	B2
7481800	Jacques	Jan 2009	B2
D586465	Faulkner et al.	Feb 2009	S
D586916	Faulkner et al.	Feb 2009	S
7488313	Segal et al.	Feb 2009	B2
7488337	Saab et al.	Feb 2009	B2
7493156	Manning et al.	Feb 2009	B2
7500971	Chang et al.	Mar 2009	B2
D590502	Geisser et al.	Apr 2009	S
7520876	Ressemann et al.	Apr 2009	B2
7532920	Ainsworth et al.	May 2009	B1
7544192	Eaton et al.	Jun 2009	B2
7551758	Florent et al.	Jun 2009	B2
7559925	Goldfarb et al.	Jul 2009	B2
7566300	Devierre et al.	Jul 2009	B2
7610104	Kaplan et al.	Oct 2009	B2
7615005	Stefanchik et al.	Nov 2009	B2
7618450	Zarowski et al.	Nov 2009	B2
7625335	Deichmann et al.	Dec 2009	B2
7632291	Stephens et al.	Dec 2009	B2
7634233	Deng et al.	Dec 2009	B2
7641644	Chang et al.	Jan 2010	B2
7641668	Perry et al.	Jan 2010	B2
7645272	Chang et al.	Jan 2010	B2
7648367	Makower et al.	Jan 2010	B1
7654997	Makower et al.	Feb 2010	B2
7680244	Gertner et al.	Mar 2010	B2
7686798	Eaton et al.	Mar 2010	B2
7691120	Shluzas et al.	Apr 2010	B2
7697972	Verard et al.	Apr 2010	B2
7717933	Becker	May 2010	B2
7720521	Chang et al.	May 2010	B2
7727186	Makower et al.	Jun 2010	B2
7727226	Chang et al.	Jun 2010	B2
7736301	Webler et al.	Jun 2010	B1
7740642	Becker	Jun 2010	B2
7751758	Yahagi	Jul 2010	B2
7753929	Becker	Jul 2010	B2
7753930	Becker	Jul 2010	B2
7758497	Hern	Jul 2010	B2
7771409	Chang et al.	Aug 2010	B2
7775968	Mathis	Aug 2010	B2
7785315	Muni et al.	Aug 2010	B1
7799048	Hudson et al.	Sep 2010	B2
7799337	Levin	Sep 2010	B2
7803150	Chang et al.	Sep 2010	B2
7833282	Mandpe	Nov 2010	B2
7837672	Intoccia	Nov 2010	B2
7840254	Glossop	Nov 2010	B2
7854744	Becker	Dec 2010	B2
7857750	Belafsky	Dec 2010	B2
D630321	Hamilton, Jr.	Jan 2011	S
7875050	Samson et al.	Jan 2011	B2
D632791	Murner	Feb 2011	S
7881769	Sobe	Feb 2011	B2
7883717	Varner et al.	Feb 2011	B2
7896891	Catanese, III et al.	Mar 2011	B2
7927271	Dimitriou et al.	Apr 2011	B2
7951132	Eaton et al.	May 2011	B2
7988705	Galdonik et al.	Aug 2011	B2
7993353	Roβner et al.	Aug 2011	B2
8002740	Willink et al.	Aug 2011	B2
8014849	Peckham	Sep 2011	B2
8016752	Armstrong et al.	Sep 2011	B2
8025635	Eaton et al.	Sep 2011	B2
8075476	Vargas	Dec 2011	B2
8080000	Makower et al.	Dec 2011	B2
8088063	Fujikura et al.	Jan 2012	B2
8088101	Chang et al.	Jan 2012	B2
8090433	Makower et al.	Jan 2012	B2
8100933	Becker	Jan 2012	B2
8104483	Taylor	Jan 2012	B2
8114062	Muni et al.	Feb 2012	B2
8114113	Becker	Feb 2012	B2
8123722	Chang et al.	Feb 2012	B2
8142422	Makower et al.	Mar 2012	B2
8146400	Goldfarb et al.	Apr 2012	B2
8147545	Avior	Apr 2012	B2
8167821	Sharrow	May 2012	B2
8172828	Chang et al.	May 2012	B2
8190389	Kim et al.	May 2012	B2
8197433	Cohen	Jun 2012	B2
8197552	Mandpe	Jun 2012	B2
8249700	Clifford et al.	Aug 2012	B2
8277386	Ahmed et al.	Oct 2012	B2
8317816	Becker	Nov 2012	B2
8337454	Eaton et al.	Dec 2012	B2
8388642	Muni et al.	Mar 2013	B2
8403954	Santin et al.	Mar 2013	B2
8414473	Jenkins et al.	Apr 2013	B2
8425457	John et al.	Apr 2013	B2
8439687	Morriss et al.	May 2013	B1
8475360	Brown	Jul 2013	B2
8521259	Mandrusov et al.	Aug 2013	B2
8529439	Ito et al.	Sep 2013	B2
8535707	Arensdorf et al.	Sep 2013	B2
8702626	Kim et al.	Apr 2014	B1
8715169	Chang et al.	May 2014	B2
8721591	Chang et al.	May 2014	B2
8740839	Eaton et al.	Jun 2014	B2
8740929	Gopferich et al.	Jun 2014	B2
8747389	Goldfarb et al.	Jun 2014	B2
8764709	Chang et al.	Jul 2014	B2
8764726	Chang et al.	Jul 2014	B2
8764729	Muni et al.	Jul 2014	B2
8777926	Chang et al.	Jul 2014	B2
8802131	Arensdorf et al.	Aug 2014	B2
8828041	Chang et al.	Sep 2014	B2
8858586	Chang et al.	Oct 2014	B2
8858974	Eaton et al.	Oct 2014	B2
8864787	Muni et al.	Oct 2014	B2
8870893	Makower et al.	Oct 2014	B2
8894614	Muni et al.	Nov 2014	B2
8894787	Boe	Nov 2014	B2
8905922	Makower et al.	Dec 2014	B2
8932276	Morriss et al.	Jan 2015	B1
8945088	Chang et al.	Feb 2015	B2
8951225	Evard et al.	Feb 2015	B2
8961398	Makower et al.	Feb 2015	B2
8961495	Chang et al.	Feb 2015	B2
9039657	Makower et al.	May 2015	B2
9055965	Chang et al.	Jun 2015	B2
9089258	Goldfarb et al.	Jul 2015	B2
9101739	Lesch, Jr. et al.	Aug 2015	B2
9107574	Goldfarb et al.	Aug 2015	B2
9167961	Makower et al.	Oct 2015	B2
9179823	Goldfarb et al.	Nov 2015	B2
9216112	Clifford et al.	Dec 2015	B2
9220879	Chang et al.	Dec 2015	B2
9241834	Chang et al.	Jan 2016	B2
9265407	Goldfarb et al.	Feb 2016	B2
9289576	Mann et al.	Mar 2016	B2
9308361	Muni et al.	Apr 2016	B2
9351750	Muni et al.	May 2016	B2
9370649	Chang et al.	Jun 2016	B2
9399121	Goldfarb et al.	Jul 2016	B2
9468453	Hart et al.	Oct 2016	B2
9554691	Goldfarb et al.	Jan 2017	B2
9603506	Goldfarb et al.	Mar 2017	B2
9610428	Muni et al.	Apr 2017	B2
9649477	Muni et al.	May 2017	B2
10098652	Goldfarb et al.	Oct 2018	B2
10124154	Evard et al.	Nov 2018	B2
10188413	Morriss et al.	Jan 2019	B1
10500380	Chang et al.	Dec 2019	B2
20010004644	Levin	Jun 2001	A1
20010005785	Sachse	Jun 2001	A1
20010021843	Bosselmann et al.	Sep 2001	A1
20010034530	Malackowski et al.	Oct 2001	A1
20010037084	Nardeo	Nov 2001	A1
20020006961	Katz et al.	Jan 2002	A1
20020013548	Hinchliffe	Jan 2002	A1
20020045924	Fox	Apr 2002	A1
20020055746	Burke et al.	May 2002	A1
20020058960	Hudson	May 2002	A1
20020068851	Gravenstein et al.	Jun 2002	A1
20020077593	Perkins et al.	Jun 2002	A1
20020090388	Humes et al.	Jul 2002	A1
20020161389	Boyle et al.	Oct 2002	A1
20030009095	Skarda	Jan 2003	A1
20030009190	Kletschka et al.	Jan 2003	A1
20030013985	Saadat	Jan 2003	A1
20030017111	Rabito	Jan 2003	A1
20030018291	Hill et al.	Jan 2003	A1
20030040697	Pass et al.	Feb 2003	A1
20030051733	Kotmel et al.	Mar 2003	A1
20030060799	Arenberg	Mar 2003	A1
20030073900	Senarith et al.	Apr 2003	A1
20030074045	Buzzard et al.	Apr 2003	A1
20030083608	Evans et al.	May 2003	A1
20030114732	Webler et al.	Jun 2003	A1
20030158598	Ashton	Aug 2003	A1
20030163154	Miyata et al.	Aug 2003	A1
20030220551	Kimball et al.	Nov 2003	A1
20040015150	Zadno-Azizi	Jan 2004	A1
20040018980	Gurney et al.	Jan 2004	A1
20040020492	Dubrul et al.	Feb 2004	A1
20040034311	Mihalcik	Feb 2004	A1
20040043052	Hunter et al.	Mar 2004	A1
20040058992	Marinello et al.	Mar 2004	A1
20040064105	Capes et al.	Apr 2004	A1
20040064150	Becker	Apr 2004	A1
20040116958	Gopferich et al.	Jun 2004	A1
20040127820	Clayman et al.	Jul 2004	A1
20040158229	Quinn	Aug 2004	A1
20040181175	Clayman et al.	Sep 2004	A1
20040193073	DeMello et al.	Sep 2004	A1
20040220155	Seibert	Nov 2004	A1
20040220516	Solomon et al.	Nov 2004	A1
20040230156	Schreck et al.	Nov 2004	A1
20040236231	Knighton et al.	Nov 2004	A1
20040249243	Kleiner	Dec 2004	A1
20040267347	Cervantes	Dec 2004	A1
20050027249	Reifart et al.	Feb 2005	A1
20050038319	Goldwasser et al.	Feb 2005	A1
20050055077	Marco	Mar 2005	A1
20050059930	Garrison et al.	Mar 2005	A1
20050059931	Garrison et al.	Mar 2005	A1
20050089670	Large	Apr 2005	A1
20050107738	Slater et al.	May 2005	A1
20050113687	Herweck et al.	May 2005	A1
20050113850	Tagge	May 2005	A1
20050119590	Burmeister et al.	Jun 2005	A1
20050124856	Fujikura et al.	Jun 2005	A1
20050131316	Flagle et al.	Jun 2005	A1
20050137621	Stahl et al.	Jun 2005	A1
20050143687	Rosenblatt et al.	Jun 2005	A1
20050182319	Glossop	Aug 2005	A1
20050228224	Okada et al.	Oct 2005	A1
20050234507	Geske et al.	Oct 2005	A1
20050240120	Modesitt	Oct 2005	A1
20050244472	Hughes et al.	Nov 2005	A1
20050283221	Mann et al.	Dec 2005	A1
20060004323	Chang et al.	Jan 2006	A1
20060047261	Joshi	Mar 2006	A1
20060063973	Makower et al.	Mar 2006	A1
20060173382	Schreiner	Aug 2006	A1
20060189844	Tien	Aug 2006	A1
20060190022	Beyar et al.	Aug 2006	A1
20060211752	Kohn et al.	Sep 2006	A1
20060271024	Gertner et al.	Nov 2006	A1
20060284428	Beadle et al.	Dec 2006	A1
20070020196	Pipkin et al.	Jan 2007	A1
20070112358	Abbott	May 2007	A1
20070129751	Muni et al.	Jun 2007	A1
20070135789	Chang et al.	Jun 2007	A1
20070167682	Goldfarb et al.	Jul 2007	A1
20070207186	Scanlon et al.	Sep 2007	A1
20070208252	Makower	Sep 2007	A1
20070208301	Evard et al.	Sep 2007	A1
20070249896	Goldfarb et al.	Oct 2007	A1
20070269385	Yun et al.	Nov 2007	A1
20070282305	Goldfarb et al.	Dec 2007	A1
20070293727	Goldfarb et al.	Dec 2007	A1
20070293946	Gonzales et al.	Dec 2007	A1
20080015544	Keith et al.	Jan 2008	A1
20080033519	Burwell et al.	Feb 2008	A1
20080051804	Cottler et al.	Feb 2008	A1
20080097516	Chang et al.	Apr 2008	A1
20080103521	Makower et al.	May 2008	A1
20080119693	Makower et al.	May 2008	A1
20080125626	Chang et al.	May 2008	A1
20080132938	Chang et al.	Jun 2008	A1
20080172033	Keith et al.	Jul 2008	A1
20080183128	Morriss et al.	Jul 2008	A1
20080188803	Jang	Aug 2008	A1
20080188870	Andre et al.	Aug 2008	A1
20080195041	Goldfarb et al.	Aug 2008	A1
20080228085	Jenkins et al.	Sep 2008	A1
20080262508	Clifford et al.	Oct 2008	A1
20080275483	Makower et al.	Nov 2008	A1
20080281156	Makower et al.	Nov 2008	A1
20080287908	Muni et al.	Nov 2008	A1
20080319424	Muni et al.	Dec 2008	A1
20090030274	Goldfarb et al.	Jan 2009	A1
20090088728	Dollar et al.	Apr 2009	A1
20090156980	Eaton et al.	Jun 2009	A1
20090163890	Clifford et al.	Jun 2009	A1
20090187089	Say et al.	Jul 2009	A1
20090187098	Makower et al.	Jul 2009	A1
20090198216	Muni et al.	Aug 2009	A1
20090240112	Goldfarb et al.	Sep 2009	A1
20090240237	Goldfarb et al.	Sep 2009	A1
20090312745	Goldfarb et al.	Dec 2009	A1
20100030031	Goldfarb et al.	Feb 2010	A1
20100042046	Chang et al.	Feb 2010	A1
20100087811	Herrin et al.	Apr 2010	A1
20100114066	Makower et al.	May 2010	A1
20100174138	Chang et al.	Jul 2010	A1
20100174308	Chang et al.	Jul 2010	A1
20100198191	Clifford et al.	Aug 2010	A1
20100198247	Chang et al.	Aug 2010	A1
20100198302	Shalev	Aug 2010	A1
20100210901	Makower et al.	Aug 2010	A1
20100211007	Lesch, Jr. et al.	Aug 2010	A1
20100268245	Chang et al.	Oct 2010	A1
20100274188	Chang et al.	Oct 2010	A1
20100290244	Nath	Nov 2010	A1
20100298862	Chang et al.	Nov 2010	A1
20110004057	Goldfarb et al.	Jan 2011	A1
20110015482	Carrillo, Jr.	Jan 2011	A1
20110060214	Makower	Mar 2011	A1
20110112512	Muni et al.	May 2011	A1
20110166190	Anderson et al.	Jul 2011	A1
20120071710	Gazdzinski	Mar 2012	A1
20120071824	Chang et al.	Mar 2012	A1
20120136207	Goldfarb et al.	May 2012	A1
20120184983	Chang et al.	Jul 2012	A1
20120245419	Makower et al.	Sep 2012	A1
20120265094	Goldfarb et al.	Oct 2012	A1
20130231529	Chang et al.	Sep 2013	A1
20130245608	Muni et al.	Sep 2013	A1
20130261388	Jenkins et al.	Oct 2013	A1
20140296898	Chang et al.	Oct 2014	A1
20150088188	Muni et al.	Mar 2015	A1
20150165175	Evard et al.	Jun 2015	A1
20150165176	Makower et al.	Jun 2015	A1
20150182735	Chang et al.	Jul 2015	A1
20150209055	Chang et al.	Jul 2015	A1
20150250992	Morriss et al.	Sep 2015	A1
20160192830	Goldfarb et al.	Jul 2016	A1
20160270863	Makower	Sep 2016	A1
20170007281	Goldfarb et al.	Jan 2017	A1
20180110407	Makower et al.	Apr 2018	A1
20190105480	Evard et al.	Apr 2019	A1
20190117245	Goldfarb et al.	Apr 2019	A1
20190201017	Morriss et al.	Jul 2019	A1
20190314620	Chang et al.	Oct 2019	A1
20190388113	Chang et al.	Dec 2019	A1
20200022718	Morriss et al.	Jan 2020	A1

Foreign Referenced Citations (139)

Number	Date	Country
2013323	Sep 1990	CA
668188	Dec 1988	CH
2151720	Jan 1994	CN
2352818	Dec 1999	CN
201005758	Jan 2008	CN
3202878	Aug 1983	DE
4032096	Apr 1992	DE
4406077	Sep 1994	DE
8810044	Nov 1998	DE
29923582	Dec 2000	DE
10104663	Aug 2002	DE
10105592	Aug 2002	DE
129634	Jan 1985	EP
0200430	Nov 1986	EP
257605	Mar 1988	EP
355996	Feb 1990	EP
418391	Mar 1991	EP
427852	May 1991	EP
0515201	Nov 1992	EP
623582	Nov 1994	EP
624349	Nov 1994	EP
744400	Nov 1996	EP
585757	Jun 1997	EP
893426	Jan 1999	EP
0920882	Jun 1999	EP
0974936	Jan 2000	EP
1042998	Oct 2000	EP
1086664	Mar 2001	EP
1112103	Jul 2001	EP
1166710	Jan 2002	EP
1413258	Apr 2004	EP
1944053	Jul 2008	EP
2662083	Nov 1991	FR
2859377	Mar 2005	FR
2916144	Nov 2008	FR
2305174	Apr 1997	GB
2125874	Nov 2008	GB
53-67935	Jun 1978	JP
S61-16750	Jan 1986	JP
10-034376	Feb 1989	JP
H10-034376	Feb 1989	JP
H01-305965	Dec 1989	JP
3-503011	Jul 1991	JP
3-504935	Oct 1991	JP
4-221313	Aug 1992	JP
4-224766	Aug 1992	JP
H5-503650	Jun 1993	JP
5-211985	Aug 1993	JP
H05-506805	Oct 1993	JP
06-17751	Mar 1994	JP
6-277296	Oct 1994	JP
7-327916	Dec 1995	JP
8-317989	Dec 1996	JP
H10-501159	Feb 1998	JP
H10-94543	Apr 1998	JP
10-24098	Jan 1999	JP
11-507251	Jun 1999	JP
2000-501634	Feb 2000	JP
2000-126303	May 2000	JP
2001-025508	Jan 2001	JP
2001-501846	Feb 2001	JP
2001-095815	Apr 2001	JP
2001-526077	Dec 2001	JP
2002-028166	Jan 2002	JP
2002-508214	Mar 2002	JP
2002-537908	Nov 2002	JP
2002-538850	Nov 2002	JP
2003-507140	Feb 2003	JP
2003-062080	Mar 2003	JP
2003-521327	Jul 2003	JP
2004-049583	Feb 2004	JP
2004-357728	Dec 2004	JP
2005-323702	Nov 2005	JP
2005-532869	Nov 2005	JP
2008-539031	Nov 2008	JP
2108764	Apr 1998	RU
2213530	Oct 2003	RU
1662571	Jul 1991	SU
WO 90011053	Oct 1990	WO
WO 90014865	Dec 1990	WO
WO 91017787	Nov 1991	WO
WO 92015286	Sep 1992	WO
WO 92022350	Dec 1992	WO
WO 94012095	Jun 1994	WO
WO 94021320	Sep 1994	WO
WO 95002430	Jan 1995	WO
WO 96029071	Sep 1996	WO
WO 97021461	Jun 1997	WO
WO 98055174	Dec 1998	WO
WO 99000064	Jan 1999	WO
WO 99024106	May 1999	WO
WO 99026692	Jun 1999	WO
WO 99030655	Jun 1999	WO
WO 99032041	Jul 1999	WO
WO 99059649	Nov 1999	WO
WO 00009190	Feb 2000	WO
WO 00009192	Feb 2000	WO
WO 00023009	Apr 2000	WO
WO 00051672	Sep 2000	WO
WO 00053252	Sep 2000	WO
WO 00067834	Nov 2000	WO
WO 01005462	Jan 2001	WO
WO 01045572	Jun 2001	WO
WO 01054558	Aug 2001	WO
WO 01056481	Aug 2001	WO
WO 01068178	Sep 2001	WO
WO 01070325	Sep 2001	WO
WO 01074266	Oct 2001	WO
WO 01082800	Nov 2001	WO
WO 01097895	Dec 2001	WO
WO 02062269	Aug 2002	WO
WO 02089899	Nov 2002	WO
WO 03049603	Jun 2003	WO
WO 03063703	Aug 2003	WO
WO 03105657	Dec 2003	WO
WO 04006788	Jan 2004	WO
WO 04018980	Mar 2004	WO
WO 04026391	Apr 2004	WO
WO 04045387	Jun 2004	WO
WO 04058045	Jul 2004	WO
WO 04082525	Sep 2004	WO
WO 05018730	Mar 2005	WO
WO 05077450	Aug 2005	WO
WO 05089670	Sep 2005	WO
WO 05117755	Dec 2005	WO
WO 06034008	Mar 2006	WO
WO 06078884	Jul 2006	WO
WO 06107957	Oct 2006	WO
WO 06116597	Nov 2006	WO
WO 06118737	Nov 2006	WO
WO 06135853	Dec 2006	WO
WO 07034203	Mar 2007	WO
WO 07035204	Mar 2007	WO
WO 07111636	Oct 2007	WO
WO 07124260	Nov 2007	WO
WO 08036149	Mar 2008	WO
WO 08045242	Apr 2008	WO
WO 08051918	May 2008	WO
WO 08134382	Nov 2008	WO

Non-Patent Literature Citations (333)

Entry
Argon Medical. Maxxim Medical. Ad for Sniper EliteTM Hydrophilic Ni—Ti Alloy Guidewire (2001).
Aust, R., et al. ‘The Functional Size of the Human Maxillary Ostium in Vivo’ Acta. Otolaryn. (9178) vol. 78 pp. 432-435.
Baim, D.S., MD ‘Grossman's Cardiac Catheterization, Angiography, and Intervention’ (2000) Lippincott Williams & Wilkins pp. 76, 84 & 214.
Barrett, S. ‘Be Wary of Neurocranial Restructuring (NCR)’ Chirobase; Jul. 2003; www.chirobase.org/06DD/ncr.html.
Bartal, N. ‘An Improved stent for Use in the Surgical Management of Congential Posterior Choanal Atresia’ J. Laryngol. Otol (1988) vol. 102 pp. 146-147.
Becker, A.E. ‘Restenosis After Angioplasty’ The Lancet (1988) vol. 331, No. 8584 p. 532.
Bellis, M. History of the Catheter-Balloon Catheter—Thomas Fogarty. www.inventors.about.com/library/inventors/blcatheter.htm?p=1.
Benninger et al.; Adult Chronic Rhinosinusitis: Definitions, Diagnosis, Epidemiology, and Pathophysilogy Arch Otolarygol Head and Neck Surg. vol. 129 (Sep. 2003) pp. A1-S32.
Bent et al. ‘The Frontal Cell as a Cause of Frontal Sinus Obstruction’ American Journal of Rhinology, vol. 8, No. 4 (1994) pp. 185-191.
Binner et al. ‘Fibre-Optic Transillumination of the Sinuses: A Comparison of the Value of Radiography and Transillumination in Antral Disease’ Clinical Otolaryngology. vol. 3 (1978) pp. 1-11.
Brown, C.L. et al., ‘Safety and Feasibility of Balloon Catheter Dilation of Paranasal Sinus Ostia: A Preliminary Investigation’ Annals of Otology, Rhinology & Laryngology (2006) vol. 115, No. 4 pp. 293-299.
Casiano et al. ‘Endoscopic Lothrop Procedure: The University of Miami Experience’ American Journal of Rhinology, vol. 12, No. 5 (1998) pp. 335-339.
Casserly, I.P. et al., Chapter 7. ‘Guides and Wires in Percutaneous Coronary Intervention’ Strategic Approaches in Coronary Intervention (2006) Lippincott Williams & Wilkins pp. 91-99.
Chien, Y.W. et al. ‘Nasal Systemic Drug Delivery’ Drugs and Pharmaceutical Sciences, vol. 39, pp. 60-63.
Cohen et al. ‘Endoscopic Sinus Surgery: Where we are and where we're going’ Current Opinion in Otolaryngology & Head and Neck Surgery, vol. 13 (2005) pp. 32-38.
Colla, A. et al., ‘Trihaloacetylated Enol Ethers-General Synthetic Procedure and Heterocyclic Ring Closure Reactions with Hydroxylamine’ Synthesis, (Jun. 1991) pp. 483-486.
Costa, M.N. et al. ‘Endoscopic Study of the Intranasal Ostium in External Dacryocystorhinostomy Postoperative. Influence of Saline Solution and 5-Flurorouracil’ Clinics (2007) vol. 62, Issue1, pp. 41-46.
Cussler, E.L. ‘Diffusion: Mass transfer in Fluid Systems’ Cambridge University Press (1996).
Davis, G.E. et al. ‘A Complication from Neurocranial Restructuring’ Arch Otolaryngol Head Neck Surg. vol. 129 (Apr. 2003) pp. 472-474.
Deutschmann, R. et al. ‘A Contribution to the Topical Treatment of [Maxillary] Sinusitis Preliminary Communication’ Stomat DDR 26, (1976) pp. 585-592.
Domb, A. et al. ‘Handbook of Biodegradable Polymers’ Harwood Academic Publishers (1997).
Doyle Nasal Splints, Jan. 25, 2007; www.doylemedical.com/nasalsplints.htm.
Draf, W. ‘Endonasal Micro-Endoscopic Frontal Sinus Surgery: the Fulda Concept’ Op Tech Otolaryngol Head Neck Surg. vol. 2 (1991) pp. 234-240.
“Durometer Made Easy Durometer Hardness Scales—General Reference Guide.” Paramount Industries, Inc. 2008. Accessed online: http://www.paramountind.com/pdfs/paramount_durometer_scale_guide.pdf.
“Durometer Shore Hardness Scale.” Smooth-On, Inc. 2016. Accessed online: https://www.smooth-on.com/page/durometer-shore-hardness-scale/.
Edmond, C. et al. ‘ENT Surgical Stimulator’ Nov. 1989.
ENT Checklist; Physical Examination Performance Checklist [date of publication unknown].
Eremychev, V.A. ‘Needles for Puncture and Drainage of the Maxillary Sinus’ Meditsinskaya Tekhnika, No. 5 (1974) pp. 54.55.
Feldman, R.L. et al., ‘New Steerable, Ultra-Low-Profile, Fixed Wire Angioplasty Catheter: Initial Experience with the Cordis OrionTM Steerable PTCA Balloon Catheter’ Cathet. Cardiovasc. Diagn. (1990) vol. 19, No. 2 pp. 142-145.
Ford, C.N. ‘A Multipurpose Laryngeal Injector Device’ Otolaryngol. Head Neck Surg. (1990) vol. 103, No. 1 pp. 135-137.
Sanborn, T.A. et al., ‘Percutaneous Endocardial Transfer and Expression of Genes to the Myocardium Utilizing Fluropscopic Guidance’ Catheter Cardiovasc. Interv. (2001) vol. 52, No. 2 pp. 260-266.
Sawbones Catalog 2001, Pacific Research Laboratories, Inc., Vashon Washington 98070 USA.
Saxon, R.R. et al., ‘Technical Aspects of Accessing the Portal Vein During the TIPS Procedure’ J. Vasc. Interv. Radiol. (1997) vol. 8, No. 5 pp. 733-744.
Schaefer, S.D., M.D. ‘Rhinology and Sinus Disease: A Problem-Oriented Approach’ (Copyright 1988) by Mosby, Inc.
Schneider. Pfizer Ad for Softip [date of publication unknown].
Shah, N.J. et al., ‘Endoscopic Pituitary Surgery—A Beginner's Guide’ Indian Journal of Otolaryngology and Head and Neck Surgery (2004) vol. 56, No. 1 pp. 71-78.
Shah, N.J. ‘Functional Endoscopic Sinus Surgery’ (1999); found at bhj.org/journal/1999_4104_oct99/sp_659.htm.
Single-Pole and Multi-Pole Lightguides for UV Spot Light Curing Systems.
Sinusitis, Maxillary, Acute Surgical Treatment. Http://www.emedicine.com/ent/topic340.htm. Aug. 29, 2006. pp. 1-11.
Sobol, et al. ‘Sinusitis, Maxillary, Acute Surgical Treatment.’ eMedicine. Retrieved from the Internet: <<http://emedicine.medscape.com/article/862030-print>> (Nov. 16, 2010) pp. 1-11.
Stammberger, H. ‘Komplikationen entzundlicher Nasennebenhohlenerkrankungen eischließ iatrogen bedingter Komplikationen’ Eur Arch Oti-Rhino-Laryngol Supple. (Jan. 1993) pp. 61-102.
Stammberger, et al. Chapter 3 ‘Special Endoscopic Anatomy of the Lateral Nasal Wall and Ethmoidal Sinuses’ Functional Endoscopic Sinus Surgery. (1991) Ch. 3, pp. 49-87.
Strohm, et al. Die Behandlung von Stenosen der oberen Luftwege mittels rontgenologisch gesteuerter Ballondilation (Sep. 25, 1999) pp. 1-4.
Strohm, et al. ‘Le Traitenment des Stenoses Voies Aeriennes Superieures Par Dilation Ay Balloon’ Sep. 25, 1999.
Strohm, et al. ‘Treatment of Stenoses of the Upper Airways by Balloon Dilation’ Sudwestdeutscher Abstract 45 (Sep. 25, 1999) pp. 1-3.
SurgTrainer Product Information 2003, Surg Trainer, Ltd. Ibaraki, Japan.
SurgTrainer Product Information ‘Incisive Human Nasal Model for ESS Training’ Surg Trainer, Ltd. Ibaraki, Japan (2004) www1.accsnet.ne.jp/˜juliy/st/en/partslist.html.
Tabor, M.H. et al., ‘Symptomatic Bilateral Duct Cysts in a Newborn—Rhinoscopic Clinic’ Ear, Nose & Throat Journal (2003) www.findarticles.com/p/articles/mi_m0BUM/is_2_82/ai_98248244 pp. 1-3.
Tarasov, D.I. et al. ‘Application of Drugs Based on Polymers in the Treatment of Acute and Chronic Maxillary Sinusitis’ Vestn Otorinoloaringol. vol. 6 (1978) pp. 45-47.
Terumo. Medi-Tech. Boston Scientific. (1993) Ad of Glidewire.
The Operating Theatre Journal (www.otjonline.com) ‘Disposable Medical Device for Wound Disclosure/The Tristel Purple Promotion—A Collaboration between Tristel PLC and Karl Storz Endoscopy (UK) Ltd.’ p. 4.
Weber, R. et al. ‘Endonasale Stirnhohlenchirugie mit Langzeiteinlage eines Platzhalters’ Laryngol. Rhinol. Otol. vol. 76 (1997) pp. 728-734. (English Abstract).
Weber, R. et al., ‘Videoendoscopic Analysis of Nasal Steroid Distribution’ Rhinology. vol. 37 (1999) pp. 69-73.
Weiner, R.I., D.O., et al., ‘Development and Application of Transseptal Left Heart Catheterization’ Cathet. Cardiovasc. Diagn. (1988) vol. 15, No. 2, pp. 112-120.
Wiatrak, B.J., et al., ‘Unilateral Choanal Atresia: Initial Presentation and Endoscopic Repair’ International Journal of Pediatric Otorhinolaryngology (1998) vol. 46, pp. 27-35.
Woog, et al. ‘Paranasal Sinus Endoscopy and Orbital Fracture Repair’ Arch Ophthalmol. vol. 116 (May 1998) pp. 688-691.
Wormald, P.J., et al., ‘The ‘Swing-Door’ Technique for Uncinectomy in Endoscopic Sinus Surgery’ The Journal of Laryngology and Otology (1998) vol. 112, pp. 547-551.
Xomed-Treace. Bristol-Myers Squibb. Ad for Laser Shield II. Setting the Standards for Tomorrow, [date of publication unknown].
Yamauchi, Y. et al., ‘Development of a Silicone Model for Endoscopic Sinus Surgery’ Proc International Journal of Computer Assisted Radiology and Surgery vol. 99 (1999) p. 1039.
Yamauchi, Y., et al., ‘A Training System for Endoscopic Sinus Surgery with Skill Evaluation’ Computer Assisted Radiology and Surgery (2001) with accompanying poster presentation.
Yanagisawa et al. ‘Anterior and Posterior Fontanelles.’ Ear, Nose & Throat Journal (2001) vol. 80. pp. 10-12.
Zimarino, M., M.D., et al., ‘Initial Experience with the EuropassTM: A new Ultra-Low-Profile Monorail Balloon Catheter’ Cathet. Cardiovasc. Diagn. (1994) vol. 33, No. 1, pp. 76-79.
Australian Office Action, Examiners First Report dated Apr. 8, 2010 for Application No. AU 2005274794.
Australian Office Action, Examiners First Report dated Dec. 9, 2011 for Application No. AU 2006292818.
Australian Office Action dated Feb. 12, 2014 for Application No. AU 2012202103.
Australian Office Action dated Aug. 1, 2014 for Application No. AU 2012244072.
Australian Office Action dated Sep. 17, 2014 for Application No. AU 2012202103.
Australian Office Action dated Sep. 30, 2014 for Application No. AU 2009293312.
Australian Office Action dated Oct. 1, 2014 for Application No. AU 2009333010.
Australian Office Action dated Jul. 8, 2015 for Application No. AU 2012244072.
Canadian Office Action dated Jul. 10, 2015 for Application No. CA 2,617,054.
Dictonary.reference.com/browse/bent; Definition of “bent” as accessed on Sep. 10, 2015.
Canadian Office Action dated Jun. 20, 2016 for Application No. 2,617,054.
European Communication dated Jul. 14, 2017 for Application No. 06784759.0.
European Communication dated May 12, 2017 for Application No. 09792627.3.
European Communication dated Aug. 2, 2017 for Application No. 12173295.2.
Friedman, M., M.D., et al. ‘Frontal Sinus Surgery: Endoscopic Technique’ Operative Techniques in Otolarynology—Head and Neck Surgery. vol. 12, No. 2 (Jun. 2001) pp. 60-65.
Friedman, et al. ‘Intraoperative and Postoperative Assessment of Frontal Sinus Patency by Transillumination’ Laryngoscope. vol. 110 (Apr. 2000) pp. 683-684.
Friedman, et al. ‘Middle Turbinate Medialization and Preservation in Endoscopic Surgery’ Otolaryngology—Head and Neck Surgery. (2000) vol. 123, No. 1, part 1, pp. 76-80.
Fung, M.K.T. ‘Template for Frontal Osteoplastic Flap’ Laryngoscope. vol. 96 (1986) pp. 578-579.
Gatot, A. et al. ‘Early treatment of Orbital Floor Fractures with Catheter Balloon in Children’ Int J. Pediatric Otorhinolaryngol (1991) vol. 21 pp. 97-101.
Gerus, I.I. et al. ‘β-Ethoxyvinyl Polyfluroroalkyl Ketones—Versatile Synthones in Fluoroorganic Chemistry’ Journal of Fluorine Chemistry. Vol. 69 (1994) pp. 195-198. Elsevier Science S.A.
Good, R.H. ‘An Intranasal Method for Opening the Frontal Sinus Establishing the Largest Possible Drainage’ Laryngoscope. vol. 18 (1908) pp. 266-274.
Gopferich ‘Polymer Degradation and Erosion: Mechanisms and Application’ Eur. J. Parm. Biophar. vol. 42 (1996) pp. 1-11.
Gorlov, D.V. et al ‘Acylation of 2-Methoxypropene with Anhydrides and Halides of Perflurocarboxylic Acids in the Presence of Teriary Amines’ Russian Chemical Bulletin. Vol. 48 No. 9 (Sep. 1999) pp. 1791-1792. Kluwer Academic/Plenum Publishers.
Gottmann, et al. ‘Balloon Dilatation in the Nasal Cavity and Paranasal Sinuses’ CIRSE. (Sep. 25, 2004) pp. 1-27.
Gottmann, et al. ‘Balloon Dilatation of Recurrent Ostial Occlusion of the Frontal Sinus’ CIRSE Abstract (Mar. 2001) B-04353.
Gottman, et al., Balloon Dilatation of Recurrent Ostial Occlusion of the Front Sinus OASIS-Online Abstract Submission and Invitation System, 1996-2006, Coe Truman Technologies, Inc.
Gottmann, et al. ‘Successful Treatment of Recurrent Post-Operative Frontal Sinus Stenoses by Balloon Dilatation’ CIRSE. (Oct. 5, 2002).
Gottmann, D. ‘Treatment of Stenoses of Upper Air Routes by Balloon Dilation’ Proceeding of the 83rd Annual Convention of Association of West German ENT Physicians (1999).
Gupta, D. et al., ‘Dacrystitis Secondary to an Iatrogenic Foreign Body in the Lacrimal Apparatus’ Ear, Nose & Throat Journal (2009) www.findarticles.com/p/articles/mi_m0BUM/is_7_88/ai_n32428620/.
Hashim, et al. ‘Balloon Compression of the Intermaxillary Sinus for Intractable Post Traumatic Bleeding from the Maxillary Artery’ Scandinavian Journal of Plastic and reconstruction Surgery and Hand Surgery (1999) vol. 33 pp. 321-324.
Hojo, M. et al., ‘Electrophilic Substitutions of Olefinic Hydrogens II. Acylation of Vinyle Ethers and N Vinyl Amides Chemistry Letters’ (1976) pp. 499-502. Chemical Society of Japan.
Hopf, J.U.G. et al. ‘Miniature Endoscopes in Otorhinolaryngologic Applications’ Min Invas Ther & Allied Technol. (1998) vol. 7, No. 3 pp. 209-218.
Hosemann, W. et al. A Dissection Course on Endoscopic Endonasal Sinus Surgery (2005) Endo-Press, Tuttlingen pp. 4-37.
Hosemann, W. et al. ‘Endonasal Frontal Sinusotomy in Surgical Management of Chronic Sinusitis: A Critical Evaluation’ American Journal of Rhinology. vol. 11, No. 1 (1997) pp. 1-9.
Hosemann, M.E. et al. ‘Experimentelle Untersuchungen sur Wundheilung in den Nasennebenholhlen. II. Spontaner Wundschluss und medikamentose Effekte im standardisierten Wundmodell.’ HNO 39 (1991) pp. 48-54. ‘Experimental investigations on wound healing of the paranasal sinuses. II. Spontaneous wound closure and pharmacological effects in a standardized animal model.’ HNO 39 (1991) pp. 48-54.
Hosemann, W.G. et al. ‘Minimally Invasive Endonasal Sinus Surgery’ Thieme, Stuttgart, New York (2000).
Hosemann, M.E. et al. ‘Normal Wound Healing of the Paranasal Sinuses—Clinical and Experimental Investigations’ Eur Arch Otorhinolarygol. vol. 248, (1991) pp. 390-394.
Hosemann, W. et al. ‘Behandlung nach Nasennebenhohleneingriffen, part 2: Theapeutische Maßnahem’ HNO akutell 7 (1999) pp. 291-302.
Hospital Corpsman Sickcall Screener's Handbook. Naval Hospital Great Lakes (Apr. 1999) www.brooksidepress.org/Products/Operationa.Medicine/DATA. 2001 pp. 1-6.
Hybels, R.L. ‘Transillumination During Osteoplastic Frontal Sinusotomy’ The Laryngoscope. vol. 91 (Sep. 1981) pp. 1560.
Ijaduola, T.G.A. ‘Use of a Foley Catheter for Short-Term Drainage in Frontal Sinus Surgery’ The Journal of Laryngology and Otology. (1989) vol. 103. pp. 375.378.
Ingals, E.F. ‘New Operation and Instruments for Draining the Frontal Sinus’ Ann. Otol. Rhinol. Layyngol. vol. 14 (1905) pp. 644-649.
Iro, H. et al., ‘A New Device for Frontal Sinus Endoscopy: First Clinical Report’ Otolaryngol. Head Neck Surg. (2001) vol. 125 No. 6 pp. 613-616.
Jacobs, J.B. ‘100 Years of Frontal Sinus Surgery’ Laryngoscope. Vol. 107 (1997) pp. 1-36.
K-Splint Internal Nasal Splints; Jan. 25, 2007; www.invotec.net/rhinology/ksplint.html.
Kaiser, H. et al. ‘Cortizontherapie, Corticoide in Klinik und Praxis’ Thieme, Stuggart (1992) pp. 390-401.
Kennedy, D.W., M.D. et al. ‘Diseases of the Sinuses: Diagnosis and Management’ (Copyright 2001) by B.C. Decker Inc.
Khomutov, S.M. et al. ‘Dissolution of a Mixture of Steroids in Cyclodextrin Solutions: a Model Description’ Pharmaceutical Chemistry Journal. vol. 35, No. 11 (Nov. 2001) pp. 627-629.
Kingdom, T.T. et al. ‘Image-Guided Surgery of the Sinuses: Current Technology and Applications’ Otolaryngol. Clin. North Am. vol. 37, No. 2 (Apr. 2004) pp. 381-400.
Klossek, J.M. et al. ‘Local Safety of Intranasal Trimcinolone Acentonide: Clinical and Histological Aspects of Nasal Mucosa in the Long-Term Treatment of Perennial Allergic Rhinitis’ Rhinology. vol. 39, No. 1 (2001) pp. 17-22.
Kozlov et al. ‘Diagnosis and Treatment of Sinusitis by YAMIK Sinus Catheters’ Rhinology (1996) vol. 34, pp. 123-124.
Kuhn, et al. ‘The Agger Nasi Cell in Frontal Recess Obstruction: An Anatomic, Radiology and Clinical Correlation’ Operative Techniques in Otolaryngology-Head and Neck Surgery. vol. 2, No. 4 (1991) pp. 226-231.
Laliberte, F. et al. ‘Clinical and Pathologic Methods to Assess the Long-Term Safety of Nasal Corticosteroids’ Allergy. vol. 55, No. 8 (2000) pp. 718-722.
Lang, E.V., et al., ‘Access Systems for Puncture at an Acute Angle’ J. Vasc. Interv. Radiol. (1995) vol. 6, No. 5 pp. 711-713.
Lanza, D.C. ‘Postoperative Care and Avoiding Frontal Recess Stenosis’ Internatinal Advanced Sinus Symposium Jul. 21-24, 1993.
Large, G.C. ‘Crystalline Tetracycline Hydrochloride in the Treatment of Acute and Chronic Maxillary Sinusitis’ Canada. M.A.J. (1958) vol. 79 pp. 15-16.
Lund, V.J. ‘Maximal Medical Therapy for Chronic Rhinosinusitis’ Otolaryngol Clin N. Am. vol. 38 (2005) pp. 1301-1310.
Maran, A.G.D. et al. ‘The Use of the Foley Balloon Catheter in the Tripod Fracture’ J. Laryngol. Otol. (1971) vol. 85, Issue 9, pp. 897-902.
May, M. et al. ‘Frontal Sinus Surgery: Endonasal Drainage Instead of an External Osteopolstic Approach’ Op Tech Otolaryngo Head Neck Surgery. 6 (1995) pp. 184-192.
Medtronic, xomed.com-MicroFrance Catalog Browser. Www.xomcat.com/xomfrance/index.php?zone=both&cat=18&sub=58&prodline=1272 (Dec. 31, 2003) pp. 1-2.
Mehan, V.K. et al., ‘Coronary Angioplasty through 4 French Diagnostic Catheters’ Cathet. Cardiovasc. Diagn. (1993) vol. 30, No. 1 pp. 22-26.
Mellor, J.M. et al ‘Synthesis of Trifluromethylnaphthalenes’ Tetrahedron. vol. 56 (2000) pp. 10067-10074. Elsevier Science Ltd.
Merriam-Webster definition of “lumen” as accessed Jun. 10, 2016, http://www.merriam-webster.com/dictionary/lumen.
Metson, R., et al., ‘Endoscopic Treatment of Sphenoid Sinusitis’ Otolaryngol. Head Neck Surg. (1996) vol. 114, No. 6 pp. 736-744.
Metson, R. ‘Holmium: YAG Laser Endoscopic Sinus Surgery: A Randomized Controlled Study’ Laryngoscope. vol. 106, Issue 1, Supplement 77 (Jan. 1996) pp. 1-18.
Miller, et al. ‘Management of Fractures of the Supraorbital Rim’ Journal of Trauma. vol. 18, No. 7 (Jul. 1978) pp. 507-512.
Min, Y-G et al. ‘Mucociliary Activity and Histopathology of Sinus Mucosa in Experimental Maxilary Sinusitis: A Comparison of Systemic Administration of Antibiotic and Antibiotic Delivery by Polylactic Acid Polymer’ Laryngoscope. vol. 105 (Aug. 1995) pp. 835-842.
Mols, B. ‘Movable Tool Tip for Keyhole Surgery’ Delft Outlook, vol. 3 (2005) pp. 13-17.
Mooney, M.R., et al., ‘Monorail™ Piccolino Catheter: A New Rapid Exchange/Ultralow Profile Coronary Angioplasty System’ Cathet. Cardiovasc. Diagn. (1990) vol. 20, No. 2 pp. 114-119.
Moriguchi, T. et al. ‘Additional-Elimination Reaction in the Trifluoroacetylation of Electron-Rich Olefins’ J. Org. Chem. vol. 60, No. 11 (1995) pp. 3523.3528. American Chemical Society.
Nasal Surgery and Accessories, Jan. 25, 2007; www.technologyforlife.com.au/ent/nasal.html.
Park, K. et al. ‘Biodegradable Hydrogels for Durg Delivery’ (1993) Technomic Publishing Inc. Lancaster.
Piccirillo, J.F. et al. ‘Physchometric and Clinimetric Validity of the 20-Item Sino-Nasal Outcome test (SNOT-20)’ Copyright 1996 Washington University, St. Louis, MO.
Piers, et al. ‘A Flexible Distal Tip with Two Degrees of Freedom for Enhanced Dexterity in Endoscopic Robot Surgery’ Proceedings 13th Micromechanics Europe Workshop (2002) pp. 271-274.
Podoshin, L et al. ‘Balloon Technique for Treatment of Frontal Sinus Fractures’ The journal of Laryngology & Otology (1967), vol. 81. pp. 1157-1161.
Pownell, P.H. et al., ‘Diagnostic Nasal Endoscopy’ plastic & Reconstructive Surgery (1997) vol. 99, Iss5 pp. 1451-1458.
Prince, et al. ‘Analysis of the Intranasal Distribution of Ointment’ J Otolaryngol. vol. 26 (1997) pp. 357-360.
Ramsdale, D.R., Illustrated Coronary Intervention: A case-oriented approach, (2001) Martin Dunitz Ltd. pp. 1-5.
Ritter, F.N. et al., Atlas of Paranasal Sinus Surgery (1991) Igaku-Shoin Medical Pub. pp. 1-81.
Robison, J. Mathews, M.D. ‘Pressure Treatment of Maxillary Sinusitis’ J.A.M.A. (May 31, 1952) pp. 436-440.
Robison, J. Mathews, M.D. ‘Pressure Treatment of Purulent Maxillary Sinusitis’ TEXAS State Journal of Medicine (May 1952) pp. 281-288.
St. Croix et al. ‘Genes Expressed in Human Tumor Endothelium’ Science, vol. 289 (May 15, 2000) pp. 1197-1202.
Sama, A., et al., ‘Current Opinions on the Surgical Management of Frontal Sinus Disease’ ENT News. Www.pinpointmedical.com/ent-news (2009) vol. 17, No. 6 pp. 60-63.
Canadian Office Action dated Dec. 16, 2015 for Application No. CA 2,751,665.
Chinese Office Action, First Office Action dated Nov. 5, 2012 for CN 200980137396.1.
Chinese Search Report dated Oct. 29, 2012 for Application No. CN 200980137396.1.
Chinese Search Report dated Jan. 11, 2013 for Application No. CN 200980152995.0.
Chinese Office Action, First Office Action dated Jan. 29, 2013 for CN 200980152995.1.
Chinese Office Action, Decision of Rejection, dated 2014 for Application No. CN 200980152995.1.
Chinese Office Action, Third Office Action, dated Feb. 27, 2014 for Application No. CN 200980152995.1.
Chinese Office Action and Search Report dated Jan. 21, 2015 for Application No. CN 201310672731.6.
European Communication dated Sep. 4, 2008 for Application No. EP 05773189.
European Communication dated Jun. 19, 2009 for Application No. EP 05773189.
European Communication dated Sep. 27, 2011 for Application No. EP 06800540.4.
European Communication dated Aug. 1, 2012 for Application No. EP 06784759.0.
European Communication dated Aug. 24, 2012 for Application No. EP 05798331.4.
European Communication dated Nov. 9, 2012 for Application No. EP 07750248.2.
European Communication dated Apr. 19, 2012 for Application No. EP 08746715.5.
European Communication dated Jan. 7, 2013 for Application No. EP 08746715.5.
European Communication dated Apr. 11, 2013 for Application No. EP 05778834.1.
European Communication dated May 10, 2013 for Application No. EP 06751637.7.
European Communication dated Sep. 3, 2013 for Application No. EP 12182998.0.
European Communication dated Feb. 26, 2014 for Application No. EP 06800540.4.
European Communication dated Aug. 11, 2014 for Application No. EP 12182998.0.
European Communication dated Aug. 26, 2014 for Application No. EP 12183000.4.
European Communication dated Nov. 26, 2014 for Application No. EP 07836108.6.
European Communication dated Feb. 17, 2016 for Application No. EP 12162712.9.
European Exam Report dated Feb. 22, 2006 for Application No. EP 02716734.5.
European Exam Report dated Feb. 8, 2007 for Application No. EP 02716734.5.
European Search Report and Written Opinion dated Sep. 11, 2009 for Application No. EP 06815174.
European Search Report dated Mar. 16, 2010 re Application No. EP 06718986.
European Search Report dated Sep. 27, 2011 for Application No. EP 10182961.
European Search Report dated Sep. 29, 2011 for Application No. EP 10182893.
European Search Report dated Jul. 23, 2012 for Application No. EP 12162709.
European Search Report dated Jul. 24, 2012 for Application No. EP 12162712.
European Search Report dated Aug. 31, 2012 for Application No. EP 12173295.
European Search Report dated Oct. 10, 2012 for Application No. EP 12175607.
European Search Report dated Nov. 22, 2012 for Application No. EP 12182993.
European Search Report dated Dec. 5, 2012 for Application No. EP 12182998.
European Search Report dated Jan. 9, 2013 for Application No. EP 12183000.
European Search Report dated Jan. 11, 2013 for Application No. EP 12183002.
European Search Report dated Aug. 13, 2013 for Application No. EP 13172140.
European Search Report dated Sep. 9, 2013 for Application No. EP 13179223.
European Search Report dated May 19, 2015 for Application No. EP 08746464.0.
European Search Report dated Jun. 23, 2015 for Application No. EP 12162712.9.
European Search Report dated Jun. 23, 2015 for Application No. EP 12162709.5.
Extended European Search Report dated Jan. 17, 2014 for Application No. EP 108426321.1.
Extended European Search Report dated Sep. 15, 2015 for Application No. EP 15163549.7.
Partial European Search Report dated Sep. 20, 2007 for Application No. EP 07252018.
Partial European Search Report dated Mar. 25, 2008 for Application No. EP 07252018.
Supplemental Partial European Search Report dated Jun. 2, 2008 for Application No. EP 05773189.
Supplemental Partial European Search Report dated Jul. 1, 2009 for Application No. EP 06815285.
Supplemental Partial European Search Report dated Nov. 19, 2010 for Application No. EP 06751637.
Supplemental European Search Report dated Jan. 29, 2010 for Application No. EP 07836108.
Supplemental European Search Report dated Feb. 2, 2010 for Application No. EP 07836109.
Supplemental European Search Report dated Feb. 17, 2010 for Application No. EP 07836110.
Supplemental European Search Report dated Mar. 1, 2010 for Application No. EP 05778834.
Supplemental European Search Report dated Mar. 16, 2010 for Application No. EP 06718986.
Supplemental European Search Report dated Jun. 22, 2010 for Application No. EP 06784759.
Supplemental European Search Report dated Sep. 23, 2010 for Application No. EP 08746715.
Supplemental European Search Report dated Jan. 28, 2011 for Application No. EP 07777004.
Supplemental European Search Report dated Mar. 31, 2011 for Application No. EP 05798331.
Supplemental European Search Report dated Aug. 30, 2011 for Application No. EP 06800540.
Supplemental European Search Report dated Sep. 29, 2011 for Application No. EP 07750248.
Supplemental European Search Report dated Jan. 14, 2014 for Application No. EP 13184009.
Supplemental European Search Report dated Jan. 17, 2014 for Application No. EP 1084263.
Supplemental European Search Report dated Dec. 9, 2014 for Application No. EP 07839152.
Supplemental European Search Report dated Feb. 13, 2014 for Application No. EP 08746464.
European Communication dated Sep. 26, 2016 for Application No. EP 12162712.9.
Extended European Search Report dated Jun. 28, 2017 for Application No. EP 17159646.3.
Supplemental European Search Report and Written Opinion dated Sep. 8, 2011 for EP 06800540.4.
Supplemental European Search Report dated Mar. 24, 2010 for Application No. EP 07836108.6.
Supplemental European Search Report dated Feb. 27, 2014 for Application No. EP 08746464.0.
PCT Search Report dated Nov. 30, 2009 for Application No. UPCT/US2009/057203.
International Preliminary Report on Patentability dated Aug. 7, 2006 for Application No. PCT/US05/25371.
International Preliminary Report on Patentability and Written Opinion dated Sep. 25, 2007 for Application No. PCT/US06/002004.
International Preliminary Report on Patentability dated Feb. 15, 2008 for Application No. PCT/US05/13617.
International Preliminary Report on Patentability and Written Opinion dated Nov. 18, 2008 for Application No. PCT/US07/11449.
International Preliminary Report on Patentability and Written Opinion dated Apr. 7, 2009 for Application No. PCT/US07/021170.
International Preliminary Report on Patentability and Written Opinion dated May 5, 2009 for Application No. PCT/US06/036960.
International Preliminary Report on Patentability and Written Opinion dated Oct. 13, 2009 for Application No. PCT/US08/059786.
International Preliminary Report on Patentability and Written Opinion dated Oct. 27, 2009 for Application No. PCT/US08/061343.
International Preliminary Report on Patentability dated Jun. 29, 2011 for Application No. PCT/US2009/069143.
International Search Report dated Jun. 3, 2002 for Application No. PCT/EP02/01228.
International Search Report and Written Opinion dated Apr. 10, 2006 for Application No. PCT/US05/25371.
International Search Report dated May 8, 2007 for Application No. PCT/US2006/16026.
International Search Report dated Aug. 17, 2007 for Application No. PCT/US05/013617.
International Search Report dated Aug. 29, 2007 for Application No. PCT/US06/002004.
International Search Report dated Sep. 25, 2007 for Application No. PCT/US06/037167.
International Search Report dated Oct. 19, 2007 for Application No. PCT/US07/003394.
International Search Report dated May 29, 2008 for Application No. PCT/US07/021170.
International Search Report dated May 29, 2008 for Application No. PCT/US07/021922.
International Search Report dated Jul. 1, 2008 for Application No. PCT/US06/022745.
International Search Report dated Jul. 3, 2008 for Application No. PCT/US2006/029695.
International Search Report dated Jul. 7, 2008 for Application No. PCT/US07/016213.
International Search Report dated Jul. 8, 2008 for Application No. PCT/US07/011474.
International Search Report dated Jul. 17, 2008 for Application No. PCT/US06/036960.
International Search Report and Written Opinion dated Jul. 21, 2008 for Application No. PCT/US05/033090.
International Search Report dated Aug. 25, 2008 for Application No. PCT/US2008/000911.
International Search Report dated Sep. 10, 2008 for Application No. PCT/US07/016212.
International Search Report and Written Opinion dated Sep. 12, 2008 for Application No. PCT/US07/16214.
International Search Report and Written Opinion dated Sep. 17, 2008 for Application No. PCT/US08/059786.
International Search Report and Written Opinion dated Sep. 17, 2008 for Application No. PCT/US08/061343.
International Search Report and Written Opinion dated Oct. 1, 2008 for Application No. PCT/US07/011449.
International Search Report dated Oct. 15, 2008 for Application No. PCT/US2008/061048.
International Search Report dated Nov. 30, 2009 for Application No. PCT/US2009/057203.
International Search Report dated Dec. 10, 2009 for Application No. PCT/US2009/052236.
International Search Report dated Dec. 16, 2009 for Application No. PCT/US2009/050800.
International Search Report dated Mar. 31, 2010 for Application No. PCT/US2009/069143.
International Search Report dated Jul. 8, 2010 for Application No. PCT/US2010/027837.
International Search Report and Written Opinion dated Oct. 6, 2010 for Application No. PCT/US2010/040548.
International Search Report dated Mar. 25, 2011 for Application No. PCT/US2010/062161.
International Search Report dated Mar. 28, 2011 for Application No. PCT/US2010/061850.
International Search Report dated Mar. 31, 2011 for Application No. PCT/US2010/060898.
International Search Report dated Aug. 9, 2011 for Application No. PCT/US2011/038751.
International Search Report dated May 18, 2012 for Application No. PCT/US2011/052321.
International Written Opinion dated Aug. 9, 2011 for Application No. PCT/US2011/038751.
Partial International Search Report dated Feb. 7, 2012 for Application No. PCT/US2011/052321.
Japanese Office Action, Examiner's Decision of Refusal dated Oct. 18, 2011 for Application No. JP 2007-509632.
Japanese Office Action, Notification of Reasons for Refusal dated Apr. 26, 2011 for Application No. JP 2007-532485.
Japanese Office Action, Notification of Reasons for Refusal dated Jan. 24, 2012 for Application No. JP 2007-532485.
Japanese Office Action, Notification of Reasons for Refusal dated Aug. 16, 2011 for Application No. JP 2008-516013.
Japanese Office Action, Notification of Reasons for Refusal dated Nov. 8, 2011 for Application No. JP 2008-524250.
Japanese Office Action, Notification of Reasons for Refusal dated Jun. 25, 2013 for Application No. JP 2012-131840.
Japanese Office Action, Notification of Reasons for Refusal dated Sep. 18, 2013 for Application No. JP 2011-527942.
Japanese Office Action, Notification of Reasons for Refusal dated Nov. 12, 2013 for Application No. JP 2011-542562.
Japanese Office Action, Notification of Reasons for Refusal dated Jan. 7, 2014 for Application No. JP 2012-266049.
Japanese Office Action, Reasons for Refusal, dated Sep. 2, 2014 for Application No. JP 2012-544859.
Japanese Office Action, Reasons for Refusal, dated Jun. 9, 2015 for Application No. JP 2014-147174.
Japanese Office Action, Notification of Reasons for Refusal dated Mar. 29, 2016 for Application No. JP 2012-266049.
Russian Office Action dated Sep. 28, 2012 for Application No. RU 2011130530.
Russian Office Action dated Mar. 19, 2013 for Application No. RU 2011130530.
USPTO Office Action dated Sep. 16, 2005 for Application No. U.S. Appl. No. 10/259,300.
USPTO Office Action dated Jul. 7, 2006 for Application No. U.S. Appl. No. 10/259,300.
USPTO Office Action dated Feb. 13, 2007 for Application No. U.S. Appl. No. 10/259,300.
USPTO Office Action dated Oct. 9, 2007 for Application No. U.S. Appl. No. 10/259,300.
USPTO Office Action dated Jan. 24, 2008 for Application No. U.S. Appl. No. 10/259,300.
USPTO Office Action dated Oct. 6, 2008 for Application No. U.S. Appl. No. 10/259,300.
USPTO Office Action dated May 29, 2007 for Application No. U.S. Appl. No. 10/912,578.
USPTO Office Action dated Nov. 14, 2007 for Application No. U.S. Appl. No. 10/912,578.
USPTO Office Action dated Dec. 10, 2007 for Application No. U.S. Appl. No. 10/912,578.
USPTO Office Action dated Oct. 18, 2007 for Application No. U.S. Appl. No. 11/037,548.
USPTO Office Action dated Dec. 6, 2007 for Application No. U.S. Appl. No. 11/037,548.
USPTO Office Action dated Apr. 9, 2008 for Application No. U.S. Appl. No. 11/037,548.
USPTO Office Action dated Nov. 28, 2007 for Application No. U.S. Appl. No. 11/234,395.
USPTO Office Action dated Sep. 12, 2008 for Application No. U.S. Appl. No. 10/829,917.
USPTO Office Action dated Nov. 17, 2008 for Application No. U.S. Appl. No. 10/829,917.
USPTO Office Action dated Mar. 18, 2009 for Application No. U.S. Appl. No. 10/829,917.
USPTO Office Action dated Nov. 9, 2009 for Application No. U.S. Appl. No. 10/829,917.
USPTO Office Action dated Oct. 29, 2008 for Application No. U.S. Appl. No. 11/347,147.
USPTO Office Action dated Feb. 4, 2009 for U.S. Appl. No. 11/347,147.
USPTO Office Action dated Aug. 6, 2009 for U.S. Appl. No. 11/347,147.
USPTO Office Action dated Nov. 7, 2008 for U.S. Appl. No. 10/944,270.
USPTO Office Action dated Jan. 28, 2009 for U.S. Appl. No. 10/944,270.
USPTO Office Action dated Apr. 21, 2009 for U.S. Appl. No. 10/944,270.
USPTO Office Action dated Nov. 17, 2008 for U.S. Appl. No. 12/117,582.
USPTO Office Action dated Mar. 3, 2009 for U.S. Appl. No. 12/117,582.
USPTO Office Action dated Aug. 6, 2009 for U.S. Appl. No. 12/117,582.
USPTO Office Action dated Nov. 17, 2008 for U.S. Appl. No. 12/118,931.
USPTO Office Action dated Mar. 4, 2009 for U.S. Appl. No. 12/118,931.
USPTO Office Action dated Jul. 30, 2009 for U.S. Appl. No. 12/118,931.
USPTO Office Action dated Nov. 25, 2008 for U.S. Appl. No. 12/117,961.
USPTO Office Action dated Aug. 6, 2009 for U.S. Appl. No. 12/117,961.
USPTO Office Action dated Dec. 5, 2008 for U.S. Appl. No. 12/120,902.
USPTO Office Action dated Oct. 21, 2009 for U.S. Appl. No. 12/120,902.
USPTO Office Action dated Mar. 17, 2009 for U.S. Appl. No. 11/690,127.
USPTO Office Action dated Mar. 23, 2009 for U.S. Appl. No. 11/804,309.
USPTO Office Action dated Mar. 23, 2009 for U.S. Appl. No. 11/926,326.
USPTO Office Action dated Aug. 28, 2009 for U.S. Appl. No. 11/150,847.
USPTO Office Action dated Dec. 29, 2008 for U.S. Appl. No. 11/193,020.
USPTO Office Action dated May 13, 2009 for U.S. Appl. No. 11/193,020.
U.S. Appl. No. 60/844,874, filed Sep. 15, 2006.
U.S. Appl. No. 60/922,730, filed Apr. 9, 2007.
U.S. Appl. No. 61/052,413, filed May 12, 2008.
U.S. Appl. No. 61/084,949, filed Jul. 30, 2008.
U.S. Appl. No. 11/789,705, filed Apr. 24, 2007.
U.S. Appl. No. 11/804,308, filed May 16, 2007.
U.S. Appl. No. 11/804,309, filed May 16, 2007.
U.S. Appl. No. 14/221,550, filed Mar. 21, 2014.
U.S. Appl. No. 14/221,621, filed Mar. 21, 2014.
U.S. Appl. No. 14/221,714, filed Mar. 21, 2014.
U.S. Appl. No. 14/265,888, filed Apr. 30, 2014.
U.S. Appl. No. 14/266,002, filed Apr. 30, 2014.
U.S. Appl. No. 14/266,025, filed Apr. 30, 2014.
U.S. Appl. No. 14/327,593, filed Jul. 10, 2014.
U.S. Appl. No. 14/464,948, filed Aug. 21, 2014.
U.S. Appl. No. 14/993,444, filed Jan. 12, 2016.
U.S. Appl. No. 15/083,826, filed Mar. 29, 2016.
U.S. Appl. No. 15/187,938, filed Jun. 21, 2016.
U.S. Appl. No. 15/624,111, filed Jun. 15, 2017.
U.S. Appl. No. 16/747,592, filed Jan. 21, 2020.

Related Publications (1)

	Number	Date	Country
	20200114132 A1	Apr 2020	US

Continuations (4)

	Number	Date	Country
Parent	15651101	Jul 2017	US
Child	16672702		US
Parent	14221550	Mar 2014	US
Child	15651101		US
Parent	11928097	Oct 2007	US
Child	14221550		US
Parent	11150847	Jun 2005	US
Child	11928097		US

Continuation in Parts (2)

	Number	Date	Country
Parent	10944270	Sep 2004	US
Child	11150847		US
Parent	10829917	Apr 2004	US
Child	10944270		US

Devices, systems and methods useable for treating sinusitis

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

Agents

CPC

Field of Search

US

International Classifications

Term Extension

Abstract